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Left ventricular (LV) contraction dyssynchrony is common among patients with heart failure and 
is often associated with significantly greater cardiac risks.  Cardiac resynchronization therapy 
(CRT) is clinically used to treat dyssynchrony by simultaneously activating the ventricles using a 
cardiac pacemaker.  Although a promising therapy, ~30% of patients fail to respond to CRT, 
possibly due to the following issues: limited knowledge regarding mechanisms underlying the 
detrimental mechano-energetic effects of dyssynchrony, lack of robust algorithms for 
quantifying dyssynchrony, and inadequate patient selection criteria.  The goal of the present 
research was to address some of these issues. 
In an isolated heart model, dyssynchrony resulted in depressed LV mechanical function 
and increased myocardial oxygen consumption.  This adverse mechano-energetic effect of 
dyssynchrony can be reconciled by the hypothesis that the observed mechanical activity at the 
global level underestimated internal cellular work, which is likely to be the true determinant of 
myocardial oxygen consumption. 
Using data from canine models, cross-correlation analysis was developed to quantify 
dyssynchrony, both at the integrated and segmental levels.  This fully automated, robust tool 
took into account the entire systolic portion of the cardiac cycle.  As a result, this methodology 
was associated with less intra-group variability compared to current methods that focus on 
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manually chosen time points, which are subject to user interpretability.  The segmental cross-
correlation analysis provided insight into the integrated LV contraction pattern. 
Changes in radial synchrony did not always predict changes in global LV function.  For 
example, in some instances, global LV depression was associated with longitudinal 
dyssynchrony and preserved radial synchrony, indicating that multi-faceted dyssynchrony 
analysis is necessary for comprehensive evaluation of contraction. 
In a chronic canine model, dyssynchrony and its adverse functional effects were 
exaggerated as heart failure progressed.  In contrast, resynchronization using LV free-wall 
pacing was equally efficacious regardless of the degree of heart failure. 
Preliminary clinical studies indicated that dyssynchrony was better characterized using 
cross-correlation analysis compared to standard indices.  Although these results are promising, 
additional studies with a larger patient cohort is necessary to translate cross-correlation analysis 
into the clinical realm as a standard tool to quantify dyssynchrony and identify patients for CRT. 
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1.0  INTRODUCTION 
1.1 CLINICAL RELEVANCE 
Effective myocardial contraction requires the synchronization of individual elements in the 
ventricular wall.  Disruption in normal contraction synchrony of the left ventricular (LV) wall 
can result from electrical and/or structural abnormalities.  Regardless of the underlying etiology, 
disruption of normal electrical conduction introduces mechanical disturbances in the intrinsic 
contraction pattern of the LV.  Clinically coined LV contraction dyssynchrony, this condition is 
common among patients with systolic heart failure and is often associated with significantly 
greater cardiac risks by exacerbating cardiac depression [1].  With dyssynchrony, individual 
regions of the LV reach their maximum shortening at different times, resulting in depression of 
global LV performance (e.g., decreased ejection fraction).  Furthermore, dyssynchrony adversely 
affects global LV energetic function, presumably by increasing oxygen consumption through the 
competing regions.  For the past decade, cardiac resynchronization therapy (CRT) has been 
clinically used to treat contraction dyssynchrony by simultaneously activating the left and right 
ventricles using a pacemaker device (i.e., biventricular pacing; Figure 1-1) [2].  Clinical 
indications for CRT include NYHA functional class III or IV heart failure, LV ejection fraction 
(EF) ≤ 35%, and QRS duration greater than 120 ms [2].  The goal of CRT is to improve global 
LV performance and energetic function by resynchronizing the ventricles. 
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 Figure 1-1. Biventricular pacing device for cardiac resynchronization therapy. 
 
CRT provides atrial-synchronized, biventricular pacing using standard pacing technology.  Following a sensed atrial 
contraction or atrial-paced event, both ventricles are stimulated to synchronize their contraction [3]. 
 
1.2 SPECIFIC AIMS 
Although CRT has shown to improve functional status and survival [4-11], about 30% of 
patients still do not respond to this therapy [12].  The following factors may contribute to this 
variability in benefit: (1) limited knowledge regarding the mechanisms underlying the 
detrimental mechano-energetic effects of dyssynchrony and the beneficial effects of CRT; (2) 
lack of robust algorithms for quantifying dyssynchrony and identifying the optimal pacing site(s) 
that improve synchrony and LV function; (3) improper criteria for patient selection; (4) 
inconsistencies in the identification of improvement or response; and (5) limited choices of 
pacing sites available in the clinical setting.  The goal of the current thesis is to address some of 
these issues.  Specifically, are aims are as follows: 
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Aim 1. Assess the impact of LV dyssynchrony on global left ventricular mechano-energetic 
function in a Langendorff isolated rabbit heart preparation.  This study is expected to 
provide insight into the mechanism behind increased myocardial oxygen consumption 
with dyssynchronous contraction. 
Aim 2. Develop an efficient, robust clinical tool to quantify dyssynchrony and identify 
responders for CRT.  Current methods use only a single point in the cardiac cycle; 
however, our newly developed tool (cross-correlation analysis) will use a novel algorithm 
that assesses the entire systolic period for a more vigorous approach to quantify 
dyssynchrony. 
Aim 3. Investigate the link between regional and global LV function under different contraction 
patterns induced by ventricular pacing at various sites.  Establishment of this link may 
help to identify responders for CRT. 
Aim 4. Apply cross-correlation analysis to a multi-plane dataset to quantify synchrony for a 
comprehensive characterization of regional LV function.  In addition, we plan to 
construct a color-coded “bull’s eye” representation of synchrony indices to facilitate 
physician interpretation in quantifying dyssynchrony and optimizing pacing sites for 
CRT. 
Aim 5. Assess global LV function and synchrony patterns in a tachycardia pacing-induced model 
of heart failure.  Compared to a healthy heart, we anticipate unique changes in regional 
and global LV function with a failing heart. 
Aim 6. Extend our analyses into the clinical realm by assessing the efficacy of cross-correlation 
analysis in a select cohort of human patients. 
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2.0  BACKGROUND 
2.1 THE INTRINSIC CONDUCTION PATHWAY AND NORMAL CONTRACTION 
PATTERNS 
The myocardium has a specialized excitatory and conductive system that activates and controls 
cardiac contraction.  Normal electrical conduction begins in the right atria where autorhythmic 
cells of the sinoatrial (SA) node create spontaneous impulses (Figure 2-1).  Inherent leaky 
sodium-calcium ion channels cause the SA node to self-excite and therefore serve as the natural 
pacemaker of the heart [13].  Rhythmic impulses of the SA node immediately spread and activate 
the atrial tissue through internodal pathways (Figure 2-1).  Concordant with atrial contraction, 
the action potentials from the SA node spread to the atrioventricular (AV) node.  A delay in 
electrical conduction is then caused by a decrease in gap junctions between successive cells at 
the AV node.  This delay is necessary to allow sufficient time for the atria to eject all blood into 
the ventricles.  Following the AV delay, the electrical impulse rapidly splits into the right and left 
bundle branches of the His-Purkinje system located in the subendocardium of the ventricular 
septum (Figure 2-1).  The right and left bundle branches spread distally to the apex then turn 
towards the free-wall of the respective ventricle about one-third from the ventricular apex.  
Importantly, the conduction velocity of the specialized Purkinje system is significantly faster 
than that of myocardial muscle to ensure rapid and concordant activation of the left and right 
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ventricles for synchronous contraction [13].  Once the electrical impulse exits the Purkinje 
system, the impulse is transmitted through gap junctions in the myocardial muscle.  The impulse 
is transmitted from the apex to the base as well as from the subendocardium to the epicardium of 
the ventricles. 
 
Figure 2-1. Intrinsic conduction pathway of the myocardium. 
 
Intrinsic conduction initiates at the sinus node and travels through the internodal pathways to the atrio-ventricular 
(A-V) node. After a delay at the A-V node, conduction travels through the A-V bundle where it is split at the left 
and right bundle branches [13]. 
 
The inherent contraction pattern of the left ventricle follows that of the electrical 
activation sequence (i.e., from apex to base).  If the electrical activation is uninterrupted, the 
ventricle contracts, moving blood from the apex towards the base where it is ejected out of the 
ventricle into the arterial circulation.  Contraction involves shortening in the radial, 
circumferential, and longitudinal directions along the helical course of the myocardial fibers.  
For example, the apex has mostly circumferentially oriented fibers from the endocardium to the 
epicardium, whereas fibers near the base are arranged obliquely on the epicardium, 
circumferentially in the middle layer, and longitudinally in the endocardium [14].  It is essential 
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that the ventricle maintains this pattern of contraction to efficiently eject blood into the arterial 
circulation to deliver vital nutrients to itself and the body.  Any disturbance in this inherent 
contraction pattern may lead to inefficient ejection and decreased ventricular performance. 
2.2 THE DISEASE: DISTURBANCES IN ELECTRICAL PROPAGATION LEAD TO 
MECHANICAL DYSSYNCHRONY 
A disturbance in the rapid conduction system (i.e., His-Purkinje system) causes abnormal 
impulse propagation and subsequently dyssynchronous activation of the left ventricle.  
Alterations in the His-Purkinje system include left bundle branch block (LBBB) and other intra-
ventricular conduction defects, manifested as widening of the QRS complex [15].  A disturbance 
in conduction can also be caused by structural abnormalities including functional changes of the 
myocardium induced by dilated cardiomyopathy and ischemic disease [16, 17].  Importantly, the 
conduction through the LV is up to four times slower than the rapid His-Purkinje system[18], 
resulting in heterogeneous mechanical activation of the LV.  When the electrical wavefront 
cannot propagate through the His-Purkinje system, it is forced to travel through the slow 
conducting myocardium.  For example, with LBBB, the right ventricle is activated before the 
LV.  The imbalance of mechanical activation begins with pre-systolic septal contraction, 
followed by late LV contraction with paradoxical movement of the septum toward the RV, and a 
final septal motion towards the LV now against a higher load [19, 20].  Instead of producing an 
efficient output, this dyssynchronous wall motion causes substantial volume shifts within the LV 
cavity, resulting in a decrease in cardiac performance.  Even with an intact His-Purkinje system, 
electrical propagation can be inhibited by scar tissue and therefore must find an alternate 
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pathway, which also leads to heterogeneous activation patterns.  Regardless of the cause, an 
electrical disturbance results in abnormal conduction and subsequent mechanical dyssynchrony, 
where blood is no longer efficiently moved out of the left ventricle, compromising global LV 
function. 
2.3 TREATMENT FOR LEFT VENTRICULAR DYSSYNCHRONY IN THE 
SETTING OF HEART FAILURE 
Cardiac resynchronization therapy is suggested for a subset of heart failure patients with cardiac 
dyssynchrony defined as prolonged QRS duration [2].  CRT is implemented via atrial-
synchronized biventricular (right and left ventricular) electrical stimulation using a pacemaker 
device (Figure 1-1).  Standard transvenous leads are position in the right atrial (RA) appendage 
and right ventricular (RV) apex, but implantation of the LV lead is more complicated.  The LV 
lead is inserted into a cardiac vein via the coronary sinus, with the goal of placing the lead tip on 
the LV free-wall at a mid-cardiac position with adequate physical and electrical separation from 
the RV lead [8, 21, 22].  However, due to considerable variability in the coronary venous 
anatomy [23], optimal lead position may not be feasible.  In this case, a surgical epicardial 
approach through a limited thoracotomy may be more appropriate.  Once the leads are positioned 
and attached to a specialized pacemaker device and all parameters are optimized, CRT can be 
implemented to resynchronize contraction of the ventricles and improve cardiac function. 
Large randomized clinical trials have demonstrated the beneficial effects on LV systolic 
function and heart failure symptoms [4, 5, 7-9, 11].  The inclusion criteria for these trials were: 
(1) NYHA functional class III or IV heart failure; (2) depressed systolic function with ejection 
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fraction ≤ 35%; and (3) QRS complex >120 ms.  Despite promising results from large 
randomized clinical trials, a large percentage of patients (~30%) do not benefit from this therapy.  
Importantly, this variability in benefit may be a result of the poor dyssynchrony selection 
criterion: electrical dyssynchrony manifested as a wide QRS. 
2.4 ELECTRICAL VS. MECHANICAL DYSSYNCHRONY 
Currently, cardiac dyssynchrony is defined as an interventricular electrical delay between the left 
and right ventricles [2].  However, increasing evidence has shown that a poor correlation exists 
between immediate response to CRT and either basal QRS duration [24] or a decrease in QRS 
duration after CRT [25].  Therefore, electrical dyssynchrony is not a robust criterion to identify 
patients likely to benefit from CRT. 
Contraction dyssynchrony can be thought of as a “disconnect” between electrical 
activation and mechanical response where inhibition of conduction (e.g., LBBB) results in 
dyssynchronous mechanical response.  Likewise, disparities can also exist in the electrical 
pathway which lead to dyssynchronous mechanical activation.  Regardless, the deleterious effect 
of dyssynchrony is mainly caused by disparities in the LV contraction pattern.  Since CRT 
should theoretically improve or restore contraction, it is reasonable to postulate that a mechanical 
marker of dyssynchrony may be a more accurate criterion for this therapy.  Surprisingly, in early 
clinical trials, only one study used a mechanical marker of LV dyssynchrony as an inclusion 
criteria for CRT [12].  More recently, increasing evidence has shown that mechanical 
dyssynchrony better predicts short-term [24] and long-term [26-29] response to CRT.  Although 
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the paradigm has now shifted to using mechanical instead of electrical markers to assess 
dyssynchrony, a robust method to quantify dyssynchrony still does not exist. 
2.5 QUANTIFYING DYSSYNCHRONY: A REGIONAL PERSPECTIVE 
Disturbances in mechanical synchrony can be assessed by different imaging techniques.  
Myocardial tagging with cardiac magnetic resonance imaging (MRI) can accurately track 
regional myocardial mechanics [30, 31].  However, MRI does not have widespread clinical 
availability and bedside use.  Therefore, the majority of studies investigating dyssynchrony and 
the response to CRT use echocardiographic techniques to assess LV mechanics. These 
techniques include M-mode assessment, two-dimensional tissue Doppler imaging (TDI), and 
two- and three-dimensional echocardiography. 
2.5.1 Echocardiographic Techniques to Assess LV Wall Motion 
M-mode echocardiography is the simplest echocardiographic technique.  This technique often 
assesses wall motion via the parasternal short-axis view, therefore only providing a one-
dimensional view of the heart.  TDI in contrast allows for two-dimensional characterization of 
wall motion.  This is one of the most widely studied techniques for the assessment of LV 
dyssynchrony [12].  Based on the Doppler effect, TDI quantifies velocity at specific locations 
within the myocardium, indicating the rate at which a myocardial segment moves toward or 
away from the transducer.  Short-axis or long-axis images can be obtained to quantify 
radial/circumferential or longitudinal velocity, respectively.  Tissue Doppler-derived velocity can 
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be measured using pulsed-wave or color-coded TDI.  A major disadvantage of pulsed-wave TDI 
is that only one segment can be assessed at a time, which makes this method very time 
consuming and less accurate.  Accordingly, there is limited evidence showing the benefits of 
pulsed-wave TDI to assess dyssynchrony and predict response to CRT [12].  In contrast, 2-D 
color-coded TDI acquires tissue velocity tracings from the entire sector (i.e., short- or long-axis 
view) allowing assessment from multiple sites simultaneously [32].  A disadvantage for this 
method is that derivation and assessment of theses tracings from images must be performed 
offline.  Regardless, color-coded TDI allows for an extensive evaluation of wall motion by 
integrating velocity tracings over time to obtain tissue displacement.  Furthermore, myocardial 
strain can be derived from TDI to quantify tissue deformation of individual segments throughout 
the cardiac cycle.  In summary, regional function can be assessed using myocardial velocity, 
displacement or strain derived from a variety of techniques. 
2.5.2 Current Approaches to Quantify Dyssynchrony 
Mechanical dyssynchrony has been defined by an array of different metrics.  The simplest index 
of dyssynchrony quantifies the time delay between septal and posterior LV wall motion 
(SPWMD) using one-dimensional M-mode echocardiography at a mid-LV, short-axis view [33-
35].  Although some studies have shown that SPWMD predicted response to CRT [34, 35], 
another study reported that this measure was insufficient to predict LV reverse remodeling [33].  
The main disadvantage of this index is that it assesses dyssynchrony in one-dimension using only 
the septum and LV free-wall.  If systolic motion is not clear due to akinesis of these regions, 
assessment of dyssynchrony using this index is not feasible.  A more accurate measure of 
dyssynchrony can be obtained from two-dimensional tissue Doppler imaging technique. 
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Dyssynchrony is commonly quantified using color-coded TDI to derive indices using 
information from time to peak systolic longitudinal velocity [26, 28, 29, 36-40].  From 
myocardial velocity tracings (i.e., velocity vs. time waveforms), time to peak systolic velocity 
can be identified for individual segments in the myocardium.  One study showed that a delay of 
≥60 ms between septal and lateral time to peak velocities was predictive of acute response to 
CRT [40].  An extension of this index is a four-segment model that included the septal, lateral, 
inferior, and anterior LV walls at the base [26]; this study reported that a delay of ≥65 ms 
predicted response to CRT.  However, the most extensive models using time to peak velocity 
have been developed by Yu et al. [29, 38, 39].  Using a 12-segment model, they showed that a 
standard deviation of ≥31 ms of the time to peak longitudinal velocities predicted response to 
CRT with a sensitivity of 96% and specificity of 78% [39].  Although prediction of response to 
CRT based on time to peak longitudinal systolic velocities appears promising, difficulties may 
exist with TD angle dependence, signal noise, translational effects of scar, and variations in heart 
rate [38, 39, 41], which can affect the outcome and predictability of this approach. 
Mechanical dyssynchrony can also be described using tissue strain data based on the 
extent and timing of myocardial deformation.  Furthermore, the rate of myocardial deformation 
(i.e., strain rate) can also be assessed.  Importantly, tissue strain echocardiography has the 
advantage over TD velocity with respect to differentiating active contraction from passive 
motion or tethering, which are important confounding variables in patients with ischemic heart 
disease [42].  Although initial studies reported relatively low predictive values for response to 
CRT using longitudinal strain rate to quantify dyssynchrony [39], radial strain has recently been 
shown to predict both acute and chronic clinical response to CRT using the maximal strain time 
delay [43, 44]. 
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The majority of these mechanical markers of dyssynchrony use information derived from 
time-to-peak amplitude of velocity or strain information.  As explained above, the native 
contraction pattern of the LV is extremely complex and becomes increasingly complicated with 
dyssynchronous deformation.  Therefore, indices that focus on a single point during contraction 
may not completely characterize the complex deformations.  We plan to address this issue 
through Specific Aims 2 and 4 by developing a more robust tool to assess contraction patterns 
and quantify dyssynchrony. 
2.6 CONSEQUENCES OF DYSSYNCHRONY: A GLOBAL PERSPECTIVE 
Disparities in normal contraction patterns are known to adversely affect global LV performance 
by a variety of mechanisms, including having regional segments reach maximal shortening at 
different times and dyssynchronous papillary muscle contraction leading to mitral valve 
dysfunction and inefficient ejection.  Importantly, this dysfunction further exacerbates systolic 
heart failure, placing patients at significantly greater cardiac risk [1].  Several animal studies 
have mimicked contraction dyssynchrony using a LBBB pattern of contraction [45-47].  LBBB 
can be achieved either by cardiac ablation of the left bundle branch or right ventricular outflow 
pacing.  Both techniques lead to a similar dyssynchronous contraction pattern [48]: early septal 
activation inducing pre-stretch of the LV wall followed by late activation of the LV free-wall 
with post-systolic shortening of the earlier activated septum [49].  This contraction pattern has 
deleterious effects on measures of global LV performance.  Studies have shown that compared to 
control, the maximum and minimum rate of pressure change (i.e., dP/dtmax and dP/dtmin, 
respectively), stroke volume, and stroke work are all significantly depressed following induction 
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of dyssynchrony [45-47].  Furthermore, global LV mechanical function (i.e., contractility) is also 
depressed with dyssynchrony [50-52] and this depression appears to be proportional to the 
degree of contraction dyssynchrony [51].  In addition, a decrease in energetic efficiency 
concomitant with the depression in function has been reported with dyssynchrony [53, 54].  
Therefore, alterations in regional contraction patterns adversely affects all aspects of global LV 
function: (1) global LV performance (e.g., cardiac output, stroke work, dP/dtmax) (2) global LV 
mechanics (i.e., contractility); and (3) global LV energetics (i.e., myocardial oxygen 
consumption). 
2.6.1 Evaluation of Global LV Performance and Mechanics 
Global LV performance and mechanics can be quantified by evaluating LV pressure-volume (P-
V) data.  The volume of the LV cavity can be determined using a conductance catheter; LV 
volume is calculated by converting intracavitary electrical conductance to volume after 
calibration factors are applied [55].  Conductance catheters also have a micromanometer pressure 
transducer to measure LV pressure.  From this technique, pressure and volume information can 
be plotted individually over time (Figure 2-2A, B) or pressure can be plotted against volume to 
derive P-V loops (Figure 2-2C).  These loops provide useful information describing volume and 
pressure changes throughout the cardiac cycle.  For example, the upper left hand corner of the P-
V loop indicates end-systole and the bottom right hand corner marks end-diastole.  In addition, 
stroke volume can be calculated as the change in volume between end-diastole and end-systole, 
and stroke work (amount of work performed by the ventricle) can be derived as the area inside of 
the P-V loop. 
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 Figure 2-2. Hemodynamic data used to derive pressure-volume loops. 
 
Left ventricular (A) pressure and (B) volume over time. (C) Left ventricular pressure plotted against LV volume 
constructing a P-V loop. The lower left and upper right hand corners of the loop marks end-diastole and end-systole, 
respectively. The width of the loop quantifies LV stoke volume and the area within the loop is proportional to LV 
stroke work. 
 
Left ventricular pressure-volume loops are an important tool in quantifying mechanical 
properties of the LV.  By varying preload or afterload, a series of P-V loops can be constructed.  
For example, during inferior vena-caval (IVC) occlusion experiments, preload is altered by 
banding the IVC, and P-V loops change according to the Frank-Starling Law (i.e., decreased 
force development due to less preload).  In their initial pioneering studies, Suga and Sagawa 
conducted experiments that defined left ventricular mechanics using these series of P-V loops 
[56].  They showed that global LV intrinsic active and passive mechanical properties can be 
defined using the end-systolic pressure (ESP)-volume (ESV) relationship (ESPVR) and end-
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diastolic pressure (EDP)-volume (EDV) relationship (EDPVR), respectively (Figure 2-3).  The 
top left point of each P-V loop defines end-systole, and the ESPVR is defined by the time-
varying elastance model: 
 es dESP E [ESV V ]= ⋅ −  (2-1) 
where Ees and Vd are parameters to be estimated from experimental measurements or 
extrapolation.  Suga and Sagawa showed that Ees and Vd were not altered with changes in filling 
or ejection characteristics and therefore represented the global systolic intrinsic mechanical 
properties of the LV [56].  Also, they found that the slope of the ESPVR, called the end-systolic 
elastance (Ees), increased with inotropic stimulation and coined Ees as a preload independent 
index of the innate contractility of the heart [56].  Glower et al. showed that the relationship 
between stroke work and end-diastolic volume was preload independent, insensitive to changes 
in afterload, and responsive to changes in inotropic state [57].  Therefore, the intrinsic systolic 
properties of the LV can also be quantified using the preload recruitable stroke work (PRSW) 
relationship: 
 w wSW M [EDV V ]= ⋅ −  (2-2) 
where Mw and Vw are parameters [57].  The linearity of the PRSW relationship allows for 
quantification of cardiac performance by a simple slope and x-axis intercept with the concept of 
determining the work performed (stroke work) by the input (end-diastolic volume) of the system.  
The end-diastolic pressure-volume relationship is typically defined by a nonlinear 
monoexponential equation: 
 o(EDV V )EDP [e 1]β⋅ −= α ⋅ −  (2-3) 
where α, β, and Vo are parameters [58].  From this relationship, the passive intrinsic mechanical 
properties of the LV can be deduced.  Specifically, Vo defines the passive unstressed volume of 
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the LV (i.e., volume at zero EDP).  Also, chamber stiffness is linearly related to EDP, and the 
slope of this relationship defines the modulus of chamber stiffness.  Importantly, these 
relationships were derived under ideal, rigorously controlled conditions.  We plan to investigate 
the utility of these tools in quantifying global LV mechanical properties during dyssynchronous 
contraction and their relationship with regional function in Specific Aim 3. 
 
Figure 2-3. Pressure-volume loops during inferior vena caval occlusion. 
 
Series of pressure-volume loops collected during altered preload from inferior vena caval occlusion. As the vena 
cava is occluded, LV pressure and volume decrease, and loops become smaller and shift to the left. The end-
diastolic points for each loop (lower right hand corner) can be fit to a monoexponential equation to derive the end-
diastolic pressure-volume relationship (EDPVR) and quantify passive global LV mechanical properties. Similarly, 
the upper left hand points for each loop (end-systolic points) can be fit to a linear equation to derive end-systolic 
pressure-volume relationship (ESPVR) and quantify active global LV mechanical properties. 
 
2.6.2 Evaluation of Global LV Mechano-Energetic Function 
Suga and Sagawa extended their initial pioneering studies by showing that the addition of the 
graphic area inside the LV pressure-volume loop (stroke work, SW, Figure 2-4A) and the 
ESPVR defined left-sided triangle (potential energy, PE, Figure 2-4A) is a mechanical 
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determinant of myocardial energetics [59, 60].  More specifically, they called this the pressure-
volume loop area (PVA, Figure 2-4B).  They showed that myocardial oxygen consumption 
(MVO2) varied linearly with PVA (Figure 2-4C) and can be represented by: 
 2PVA a MVO b= ⋅ +  (2-4) 
where the slope (i.e., a) represents the energy cost of the PVA and its inverse indicates the 
contractile efficiency from oxygen consumption to PVA, and the intercept (i.e., b) represents the 
MVO2 of basal metabolism and excitation-contraction coupling.  This relationship is important 
because it offers information about the underlying processes of the left ventricle simply by 
obtaining global mechanic and energetic measurements.  Importantly, there is limited knowledge 
regarding the mechanisms underlying the detrimental mechano-energetic effects of 
dyssynchrony.  We plan to assess this issue through Specific Aim 1. 
 
Figure 2-4. Global left ventricular mechano-energetic function. 
 
(A) Potential energy (PE) is enclosed by the ESPVR, EDPVR, and left-hand side of pressure volume loop. Area 
enclosing the pressure-volume loop is stroke work (SW). (B) The addition of PE and SW is pressure-volume area 
(PVA). (C) Each PVA calculated linearly correlates with the measured myocardial oxygen consumption (MVO2) 
during that contraction. Grey circle corresponds to the PVA calculated from (B). 
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2.7 THE LINK BETWEEN REGIONAL AND GLOBAL LV FUNCTION 
One would expect that the degree of global LV functional improvement with CRT would be 
proportional to the improvements in contraction synchrony.  However, establishment of the link 
between global LV function and contraction synchrony is confounded by the lack of standard 
and comprehensive indices for synchrony and criteria for defining CRT responders.  This link is 
important because it may help to identify those likely to benefit from this therapy.  Response to 
CRT is commonly assessed by clinical status, echocardiographic parameters, or both.  Clinical 
status can be established by the 6-minute walk test, NYHA functional class, and quality of life 
score [12].  The majority of studies demonstrate improvement in clinical status with CRT, 
however, many clinical parameters are subjective and a substantial placebo effect may be present 
in a large percentage of patients [4].  A more objective definition of response may involve 
echocardiographic-derived parameters.  However, again, multiple parameters could be derived 
from echocardiographic evaluation to determine response such as ejection fraction, end-systolic 
volume, end-diastolic volume, or mitral regurgitation.  Although the degree of improvement in 
EF with CRT has varied in different studies [4, 8, 61], changes in LV volumes seem to more 
consistently define response to CRT [4, 8, 9, 61].  A reduction of ≥10% in ESV following CRT, 
called reverse remodeling, has become a very commonly used marker to indicate response to 
CRT [62].  However, a universally accepted index of dyssynchrony still remains to be 
established.  Results of the Predictors of Response to CRT (PROSPECT) trial suggested that 
mechanical dyssynchrony defined as a variety of echocardiographic-derived measures such as 
time delay between earliest and latest peak systolic velocity could not predict response to CRT 
defined as either reverse remodeling or clinical status [63]. 
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Another relevant factor that will affect response to CRT is the identification of optimal 
pacing site(s) for individual patients.  The standard pacing modality for CRT is biventricular 
pacing with RV apical and LV free wall pacing sites.  However, single-site LV free-wall pacing 
may be more beneficial to some patients rather than biventricular pacing.  In addition, LV apical 
pacing may be superior to LV free-wall pacing in other patients.  Therefore, the current body of 
work was aimed to understand the mechanisms underlying the detrimental mechano-energetic 
effects of dyssynchrony and to investigate the link between regional and global LV function 
under varying contraction patterns induced by ventricular pacing at different sites. 
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3.0  STUDY 1: INSIGHTS INTO THE EFFECTS OF CONTRACTION 
DYSSYNCHRONY ON GLOBAL LEFT VENTRICULAR MECHANO-
ENERGETIC FUNCTION 
Specific Aim 1. To assess the direct impact of LV dyssynchrony on global left ventricular 
mechano-energetic function in a Langendorff isolated rabbit heart preparation. 
3.1 INTRODUCTION 
The effects of contraction dyssynchrony on global LV mechanical function has been well 
documented, however its effect on LV energetic function has received less attention.  
Furthermore, results from few studies examining this issue have not been consistent.  The blood-
perfused isolated heart preparation offers a rigorously controlled environment to evaluate 
intrinsic LV mechano-energetic function.  Here the heart is devoid of external neurohumoral 
stimuli, loading conditions can be independently controlled [64], and global LV mechano-
energetic function can be quantified in terms of the myocardial oxygen consumption (MVO2)-
pressure-volume area (PVA) relationship [65, 66]. 
The primary goal of this study was to assess the effects of contraction dyssynchrony on 
global LV mechano-energetic function in an isolated rabbit heart preparation.  We used a right 
ventricular outflow tract (RVOT) pacing-induced model of LBBB-like contraction 
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dyssynchrony.  It should be noted that RVOT pacing was used to create dyssynchrony; it was not 
meant to correspond to a clinically used pacing site (e.g., right ventricular apex). 
3.2 METHODS 
3.2.1 Langendorff Isolated Rabbit Heart Preparation 
The isolated heart preparation is ideally suited for studying global LV mechano-energetics.  This 
preparation consists of an isolated heart, a perfusion medium, and a loading system.  Oscar 
Langendorff devised this method to study the mechanical activity of the isolated mammalian 
heart [67].  The basic principle behind the Langendorff heart (or isolated heart) preparation is 
retrograde perfusion of the coronary circulation.  When the aorta is cannulated and ligated, the 
perfusion medium closes the aortic valve and is forced through the coronary ostia where it enters 
the coronary vasculature providing vital nutrients to the myocardium.  Although the ventricles 
remain essentially empty, after traveling through the coronary vasculature, the perfusate travels 
to the right atrium and right ventricle where it then exits the heart through the pulmonary artery. 
3.2.2 Biological Preparation 
This investigation conforms with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).  
Eleven New Zealand rabbits weighing 2.60 ± 0.04 kg were used in an isolated perfused 
Langendorff preparation to study LV mechano-energetic function.  Animals were anesthetized 
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with an intramuscular injection of ketamine [45 mg•kg-1] and xylazine [5 mg•kg-1] and thereafter 
an intravenous catheter was inserted into the ear vein to provide a continuous infusion of 
ketamine [1.38 mg•min-1•kg-1].  The rabbits were artificially ventilated with room air via a 
tracheotomy.  After median sternotomy, the heart was removed and a metal cannula was inserted 
into the aorta to begin retrograde perfusion of the coronary arteries at constant perfusion pressure 
(80 mmHg) and temperature (37 °C).  Hearts were perfused with oxygenated (95% O2/5% CO2 
mixture) crystalloid perfusate (modified Krebs-Hanseleit (KH) solution) containing washed 
erythrocytes (see Appendix A.1).  Previous studies have shown that perfusion with washed 
erythrocytes is superior to crystalloid in that the performance of the heart is stable over a longer 
period of time and the metabolic measurements are more reliable [68, 69].  Oxygenation was 
accomplished using a hollow fiber membrane contactor (Membrana, Charlotte, NC) and a 95% 
O2/5% CO2 mixture.  The perfusate was not recirculated and the coronary perfusion pressure was 
held constant using a servo-controlled roller pump.  To prevent microaggregates from entering 
the heart, an in-line 40 μm filter was used.  A thin latex balloon, secured at the end of an 
automated volume-injection device, was positioned in the LV via the mitral orifice.  The balloon 
did not generate any intrinsic pressure at its maximum volume; therefore the measured pressure 
represented that of the LV only.  A suture around excess left-atrial tissue secured the heart to the 
volume-injection device.  Epicardial pacemaker leads were placed on the right atrium (RA) and 
right ventricular (RV) free-wall near the anterior infundibulum, also known as the RV outflow 
tract.  After all protocols were completed, the atria and RV were removed and the LV was 
weighed (3.45 ± 0.13 g). 
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3.2.3 Perfusion Medium 
The isolated hearts were perfused with washed bovine erythrocytes suspended in a modified KH 
solution [70].  Whole bovine blood was collected from a local slaughterhouse and 
anticoagulation was maintained with heparin [10 U•mL-1].  Gentomyosin [250 mg•L-1] was 
added to retard bacterial growth, and blood was filtered through a 40 μm filter to remove gross 
particles.  Red blood cells (RBCs) were isolated by washing the whole blood in KH solution 
(without calcium) using a cell-saver machine (Haemonetics Corp., Braintree, MA) (see 
Appendix A.1).  Isolated RBCs were then diluted with KH solution to obtain a hematocrit of 32 
± 0.6%.  Calcium chloride [1.8 mM] was added after another heparin bolus [10 U•mL-1].  
Albumin [0.3%] was used to maintain osmolarity, and a pH of 7.46 ± 0.02 was obtained with the 
addition of sodium bicarbonate [3%] to the final suspension. 
3.2.4 Experimental Measurements 
Instantaneous left ventricular pressure was measured by a catheter-tip pressure transducer (Millar 
Instruments Inc., Houston, TX) positioned in the LV via a side port in the volume-injection 
system.  Left ventricular end-diastolic volume was controlled using an infusion pump (Harvard 
Apparatus, Holliston, MA).  Instantaneous pressure was digitized on–line at a sampling rate of 
1000 Hz.  Total coronary flow (Qcor) was measured by an ultrasonic, in-line, transit-time flow 
probe (2N158, Transonic) in series with the aortic perfusion cannula.  Arterio-venous oxygen 
content difference (AVO2) was measured by a continuous oxygen difference analyzer (A-VOX 
Systems, San Antonio, TX).  The use of this device for accurate measurement of AVO2 has been 
verified [71, 72].  Arterial blood was collected from a side port in the aortic perfusion cannula 
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directly above the flow probe and venous blood was directed to the AVO2 analyzer via a 12 Fr. 
Foley catheter inserted into the right ventricle through the pulmonary artery.  Myocardial oxygen 
consumption (MVO2) was calculated as the product of Qcor and AVO2.  Since the right ventricle 
was kept collapsed with the Foley catheter, the measured MVO2 was taken to represent oxygen 
consumption of the LV only. 
3.2.5 Calculation of Pressure-Volume Area 
Instantaneous LV pressure data were recorded during steady-state isovolumic contractions at 
four to six LV EDVs within the end–diastolic pressure range of 5-30 mmHg (Frank-Starling 
protocol, Figure 3-1A).  After each volume step, we waited approximately 2 minutes to allow 
for equilibrium of the metabolic state before collecting data.  The functional state of the heart 
was quantified in terms of peak active and passive P-V relationships (Figure 3-1B) [56].  The 
ESPVR was derived by fitting peak active pressure points to a linear elastance model (Equation 
2-1) and end-diastolic P-V points were fit to a monoexponential equation (Equation 2-2) to 
derive the EDPVR.  ESPVR and EDPVR were calculated from raw data using a custom-written 
software program (The MathWorks Inc., Natick, MA) (see Appendix A.2).  Using the same 
custom-written software, PVA was calculated as the area enclosed by ESPVR, EDPVR, and the 
pressure-volume trajectory for each EDV (Figure 3-1B).  MVO2 was linearly correlated to PVA 
using Equation 2-4 (Figure 3-1C). 
 24 
 Figure 3-1. Pressure-volume area concept. 
 
(A) LV pressure was collected for incremental volumes during isovolumic contraction. (B) ESPVR and EDPVR 
were then fitted through peak end-systolic and end-diastolic points (dashed and dotted lines, respectively). PVA was 
calculated as the area enclosed by the ESPVR, EDPVR, and pressure-volume trajectory for that volume increment 
(e.g., gray area is the PVA for the first volume increment). (C) MVO2 was linearly correlated to PVA at its 
corresponding volume step. Abbreviations: ESPVR = end-systolic pressure-volume relationship; EDPVR = end-
diastolic pressure-volume relationship; LV = left ventricular; MVO2 = myocardial oxygen consumption; PVA = 
pressure-volume area. 
 
3.2.6 Pacing Protocols 
Mechanical (LV pressure and volume) and energetics (Qcor and AVO2) data were first collected 
under right-atrial (RA) pacing, which served as the heart rate control condition.  Hearts were 
paced at 111 ± 7 beats•min-1.  After mechano-energetic data were collected under RA pacing, 
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contraction dyssynchrony was induced by simultaneous RA-RVOT pacing, referred to as RVOT 
pacing.  Approximately 3 minutes after the induction of contraction dyssynchrony, mechano-
energetic data were collected again.  The total experimental duration was 73±5 minutes. 
3.2.7 Statistical Analysis 
Data are presented as mean ± SEM.  The statistical analysis consisted of comparing relationships 
(e.g., ESPVR and MVO2-PVA) between two conditions: control (RA pacing) and 
dyssynchronous (RVOT pacing) contractions.  Because these relationships were obtained for 
both conditions from each heart, a repeated measures ANCOVA structure exists.  Importantly, 
multi-linear regression analysis with dummy variables allows for only fixed effects (i.e., it does 
not allow for variability between animals and assumes independence across measurements 
within animals).  However, a mixed model approach assumes dependence across repeated 
measurements within an animal therefore allowing for random effects in addition to fixed effects 
[73].  Therefore, statistical analysis was performed using a mixed linear model to account for 
random (i.e., between hearts within a condition) and fixed (i.e., between conditions) effects via 
SAS statistical software package (SAS Institute Inc., Cary, NC) (see Appendix A.3).  
Significance was determined as P<0.05. 
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3.3 RESULTS 
3.3.1 Effects of Contraction Dyssynchrony on Global LV Mechanical Function 
RVOT pacing-induced contraction dyssynchrony resulted in a small change in global LV 
mechanical function compared to RA pacing (Figure 3-2, “Mechanics” panels).  The ESPVR 
decreased in five of eight experiments with RVOT pacing and was unchanged in three 
experiments.  The depression in global LV function was also apparent when comparing pressures 
at each end-diastolic volume during the Frank-Starling protocol (Table 3-1).  For example, the 
maximum peak active systolic pressure generated was 92 ± 5 mmHg after the induction of 
dyssynchrony, which was approximately a 10% decrease from the RA pacing value (101± 6 mm 
Hg).  Statistical analysis of all data using a mixed model approach showed that the ESPVR 
during RVOT pacing was significantly different from that of RA pacing.  The slope of the 
ESPVR (i.e., Ees) was not altered with RVOT pacing (Figure 3-3A, RA pacing: 56.1 ± 5.1, 
RVOT pacing: 58.5 ± 5.0 mmHg•mL-1, P=NS).  However, the ESPVR volume intercept (Vd) 
increased from 0.58 ± 0.10 mL with RA pacing to 0.67 ± 0.10 mL with RVOT pacing (P<0.05, 
Figure 3-3B).  Therefore, the depression in global LV mechanical function with dyssynchrony 
manifested as a small, but statistically significant rightward shift of the ESPVR. 
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 Figure 3-2. Raw data for isolated rabbit heart preparations (n=11). 
 
Left panels are global LV mechanical data expressed as ESPVR, and right panels are global LV energetic data 
expressed as MVO2-PVA relationships. Closed and open circles represent values under RA and RVOT pacing, 
respectively. Solid and dashed lines are relationships for RA and RVOT pacing, respectively. Note that for all 
experiments, the ESPVR decreased slightly and the MVO2-PVA relationship increased with RVOT pacing. 
Abbreviations: ESP = end-systolic pressure (mmHg); EDV = end-diastolic volume (mL); PVA = pressure-volume 
area (mmHg•mL•beat-1•100g LV-1); MVO2 = myocardial oxygen consumption (mL O2•beat-1•100g LV-1); RA = 
right atrial; RVOT = right ventricular outflow tract; other abbreviations as in Figure 3-1. 
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Table 3-1. Global LV mechanical and energetic variables during isovolumic contractions. 
Pacing LV EDV LV ESP PVA AVO2 Qcor MVO2 n 
1.4 44 ± 4 540 ± 100 1.7 ± 0.4 9.3 ± 1.4 3.08e-2 ± 0.42e-2 9 
1.6 55 ± 4 795 ± 126 1.6 ± 0.4 10.1 ± 1.4 3.50e-2 ± 0.52e-2 8 
1.8 67 ± 4 1123  ±  114 1.8 ± 0.3 10.2 ± 1.3 4.21e-2 ± 0.44e-2 10 
2.0 82 ± 4 1502 ± 121 2.1 ± 0.3 10.0 ± 1.3 4.63e-2 ± 0.47e-2 10 
2.2 91 ± 4 1896 ± 150 2.4 ± 0.4 9.5 ± 1.3 4.98e-2 ± 0.53e-2 9 
RA Pacing 
2.4 101 ± 6 2431 ± 178 2.5 ± 0.5 10.5 ± 1.5 5.43e-2 ± 0.68e-2 8 
1.4 38 ± 3 426 ± 76 1.9 ± 0.4 9.2 ± 1.3 3.56e-2 ± 0.45e-2 11 
1.6 52 ± 3 662 ± 84 2.0 ± 0.4 9.4 ± 1.2 4.05e-2 ± 0.49e-2 11 
1.8 65 ± 3 956 ± 88 2.2 ± 0.4 9.5 ± 1.2 4.62e-2 ± 0.54e-2 11 
2.0 78 ± 3 1308 ± 98 2.2 ± 0.3 9.7 ± 1.2 4.82e-2 ± 0.54e-2 10 
2.2 88 ± 4 1702 ± 116 2.6 ± 0.4 9.1 ± 1.2 5.31e-2 ± 0.62e-2 9 
RVOT Pacing 
2.4 92 ± 5 2174 ± 162 2.9 ± 0.4 9.2 ± 1.4 6.07e-2 ± 0.80e-2 7 
 
Data: mean ± SEM for each isovolumic volume during the Frank-Starling protocol; n, number of experiments with 
data at each end-diastolic volume. AVO2 = arterial-venous oxygen content difference (mL O2•100 mL-1); EDV = 
end-diastolic volume (mL); ESP = end-systolic pressure (mmHg); LV = left ventricular; MVO2 = myocardial 
oxygen consumption (mL O2•beat-1•100g LV-1•10-2); PVA = pressure-volume area (mmHg•mL•100gLV -1); Qcor = 
coronary blood flow (mL•min-1); RA = right atrial; RVOT = right ventricular outflow tract. 
 
 
Figure 3-3. Global LV mechanical function quantified by the ESPVR. 
 
(A) Compared to RA pacing, the slope (Ees) of the ESPVR was not different compared to RVOT pacing. (B) 
However, RVOT pacing increased the volume-axis intercept (Vd) of the ESPVR.  Data: n=11; *P<0.05 vs. RA 
pacing as analyzed using all data in a mixed statistical model. Abbreviations: Ees = end-systolic elastance; Vd = dead 
volume or volume-axis intercept of ESPVR.  Other abbreviations as in Figures 3-1 and 3-2. 
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3.3.2 Effects of Contraction Dyssynchrony on Global LV Mechano-Energetic Function 
Dyssynchronous contraction with RVOT pacing had an adverse effect on LV energetic function.  
In spite of lower PVA, dyssynchronous contraction for any given end-diastolic volume was 
associated with greater AVO2 and little change in Qcor (Table 3-1).  Thus, although global LV 
mechanical function was depressed, MVO2 was elevated during dyssynchronous contraction 
compared to RA pacing (Figure 3-2, “Energetics” panels).  The increase in MVO2 was primarily 
due to an increase in AVO2. 
Statistical analysis of all data using the mixed model approach showed that a trend 
towards a significantly lower MVO2-PVA relationship slope was observed with RVOT pacing 
(Figure 3-4A; RA pacing: 1.49x10-5 ± 0.17x10-5, RVOT pacing: 1.68 x10-5 ± 0.17 x10-5 mL 
O2•mmHg-1•ml-1, P=0.055).  However, compared to RA pacing, the MVO2-PVA relationship 
intercept markedly increased with dyssynchronous contraction (Figure 3-4B; RA pacing: 0.025 
± 0.003, RVOT pacing: 0.029 ± 0.003 mL O2•beat-1•100gLV-1, P<0.05). 
 
Figure 3-4. Global LV energetic function quantified by the MVO2-PVA relationship. 
 
(A) Compared to RA pacing, RVOT pacing did not alter the slope (i.e., a) of the MVO2-PVA relationship. (B) 
However, RVOT pacing increased the intercept (i.e., b) of the MVO2-PVA relationship. Data: n=11; *P<0.05 vs. 
RA pacing as analyzed using all data in a mixed statistical model. Abbreviations as in Figures 3-1 and 3-2. 
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The responses of mechano-energetic function between RA and RVOT pacing can be 
better appreciated by the presentation of the data in Figure 3-5.  Mean (±SEM) data points at 
each end-diastolic volume during isovolumic contraction are plotted for the ESPVR and MVO2-
PVA relationship.  Decreased global LV mechanical function with dyssynchrony was apparent 
by the marked rightward shift of ESPVR (i.e., increase in Vd) compared to RA pacing.  
Dyssynchronous contraction resulted in significantly greater oxygen consumption, as illustrated 
by the upward shift of the MVO2-PVA relationship.  Thus, significantly greater energy (i.e., 
MVO2) was required with dyssynchrony to achieve the same mechanical output (i.e., PVA). 
 
Figure 3-5. Mean (±SEM) data points for global LV mechanical and energetic function. 
 
(A) Compared to RA pacing, the ESPVR was depressed with RVOT pacing indicated by a rightward shift of the 
ESPVR volume intercept. (B) Despite the depression in mechanics, RVOT pacing adversely affected global LV 
energetics manifested as an increase in the MVO2-PVA intercept. Data: n=11; RA vs. RVOT pacing as analyzed 
using all data in a mixed statistical model. Abbreviations as in Figures 3-1 and 3-2. 
 
In the presence of contraction dyssynchrony, we hypothesized that there is a disconnect 
between the mechanical activity occurring at the regional level and the mechanical activity that is 
observable at the global level.  We believe that the summation of all regional mechanical activity 
represents an internal PVA (say PVA′) that is greater than the PVA observable at the global 
level.  Although only a portion of PVA′ is observed at the global level, this internal PVA 
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ultimately determines the measured MVO2 during contraction dyssynchrony.  Assuming that the 
MVO2-PVA′ relationship with RVOT pacing is the same as the MVO2-PVA relationship with 
RA pacing [MVO2 RA = aRA•PVARA + bRA], we calculated PVA′ (i.e., internal PVA) for each 
MVO2 measured under RVOT pacing by: PVA′ = (MVO2 RVOT – bRA)/aRA (Figure 3-6).  Thus, 
the lost PVA, which is the difference of calculated PVA′ and measured PVA with RVOT pacing 
(i.e., ΔPVA = PVA′ – PVARVOT), represents the mechanical energy that is not observable at the 
global level.  Accordingly, excess oxygen consumption that was wasted during global 
mechanical energy loss is defined as the difference between measured MVO2 with RVOT pacing 
and measured MVO2 with RA pacing (i.e., ΔMVO2 = MVO2 RVOT – MVO2 RA). 
 
Figure 3-6. Demonstration of PVA′ calculation and concept of lost PVA and excess MVO2. 
 
Opened and closed circles represent measured MVO2-PVA data points for RA and RVOT pacing, respectively, 
during one isovolumic contraction.  Using the MVO2 measured under RVOT pacing, PVA′ (diamond) is calculated 
according to the MVO2-PVA relationship under RA pacing [i.e., PVA′ = (MVO2 RVOT – bRA)/aRA].  Lost PVA is 
calculated by the difference between PVA′ and PVARVOT.  Excess MVO2 (i.e., ΔMVO2) is calculated by the 
difference between MVO2 RVOT and MVO2 RA.  Abbreviations: RA = right atrial; RVOT = right ventricular outflow 
tract.  Other abbreviations as in Figure 3-1. 
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For our dataset, a significant correlation (R2=0.54 P<0.001, Figure 3-7) existed between 
excess MVO2 (i.e., MVO2 RVOT – MVO2 RA) and excess PVA (PVA′ – PVARVOT).  It should be 
noted that this message reiterates the parallel shift (i.e., increased MVO2 for a given PVA) 
observed with the MVO2-PVA relationship as shown in Figure 3-5.  However, this presentation 
clearly shows how the excess MVO2 observed with RVOT pacing can be explained by the 
mechanical energy loss at the global level. 
 
Figure 3-7. Proposed mechanism explaining increased MVO2 with RVOT pacing. 
 
Correlation between excess MVO2 (ΔMVO2 = MVO2 RVOT – MVO2 RA) and excess PVA (ΔPVA = PVA′ – 
PVARVOT) calculated for each end-diastolic volume in all experiments. See text for details. Abbreviations as in 
Figures 3-1 and 3-2. 
 
3.4 DISCUSSION 
The current study reports two primary findings.  First, a small, but significant depression in 
global LV mechanical function was observed with RVOT pacing.  We suspect that 
dyssynchronous contraction induced by RVOT pacing is responsible for the depression in global 
LV mechanics.  Second, despite the depression in LV mechanical function, LV contraction 
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dyssynchrony was associated with greater oxygen consumption.  Because RVOT pacing 
consumed more oxygen at a given PVA, dyssynchronous contraction results in decreased 
myocardial mechanical conversion efficiency (i.e., PVA/MVO2).  In addition, we showed that 
the increase in oxygen consumption with dyssynchrony significantly correlated with the 
mechanical energy loss at the global level (i.e., the energy that did not contribute to efficient 
mechanical output).  Certain methodological issues are considered first, before we discuss these 
findings in detail. 
3.4.1 Methodological Considerations 
3.4.1.1 Dyssynchrony Model 
In the current study, we used RVOT pacing to induce LV contraction dyssynchrony.  Pacing at 
the RVOT is known to prematurely excite the septum and consequently produce delayed LV 
free-wall contraction causing a LBBB-like contraction pattern [42].  However, 
echocardiographic evaluation of septal to free-wall dyssynchrony with RVOT pacing has not 
been confirmed in the isolated rabbit heart preparation.  We attempted to quantify septal to free-
wall motion in the isolated rabbit heart by echocardiography, but were unable to obtain reliable 
images for evaluation of contraction dyssynchrony.  In addition, we recognize that RV apical 
pacing, which has been implicated in dyssynchrony and heart failure exacerbation, is more 
relevant in the human setting than RVOT pacing.  However, we previously have shown in 
canines that RVOT pacing induces marked dyssynchrony similar to a LBBB-contraction pattern 
and is also associated with depression of global LV function [42, 74].  Therefore, we decided to 
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use RVOT pacing as a reliable model of dyssynchronous contraction and depression of global 
LV function. 
3.4.1.2 Stability of Isolated Heart Preparation 
Although the isolated perfused heart preparation has been extensively used to study various 
aspects of mechano-energetic function [59, 60, 66, 69, 75], there is always the potentially 
confounding effects of time.  Therefore, we conducted two experiments with RA pacing alone 
and collected data at the same time intervals as the original protocol.  We observed that although 
global LV mechanical function slightly decreased with time (Figure 3-8, RA1 vs. RA2), MVO2-
PVA relationships were shifted downwards.  These changes in MVO2-PVA relationships are in 
the opposite direction to those observed with RVOT pacing-induced dyssynchrony (Figure 3-2, 
“Energetics” panels).  However, they are consistent with downward shifts in MVO2-PVA 
relationships observed with acute depression in LV contractile state (e.g., reduced extracellular 
calcium, infusion of β-receptor antagonists) [59, 76].  Therefore, time-dependent preparation 
deterioration is not a confounder for the observed adverse effect of contraction dyssynchrony on 
global LV mechano-energetic function. 
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 Figure 3-8. Validation of isolated rabbit heart preparation stability. 
 
Global LV mechanical and energetic function for two rabbits (A-B: rabbit #1; C-D: rabbit #2) under RA pacing 
conditions only. Although a slight decrease in ESPVR was observed in both experiments for the two pacing 
protocols (i.e., RA1 and RA2 in A and C), mechano-energetic coupling was not adversely affected with time, as 
indicated by a decrease in the MVO2-PVA relationship (B, D). Abbreviations as in Figures 3-1 and 3-2. 
 
3.4.1.3 Isovolumic Contractions 
Because all data were collected with hearts contracting under isovolumic conditions (i.e., with a 
fixed LV volume throughout the cardiac cycle), the relevance of our observations to ejecting 
contractions may be questioned.  However, previous studies have shown that for a fixed 
contractile state, MVO2-PVA relationship is independent of loading conditions (preload and/or 
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afterload) such that isovolumic or ejecting contractions yield the same relationship [66, 77].  
Therefore, the observations reported here should be equally valid for ejecting contractions. 
3.4.2 Interpretation of the Changes in MVO2-PVA Relationship with LV Dyssynchrony 
In the present study, LV contraction dyssynchrony resulted in increased MVO2 for a given PVA.  
Specifically, MVO2–PVA intercept significantly increased (P=0.03) with RVOT pacing-induced 
dyssynchrony.  Although MVO2–PVA slope tended to increase, it did not reach statistical 
significance (P=0.055).  Based on the scatter in our data with control RA pacing (Figure 3-4), it 
is likely that an increase in the number of experiments will yield a statistically significant 
increase in the slope value as well.  It should be noted, however, that an increase in slope further 
strengthens our main observation of increased MVO2 for a given PVA in the presence of LV 
contraction dyssynchrony. 
A potential mechanism explaining the increase of MVO2 with RVOT pacing is as 
follows: the observed PVA in the setting of contraction dyssynchrony may underestimate the 
mechanical activity at the cellular level (termed “internal” PVA) that determines the measured 
MVO2.  In other words, in the presence of contraction dyssynchrony, there is a disconnect 
between mechanical activity occurring at the regional level and the mechanical activity 
observable at the global level such that the “summation” of all regional mechanical activity (i.e., 
PVA′) is greater than the experimentally measured (global) PVA.  This is not a completely 
theoretical conjecture; there is experimental evidence for it.  Early activated regions with 
ventricular pacing are associated with pre-systolic shortening (or shortening against minimal 
load) and therefore, perform minimal regional work and contribute little to pressure generation 
[18, 78].  In contrast, the late-activated regions are typically stretched due to the shortening of 
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the early activated regions [18, 78] and they contract against higher load, resulting in greater 
regional work.  The temporal discordance of contraction results in a loss of mechanical energy 
(i.e., energy that does not contribute to pressure generation or volume displacement at the global 
level).  This is primarily due to contraction of one region that stretches the other region over the 
systolic period (i.e., in early systole: stretching of late activated region by contraction of early 
activated region; in late systole: stretching of early activated region by contraction of late 
activated region).  In addition to differential deformation patterns in early and late activated 
regions, it has been shown that myocardial blood flow is significantly higher in late activated 
regions than at earlier activated regions [78].  Specifically, Prinzen et al. [78] have shown that 
compared to control RA pacing, RVOT pacing resulted in 87% lower fiber strain and 19% less 
blood flow in early activated regions.  In contrast, fiber strain and blood flow increased by 268% 
and 142% for the late activated regions.  It is interesting to note that the increments for the late 
activated regions are significantly more than the decrements for the early activated regions, 
which supports the notion that the mechanical activity summated over all regions could be 
greater under RVOT pacing. 
Although we were unable to measure regional mechanical activity at various locations 
within the LV to obtain a direct measure of PVA′, we had the knowledge of the system mechano-
energetic behavior (MVO2-PVA relationship) under synchronous contraction (i.e., control RA 
pacing).  The luxury of having this extra piece of information allowed us to calculate PVA′ (i.e., 
PVA that was consistent with measured MVO2 under RVOT pacing).  Our dataset revealed a 
significant correlation between excess MVO2 (i.e., MVO2 RVOT – MVO2 RA) and the PVA that 
was not converted into an efficient mechanical output (i.e., the portion of PVA′ not observable at 
the global level).  We readily accept that the excess MVO2-lost PVA relationship in Figure 3-7, 
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which requires invoking the concept of PVA′ and associated calculations as described above, 
conveys exactly the same information as the MVO2-PVA relationships in Figure 3-5B.  
However, the format of data presentation in Figure 3-7 makes it easy to appreciate the 
relationship between the lost PVA (i.e., PVA not seen at the global level) and excess MVO2 
associated with RVOT pacing-induced dyssynchrony. 
3.4.3 LV Dyssynchrony and Mechano-energetics: Comparison with Previous Studies 
Similar to the current study, Burkhoff et al. [79] investigated the influence of ventricular pacing 
on mechano-energetic function using the MVO2-PVA relationship.  In an isolated canine heart 
preparation, they observed a concomitant decrease in global LV mechanics and energetics 
following RV free-wall pacing such that the MVO2-PVA relationship was not affected.  This is 
inconsistent with our observation of an upward shift in the MVO2-PVA relationship following 
dyssynchrony induced by RVOT pacing.  The difference in the pacing site (RVOT in the current 
study vs. RV free-wall in the Burkhoff study) may explain this discrepancy.  Contraction patterns 
are known to depend on ventricular pacing sites.  We hypothesize that RV free-wall pacing 
(Burkhoff study) produced larger early activated regions as compared to RVOT pacing (current 
study), primarily because RVOT pacing provides a more direct route to the His Purkinje system.  
This differential contraction pattern may explain the apparent discrepancy in MVO2: the greater 
amount of early activated regions in the Burkhoff study resulted in reduced total regional work 
and consequently, MVO2 and the opposite was true for the current study.  This conjecture is 
consistent with the potential mechanism proposed above to explain changes in the MVO2-PVA 
relationship with contraction dyssynchrony (i.e., the observed PVA may underestimate the 
internal PVA at the cellular level that determines the measured MVO2).  The discrepancy 
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between our results and those of Burkhoff et al. underscores the notion that all dyssynchronous 
contractions are not created equal; the mechano-energetic consequences are dependent on the 
specific pattern of dyssynchrony.  Further studies are required to investigate the mechanism of 
changes in global LV mechano-energetics under different contraction patterns. 
3.4.4 Clinical Implications 
It is important to note that we observed an increase in myocardial oxygen consumption with 
dyssynchrony (RVOT pacing), even though the mechanical function was depressed.  
Interestingly, data from the DAVID Trial indicated that right ventricular stimulation was 
associated with deleterious effects, leading to progressive decline of global LV function and 
higher risk of congestive heart failure due to ventricular desynchronization [80].  Although there 
is a difference in RV pacing site (RVOT vs. RV apical), the increased energetic demand 
associated with ventricular dyssynchrony as observed in the current study may be a contributing 
factor to the progressive decline in global LV function observed in the DAVID Trial.  It is 
reasonable to speculate that worsening of myocardial mechanical conversion efficiency with 
dyssynchrony may contribute to the exacerbation of heart failure.  In addition, Nelson et al. [22] 
reported that patients with LBBB and dilated cardiomyopathy benefited from left ventricular 
pacing as indicated by improved systolic function and decreased myocardial energy demands.  
We can interpret these findings in the context of our results: cardiac resynchronization therapy 
(CRT) corrects dyssynchronous contraction, eliminating the difference between internal and 
external (measured) PVA and excess MVO2.  This supports our proposed mechanism that the 
dyssynchronous myocardial elements are responsible for increased myocardial oxygen demands.  
Although CRT-induced improvement in mechanical function is well established, our results 
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reveal how this therapy may reverse the adverse effects of dyssynchrony on global LV energetic 
function. 
3.5 CONCLUSIONS 
Following RVOT pacing-induced contraction dyssynchrony, global LV mechano-energetic 
function was adversely affected.  Although a small, but significant depression in global LV 
mechanical function was observed with RVOT pacing, this contraction pattern was associated 
with an increase in MVO2 for a given PVA, resulting in decreased myocardial mechanical 
conversion efficiency (i.e., PVA/MVO2).  A possible mechanism explaining the observed 
increase in MVO2 with dyssynchrony is that the observed PVA at the global level underestimates 
the internal PVA at the cellular level, which is likely to be the true determinant of MVO2.  
Irrespective of the mechanism of action, our data clearly demonstrate that dyssynchronous 
contraction not only depresses global LV mechanical function, but also places an energetic 
burden on the myocardium.  Combined results of the present and previous studies underscore the 
notion that all dyssynchronous contractions are not created equal; mechano-energetic 
consequences are dependent on the specific pattern of dyssynchrony induced by different pacing 
sites. 
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4.0  STUDY 2: DIFFERENTIAL EFFECTS OF LEFT VENTRICULAR PACING 
SITES IN AN ACUTE CANINE MODEL OF CONTRACTION 
DYSSYNCHRONY 
Specific Aim 2. To develop an efficient, robust clinical tool to quantify dyssynchrony and 
identify responders for CRT. 
Specific Aim 3. To investigate the link between regional and global LV function under 
different contraction patterns induced by ventricular pacing at various sites. 
4.1 INTRODUCTION 
The clinical efficacy of CRT is generally quantified in terms of its effects on LV systolic 
function and other hemodynamic indices, such as LV ejection fraction, stroke volume, stroke 
work, maximum rate of LV  pressure increase (dP/dtmax), and aortic pulse pressure [41, 46, 47, 
81, 82].  As previously mentioned, several clinical trials have documented that CRT improves 
functional status and survival [4-11], but 20-30% of patients do not benefit from this therapy 
[12].  Two potential factors that may contribute to this variability in CRT benefit include limited 
knowledge regarding the mechanisms underlying the beneficial effects of CRT and lack of 
robust algorithms for identifying the optimal pacing site(s).  Accordingly, although several 
studies have focused on deriving an algorithm to assess contraction dyssynchrony [39, 42, 44, 
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83], an ideal standard is yet to be developed, particularly from the perspective of robustness and 
ease-of-use. 
The primary goal of the present study was to assess the effects of LV pacing site (apex vs. 
free-wall) on restoration of radial contraction synchrony and global LV performance in a canine 
model of contraction dyssynchrony.  We also report a new robust algorithm to quantify radial 
synchrony.  Portions of this work have been previously published elsewhere [74]. 
4.2 METHODS 
4.2.1 Preparation 
The protocol was approved by the Institutional Animal Care and Use Committee and conformed 
to the position of the American Physiological Society on research animal use.  Seven mongrel 
dogs, weighing 21.0 ± 1.5 kg were studied after an overnight fast.  All dogs were anesthetized 
with sodium pentobarbital (30 mg·kg-1 induction; 1.0 mg·kg-1·h-1 with intermittent boluses, as 
needed), their tracheas intubated (8 Fr. Portex endotracheal tube) and mechanically ventilated 
(Harvard dual-phase animal ventilator) with a 10 mg·kg-1 tidal volume.  Frequency was adjusted 
to maintain an arterial pCO2 between 35-40 mm Hg.  A 6 Fr. 11 pole multi-electrode 
conductance catheter (Webster Laboratories, Irvine, CA) and an LV micromanometer catheter 
(MPC-500, Millar, Houston, TX) were placed for LV pressure-volume analysis via the right 
internal carotid artery and the left common carotid artery, respectively, as previously described 
by us [84].  These devices allowed for the continuous measurement of LV pressure and volume 
allowing calculation of LV stroke volume and stroke work.  The pericardium was opened and 
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epicardial pacemaker leads were placed on the right atrium (RA), right ventricular (RV) free-
wall near the anterior infundibulum (i.e., RV outflow tract), LV mid-free-wall near the mid-
posterior-lateral wall, and LV apex for multi-site stimulation.  The pericardium was re-opposed 
with multiple interrupted sutures and positive end-expiratory pressure (PEEP) applied to re-
expand the lungs.  Afterward, 5 cm H2O PEEP was applied to maintain end-expiratory lung 
volume for the remainder of the experiment.  Fluid resuscitation was performed prior to starting 
the protocol to restore apneic LV end-diastolic volume to values similar to where they were prior 
to sternotomy. 
4.2.2 Protocol 
All measurements were made with respirations suspended at end-expiration of 5 cm H2O PEEP 
to control for the effects of cardiopulmonary interactions.  The protocol consisted of pacing and 
then creating a stable apneic steady state for data acquisition.  To avoid retrograde conduction for 
all pacing steps of the protocol, RA pacing was performed at frequencies 5-10 min–1 above the 
intrinsic rhythm.  Right atrial pacing is defined as normal ventricular contraction for subsequent 
comparisons.  All succeeding ventricular pacing studies were then done with sequential pacing at 
an A-V delay of 30 ms.  This pacing delay prevented ventricular fusion beats from contaminating 
the ventricular pacing effects of CRT.  Contraction dyssynchrony was created by simultaneous 
RA and high RV free-wall pacing, which induced a LBBB-like contraction pattern.  We then 
compared the impact of counter-pacing at two different LV sites on the RV pacing induced 
dyssynchronous contraction pattern.  We chose to simultaneously pace at either the LV apex or 
posterior-lateral LV free-wall at the mid-ventricular level below the left circumflex artery to 
mimic CRT, referred to as CRTa and CRTf, respectively.  The order of apical and free-wall 
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pacing was alternated among sequential animals to eliminate any sequencing effects.  Pacing was 
sustained for > 30 seconds before measurements were made for each step so that hemodynamic 
equilibrium could be established.  In practice, hemodynamic stability usually took < 15 seconds 
to occur.  Between each ventricular paced rhythm interval, the animals were returned to RA 
pacing and all hemodynamic variables were stabilized to baseline levels before the next step in 
the protocol was initiated. 
4.2.3 Echocardiographic Tissue Doppler and Tissue Strain Imaging 
An echocardiographic system with tissue Doppler (TD) imaging capabilities was used (Aplio 
SSA-770A, Toshiba Medical Systems Corporation, Tokyo, Japan) with a 3.0 MHz transducer.  
Digitized routine and color-coded TD images were acquired from mid-LV short-axis levels using 
epicardial imaging and a transducer stand.  TD system frame rates were a minimum of 49 
frames·sec-1 with a pulse repetition frequency of 4.5 kHz.  Velocity ranges were from ± 17.0 to ± 
13.0 cm·sec-1 to select the lowest possible range to maximize the sensitivity of low velocity 
values while aliasing did not occur.  Color TD video data were analyzed off-line using custom 
software (TDI-Q, Toshiba Medical Systems Corporation, Tokyo, Japan) as described by us for 
this canine preparation [42].  Briefly, the myocardial vector (V) of motion toward a manually 
placed point of contraction center was calculated as: Vmotion = Vbeam/cosine(θ), where θ is the 
angle of incidence of the ultrasound beam.  Sectors were masked where the angle of incidence 
approached 90º and Doppler calculations were not possible.  The mid-LV short-axis image was 
segmented into six sectors: mid-septum (MS), antero-septum (AS), antero-lateral (AL), postero-
lateral (PL), posterior (P) and inferior (I), manually drawn as linear polygons placed in the inner 
third of the wall (Figure 4-1, left panel).  This subendocardial region was selected to represent 
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the major component of transmural thickening and to minimize translational or right ventricular 
effects on regional LV wall dynamics.  A tracking algorithm was employed with manual 
adjustment of the size and shape of the regions of interest to maintain its subendocardial location 
throughout the cardiac cycle.  Strain was calculated as time integral of velocity gradient that was 
calculated along radii of a distance (∆r) toward the contractile center.  Angle corrected, color-
coded Lagrangian strain was calculated as percent wall thickening toward the contraction center 
and displayed on a continuous scale from dark red to bright orange-yellow as positive strain 
corresponding to wall thickening.  Radial strain waveforms were derived for each myocardial 
segment (Figure 4-1, right panel) and stored for off-line analysis. 
 
Figure 4-1. Tissue Doppler image and tissue Doppler-derived strain waveforms. 
 
Left Panel: Short-axis TDI showing segmentation of mid-LV. Right Panel: Strain waveforms derived from 
velocity data were obtained at each of the six segments under four pacing modalities: (A) RA pacing, (B) RV 
pacing, (C) CRTa, and (D) CRTf; line colors of waveforms correspond to segments labeled in TDI. Abbreviations: 
TDI = tissue Doppler image; RA = right atrial; RV = right ventricular; CRTa = cardiac resynchronization therapy at 
LV apex; CRTf = cardiac resynchronization therapy at LV free-wall. 
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4.2.4 Contraction Synchrony Analysis 
Regional radial synchrony was analyzed by implementing a newly developed algorithm on time-
strain curves constructed from color-coded strain data at the mid-LV level.  The new index 
derived from this algorithm was compared to other commonly used indices of dyssynchrony. 
4.2.4.1 Cross-Correlation Synchrony Index 
A new index of synchrony was developed in the time-domain via a pair-wise correlation analysis 
of radial strain waveforms over systole for six myocardial segments.  The peak of the QRS wave 
on ECG defined the onset of systole. Off-line analysis of data indicated that global end-systole, 
defined by the dicrotic notch of aortic pressure waveform, and time of latest peak radial strain 
occurred in close proximity.  Thus, end-systole was defined by the time of latest peak strain.  
Only the systolic portion of the strain waveforms was used for all cross-correlation analyses.  
Given that strain data were acquired for 6 segments, there are 15 segment pairs.  For each 
segmental pair, multiple linear regression was performed to derive cross-correlation coefficients 
(range of -1.0:1.0 meaning maximum dyssynchrony: maximum synchrony) for a number of 
“time delays” using a custom written MATLAB (v. R2006a, The MathWorks, Inc.) program (see 
Appendix B.1).  For each segmental pair, a cross-correlation spectrum was obtained by shifting 
one segment in time with respect to the other (Figure 4-2). 
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 Figure 4-2. Example of cross-correlation spectrum. 
 
(A) Raw data illustrated as two sine waveforms of various phases.  (B) Cross-correlation spectra obtained for the 
pair of sine waveforms.  Note that since the waveforms are mirror opposites in morphology, the cross-correlation 
coefficient is -1.0.  However, if shifted by ±π, the waveforms now perfectly “line-up” and a cross-correlation 
coefficient of +1.0 are obtained. 
 
From this cross-correlation spectrum, three values can be derived that could potentially 
describe the synchrony of contraction: (1) cross-correlation value at zero time-shift 
(corresponding to the raw, unshifted waveforms), (2) maximum cross-correlation value and (3) 
time shift corresponding to the maximum cross-correlation value which indicates the shift 
necessary to optimally “line-up” the two waveforms.  Each of the values that were derived from 
the spectrum for all 15 segmental pairs were summed.  For example, at zero time shift, all cross-
correlation coefficients were summed and used as an overall index of synchrony; a value of 15 
for this index would imply perfect synchrony and lower values would correspond to 
progressively greater dyssynchrony.  An example of cross-correlation analysis for one segmental 
pair is shown in Figure 4-3. 
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 Figure 4-3. Example of cross-correlation method developed to analyze contraction synchrony. 
 
Top Panels: Regional myocardial strain waveforms for all six segments under (A) RA pacing and (B) RV pacing. 
End systole was determined by the time to latest peak strain (dashed line). Waveform colors correspond to the 
segments labeled in Figure 4-1, left panel. Bottom Panels: Cross-correlation analysis applied to one segmental pair 
(MS-PL) over systole. (C) With RA pacing, the two segments are contracting almost synchronously, as indicated by 
high cross-correlation value (0.96) over the systolic duration. (D) In contrast, significant contraction dyssynchrony is 
evident with RV pacing manifested as mid-septal to postero-lateral contraction delay and a low cross-correlation 
value (-0.40) over the systolic duration. Abbreviations: MS = mid-septal; PL = postero-lateral; other abbreviations 
as in Figure 4-1. 
 
4.2.4.2 Additional Synchrony Indices 
Two commonly used indices of dyssynchrony were also calculated to provide a preliminary 
validation of our new index and to confirm that our findings were not a result of the specific 
algorithm used in the analysis.  These two indices were: 1) maximal time delay of peak systolic 
strain calculated from data for multiple segments [42], and 2) standard deviation (SD) of time to 
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peak systolic strain calculated from data for multiple segments [85].  Although Yu et al. [85] 
used velocity instead of strain to calculate the SD index in their study; the conceptual 
underpinnings are the same – higher value of SD indicates a greater degree of dyssynchrony. 
4.2.5 Global LV Performance Analysis 
Indices of global performance (e.g., LV stroke volume, LV stroke work, LV dP/dtmax and 
dP/dtmin) were calculated from LV pressure-volume data obtained under steady-state apneic 
conditions for each pacing modality using standard formulae [84]. 
4.2.6 Statistical Analysis 
Data are expressed as mean ± SEM.  One-way analysis of variance (ANOVA) with repeated 
measures was used to evaluate the effects of different pacing modalities on regional LV 
synchrony and indices of global LV performance.  Tukey-Kramer test was employed for post 
hoc pair-wise comparisons following each ANOVA.  Significance was determined as P<0.05.  
Linear regression analysis was used to compare the newly developed index of contraction 
synchrony with the existing dyssynchrony indices. 
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4.3 RESULTS 
4.3.1 Synchrony Indices Derived from Cross-Correlation Analysis 
Although derivation of a cross-correlation spectrum was promising in theory, the complexity of 
physiological signals introduced certain challenges.  For example, the two sine waves shown in 
Figure 4-2 are mirror opposites of each other.  However, with dyssynchrony, waveforms tend to 
exhibit complex patterns with multi-faceted behavior (i.e., thinning/thickening over different 
portions of the cardiac cycle).  Therefore, two waveforms may never “line-up”.  Thus, although 3 
different synchrony indices were derived from the cross-correlation spectrum (see Section 
4.2.4.1), only the cross-correlation sum at zero time delay was used as an index of radial 
synchrony. 
4.3.2 Induction of LV Contraction Dyssynchrony 
RV pacing induced radial contraction dyssynchrony manifested as a significant decrease in the 
synchrony index from 11.1 ± 0.8 (RA pacing) to 4.8 ± 1.2 (P<0.01, Figure 4-4).  Regional 
dyssynchrony was correlated with marked depression in LV pressures, volumes, and global LV 
functional indices [e.g., stroke volume (SV): 15 ± 2 to 10 ± 1 mL; cardiac output (CO): 2.0 ± 0.3 
to 1.4 ± 0.1 L•min-1; stroke work (SW): 137 ± 22 to 60 ± 14 mJ; LV dP/dtmax: 1346 ± 144 to 
1087±166 mm Hg•s-1; LV dP/dtmin: -1679 ± 221 to -1072 ± 165; all P<0.05].  Hemodynamic 
data and calculated variables under the control condition (RA pacing) and contraction 
dyssynchrony model (RV pacing) are presented in Table 4-1.  Overall, RV pacing was 
associated with both marked radial dyssynchrony and depression of global LV performance. 
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 Figure 4-4. Mean values of radial synchrony index at mid-LV. 
 
Compared to control (RA pacing), RV pacing resulted in a marked decrease in synchrony and both modes of CRT 
(i.e., CRTa and CRTf) restored synchrony to the control level (i.e., RA pacing). Data: mean ± SEM; n=7; ‡P<0.01 
vs. RA pacing. Abbreviations as in Figure 4-1. 
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Table 4-1. Global LV performance values for different pacing modalities. 
 RA Pacing RV Pacing CRTa CRTf 
HR (beats•min-1) 133 ± 6 133 ± 6 133 ± 6 133 ± 6 
ΔHR   0 ± 0 % 0 ± 0 % 
     
MAP (mm Hg) 91 ± 7 71 ± 7 § 71 ± 6 72 ± 7 
ΔMAP   2 ± 5 % 3 ± 7 % 
     
LV EDP (mm Hg) 11 ± 2 10 ± 2 10 ± 2 9 ± 2 
ΔLV EDP   -1 ± 9 % -13 ± 3 % 
     
LV ESP (mm Hg) 96 ± 8 77 ± 8 § 77 ± 7 77 ± 8 
ΔLV ESP   1 ± 4 % 1 ± 5 % 
     
LV EDV (mL) 46 ± 7 41 ± 6 § 39 ± 7 39 ± 6 
ΔLV EDV   -8 ± 3 % -5 ± 3 % 
     
LV ESV (mL) 31 ± 5 30 ± 6 23 ± 6 ‡ 27 ± 6* 
ΔLV ESV   -36 ± 9 % -12 ± 4 % 
     
SV (mL) 15 ± 2 10 ± 1 § 16 ± 2 ‡ 12 ± 1** 
ΔSV   58 ± 16 % 13 ± 9 % 
     
CO (L•min-1) 2.0 ± 0.3 1.4 ± 0.1 § 2.1 ± 0.2 ‡ 1.5 ± 0.2** 
ΔCO   58 ± 16 % 13 ± 9 % 
     
dP/dtmax (mm Hg•s-1) 1346 ± 144 1087 ± 166 § 1109 ± 116 1144 ± 138 
ΔdP/dtmax   8 ± 8 % 9 ± 8 % 
     
dP/dtmin (mm Hg•s-1) -1679 ± 221 -1072 ± 165 § -1218 ± 181 -1243 ± 216 
ΔdP/dtmin   17 ± 7 % 17 ± 9 % 
     
SW (mJ) 137 ± 22 60 ± 14 § 113 ± 13 ‡ 75 ± 12* 
ΔSW   180 ± 94 % 65 ± 43 % 
 
Data: mean ± SEM; n=7. For CRT, below each performance index is the percentage change with respect to RV 
pacing. §P<0.05, RV pacing vs. RA pacing; ‡P<0.01, CRTa vs. RV pacing or CRTf vs. RV pacing; *P<0.05, 
**P<0.01, CRTf vs. CRTa. Abbreviations: HR = heart rate; MAP = mean arterial pressure; LV EDP, LV ESP = left 
ventricular end-diastolic and end-systolic pressure, respectively; LV EDV, LV ESV = left ventricular end-diastolic 
and end-systolic volume, respectively; SV = stroke volume; CO = cardiac output; dP/dtmax, dP/dtmin = maximum and 
minimum rate of change of LV pressure, respectively; SW = LV stroke work; RA = right atrial; RV = right 
ventricular; CRTa = cardiac resynchronization therapy at LV apex; CRTf = cardiac resynchronization therapy at LV 
free-wall. 
4.3.3 Resynchronization with CRT 
As illustrated in Figure 4-4, CRT using LV apical pacing (CRTa) restored radial synchrony to 
that seen with RA pacing, with the synchrony index increasing to 11.7 ± 0.6 (P<0.01 vs. RV 
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pacing and P=NS vs. RA pacing).  Similarly, CRT using LV free-wall pacing (CRTf) also 
significantly improved radial synchrony by increasing the synchrony index to 9.8 ± 1.1 (P<0.01 
vs. RV pacing and P=NS vs. RA pacing).  The synchrony index was not significantly different 
between the two CRT modes (P=NS, CRTf vs. CRTa). 
Although some scatter existed, the newly developed synchrony index (i.e., cross-
correlation coefficient sum) was significantly correlated with two commonly used measures of 
dyssynchrony (Figure 4-5A, B).  Quantification of dyssynchrony using these two indices 
(Figure 4-5C, D) yielded the same results as those obtained using the cross-correlation analysis 
(i.e., decreased synchrony with RV pacing and significant improvement of synchrony with both 
CRT modes). 
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 Figure 4-5. Comparison of the new synchrony index with two currently used indices. 
 
Top Panels: Significant correlations were observed between the newly developed measure of synchrony (cross-
correlation coefficient sum) and the two currently used indices [(A) time difference between earliest and latest peak 
segmental strain (Time Delay); (B) standard deviation (SD) of time to peak strain for six segments]. Bottom Panels: 
Mean values of commonly used dyssynchrony indices [(C) Time Delay; (D) SD of Time to Peak Strain] for each 
pacing mode. For both indices, compared to the control condition (RA pacing), RV pacing resulted in marked 
increase in contraction dyssynchrony, as indicated by increased values, and both CRT modes restored synchrony to 
RA values. Data: mean ± SEM; n = 7; ‡P<0.01 vs. RA pacing. Abbreviations as in Figure 4-1. 
4.3.4 CRT and Global LV Performance 
Hemodynamic data and calculated variables under RV pacing and both CRT modes (CRTa and 
CRTf) are presented in Table 4-1.  Below each performance index is the percent change with 
respect to its value with RV pacing. 
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When CRTa was used to correct for RV pacing-induced contraction dyssynchrony, mean 
arterial pressure (MAP) and LV end-systolic pressure (ESP) did not change.  However, global 
LV systolic performance was significantly improved with CRTa (SV: 16 ± 2 mL; CO: 2.1 ± 0.2 
L•min-1; SW: 113 ± 13 mJ; all P<0.01, CRTa vs. RV pacing).  The increase in CO was primarily 
a result of significantly lower LV end-systolic volume (ESV: 23 ± 6 mL; P<0.01, CRTa vs. RV 
pacing).  Although most LV systolic performance indices were increased with CRTa, LV 
dP/dtmax did not change (P=NS, CRTa vs. RV pacing).  Furthermore, diastolic performance was 
unaltered compared to the RV pacing mode as evidenced by unchanged LV dP/dtmin and end-
diastolic volume (P=NS, CRTa vs. RV pacing). 
Surprisingly, despite a significant improvement of radial synchrony with CRTf, global 
LV function was not altered with respect to RV pacing.  Furthermore, SV, SW and CO were all 
significantly less with CRTf than with CRTa (P<0.05 vs. CRTa).  Thus, there seems to be 
discordance between restoration of radial synchrony and global LV performance following 
CRTf. 
The differential response with respect to the improvement in global LV systolic function 
between the two CRT modes can be better appreciated from the data illustrated in Figure 4-5.  
For CRTf, the changes in global LV systolic performance indices hovered around zero, even 
when there was significant improvement in radial synchrony.  In contrast, CRTa resulted in 
improvements in both radial synchrony and global LV systolic performance.  Despite the 
variability in global LV performance (especially for dP/dtmax), the changes in these indices were 
proportional to the improvements in radial synchrony with CRTa (Figure 4-6). 
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 Figure 4-6. Percentage change in global LV performance indices and synchrony index. 
 
Relationships between percentage changes in global performance indices [(A) dP/dtmax, (B) CO, (C) SW] and 
percentage changes in synchrony index. Percentage changes were calculated with respect to the values for RV 
pacing. Closed and open circles correspond to CRTa and CRTf values, respectively.  As CRTa improves synchrony, 
there is a concordant improvement in global LV performance. However, despite increasing synchrony with CRTf, 
global LV performance is unaltered. Abbreviations as in Figure 4-1 and Table 4-1. 
 
Representative pressure-volume loops for RV pacing and both CRT modes are shown in 
Figure 4-7.  Compared to RV pacing (i.e., the dyssynchrony model), CRTa significantly 
decreased LV end-systolic volume, without any change in end-systolic pressure (Table 4-1), 
indicating augmented global LV contractile state.  Although a similar pattern of changes in ESV 
and ESP was seen with CRTf, the decrease in ESV did not reach statistical significance (Table 
4-1), indicating modest or no change in global LV contractility with respect to RV pacing. 
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 Figure 4-7. Representative P-V loops under dyssynchrony and CRT. 
 
With respect to RV pacing (red), CRTa (green) resulted in significantly lower end-systolic volumes, with little 
change in end-systolic pressures, suggesting increased LV contractility with CRTa. In contrast, CRTf (blue) was 
associated with modest or no change in LV contractility as judged by the changes in end-systolic pressure-volume 
points (see Table 4-1 for group average values). Abbreviations as in Figure 4-1. 
 
4.3.5 Effects of LV Pacing Alone 
Given that LV pacing can create dyssynchronous contraction by itself [18], we assessed radial 
dyssynchrony under LV apical (LVa) and LV free-wall (LVf) pacing alone (i.e., in the absence 
of simultaneous RV pacing).  With LVa pacing alone, our synchrony index decreased slightly 
(9.8 ± 1.1); however this was not significantly different from the RA pacing value (11.1 ± 0.8; 
P=0.23).  In contrast, LVf pacing alone significantly decreased the synchrony index to 4.5 ± 1.7 
(P = 0.002, LVf vs. RA).  Thus, the observation that CRTf failed to improve global LV systolic 
performance in spite of a significant improvement in radial synchrony may be a consequence of 
the dyssynchronous effects of LVf pacing alone.  In addition, radial synchrony may not have 
been restored with CRTf at all cross-sectional planes (we only examined synchrony at the mid-
LV level). 
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4.4 DISCUSSION 
The current study reports three primary findings. (1) Although both modes of CRT (CRTa and 
CRTf) significantly restored radial synchrony, only CRTa increased global LV systolic function.  
(2) The improvement in global LV systolic function with CRTa appears to be driven by 
increased LV contractility, as indicated by an increase in SV with unchanged LV EDV, LV ESP, 
and HR.  (3) The dissociation between changes in synchrony and global LV performance with 
CRTf suggests that regional analysis from a single plane may not be sufficient to adequately 
characterize contraction synchrony.  We also report a new index to quantify LV synchrony using 
pair-wise cross-correlations of six LV wall regions.  Before we discuss the current findings, we 
will first address certain methodological considerations. 
4.4.1 Methodological Considerations 
4.4.1.1 Dyssynchrony Model 
Two relevant issues need to be noted here.  First, we did not study the impact of dyssynchrony or 
CRT in the setting of chronic structural conduction abnormalities such as blockage of the His-
Purkinje System or myocardial ischemia/infarction.  Instead, we used RV pacing as a model of 
LBBB-like contraction pattern.  Right ventricular pacing is known to produce delayed LV 
contraction [20] and consequently, LV contraction dyssynchrony, which has been shown to 
decrease stroke volume, stroke work, and LV pressures [42].  Although RV pacing-induced 
dyssynchrony has been used previously [19, 20, 42], functional differences in contraction 
resynchronization using an intact conduction system may not extrapolate to studies where 
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anatomical LBBB is present.  Second, we studied the effect of dyssynchrony and CRT in 
healthy, non-failing hearts.  Contractile and structural changes occur in heart failure that may 
alter the response of CRT.  Future studies involving a heart failure model with structural defects 
will address these issues. 
4.4.1.2 Consequence of Short A-V Delay 
The animal model used in the current study involved an intact conduction system; therefore a 
short A-V delay was necessary to avoid intrinsic activation of the ventricles (i.e., fusion beats).  
However, a short A-V delay often leads to inefficient atrial emptying because the atrium is 
forced to contract against the closed mitral valve [86], which adversely affects A-V coupling by 
decreasing LV preload.  Therefore, the observed lower end-diastolic volumes with RV pacing 
and CRT may be a consequence of the short A-V interval used in the current study.  It should be 
noted, however, that our inferences regarding the differential effects of the modes of CRT (CRTa 
vs. CRTf) on LV global performance are not confounded by the short A-V delay because this 
short delay existed for all three conditions (RV pacing, CRTa, CRTf ) that were included in the 
statistical analysis.  Furthermore, in a previous study using this model we performed A-V nodal 
ablation and saw no differences in regional or global function with CRT as compared to the 
intact A-V node condition (data not shown). 
4.4.2 Quantification of Dyssynchrony 
Quantification of contraction dyssynchrony is an emerging interest in cardiology and several 
different indices have been reported to assess it.  We developed a new algorithm to quantify LV 
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synchrony by pair-wise cross-correlation analysis of LV regional TD segmental strain.  
Previously, mechanical dyssynchrony has been quantified using time to peak systolic 
longitudinal velocity using TD from echocardiographic apical views and expressed principally as 
either the standard deviation of 12 segments or the maximum opposing wall delay [39, 43, 87, 
88].  However, difficulties may exist with TD angle dependence, signal noise, translational 
effects of scar, and variations in heart rate [12, 38, 39, 41], which can make this approach less 
robust.  Angle-corrected TD imaging minimizes some but not all of the angle dependence bias.  
Importantly, tissue strain echocardiography has the advantage over TD velocity with respect to 
differentiating active contraction from passive motion or tethering, which are important 
confounding variables in patients with ischemic heart disease [42]. 
Mid-ventricular cross-sectional radial strain has recently been shown to predict both 
acute and chronic clinical response to CRT using the maximal time delay between earliest and 
latest peak strain [43, 44].  Although our new index significantly correlated with this index, 
cross-correlation analysis is expected to be superior in assessing LV contraction synchrony.  Our 
synchrony algorithm assesses the entire systolic portion of the time-strain waveform, and thus 
offers a more robust method in assessing contraction synchrony.  It also overcomes the limitation 
of variations in heart rate because each region is compared to a common end-systole.  However, 
because our new algorithm was applied to a non-ischemic, non-heart failure model, we cannot 
prove superiority over other indices at this time.  Future studies involving an ischemic model will 
address this issue.  Importantly though, as this algorithm is assessed, one limitation must be kept 
in mind: the inability of cross-correlation analysis to distinguish differences in amplitude.  If 
heterogeneity of contractile state exists between segments that are temporally synchronous, 
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cross-correlation analysis will not identify the contractile disparity.  However, this type of 
dyssynchrony may not be amenable to pacing therapy [89]. 
The current study used TD radial strain at a mid-papillary view to assess contraction 
dyssynchrony.  Although twelve longitudinal segments were used to calculate the dyssynchrony 
index in other studies [85], we were limited to six segments in our analysis for two reasons: 1) 
Doppler calculations are not possible where the angle of incidence approaches 90º, and 2) 
increasing the number of segments in processing TD data increases the signal-to-noise ratio, 
which jeopardizes the reliability of the data.  We plan to improve our analysis in future studies 
by using speckle-tracking algorithm of routine echocardiographic images, which will allow us to 
apply our cross-correlation analysis on more LV regions to better quantify contraction 
synchrony. 
4.4.3 LV Pacing Sites: Implications for CRT and Contraction Synchrony Analysis 
We saw significant improvements in global LV performance compared to RV pacing only with 
CRTa, even though both CRTa and CRTf significantly improved contraction synchrony.  Thus, it 
appears that LV apical pacing is superior to LV free-wall pacing in CRT if no structural 
limitations to cardiac conduction co-exist.  Recently Helm et al. [90] have reported that CRT 
response was better with LV apical pacing compared to more basal stimulation.  They used a 
custom epicardial sock with 128 stimulating/recording electrodes and showed that mechanical 
synchrony and global LV function was better preserved as the LV pacing site was moved more 
apically.  Similarly, Peschar et al. [91] and Prinzen et al. [92] reported beneficial effects on 
global LV performance following biventricular (RV apex + LV apex) pacing in healthy dogs.  
Furthermore, Vanagt et al. [93] showed that the LV apex was the optimal pacing site in both 
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canines and humans.  Apical stimulation may be more beneficial to global LV function because 
it triggers mechanical activity closest to the intrinsic pattern of contraction.  Propagation of 
electrical signals is fastest when the stimulation is nearest to the sites where the intrinsic 
impulses exit the Purkinje system [18].  Since impulses exit the Purkinje system in the lower 
third of the LV wall [94], apical stimulation should induce an activation pattern similar to 
intrinsic myocardial activation thus contributing to improved global LV performance. 
We used changes in the end-systolic pressure-volume point to draw the conclusion that 
only CRTa significantly increased LV contractile state as compared to RV pacing.  It is 
acknowledged that the entire end-systolic pressure-volume relationship (ESPVR) would have 
been better for this purpose.  However, significant reductions in LV ESV with little or no change 
in ESP provide a reasonably sound basis for our conclusion.  Although ESPVR has been used to 
quantify changes in LV contractile state following restoration of synchrony [52, 95], most 
previous studies have used dP/dtmax as the index of LV contractility.  In the present study, CRTa 
did not increase the group average value of dP/dtmax, but this response was variable among 
different experiments (Figure 4-6).  We attribute this variability to concomitant changes in LV 
end-diastolic volume, which, together with LV contractility, can affect LV dP/dtmax [96].   
In contrast to our results regarding CRTf, some studies have reported a benefit in LV 
global function with LV free-wall pacing.  Leclercq et al. [81] induced LBBB via radiofrequency 
ablation in canines, and showed that both single-site and multi-site LV free-wall pacing 
significantly increased dP/dtmax and aortic pulse pressure compared to their LBBB mode.  
Verbeek et al. [46] also showed increases in dP/dtmax and stroke work with LV free-wall pacing 
relative to LBBB values.  The differences in the dyssynchrony model may contribute to the 
discrepant observations.  Whereas we used a pacing-induced model of dyssynchrony, Leclercq et 
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al. and Verbeek et al. used a structural insult to induce dyssynchrony.  However, it is important 
to note that several other studies have supported our finding that LV free-wall pacing is an 
inferior pacing site in the context of resynchronization [90-93].  The conflicting results 
concerning benefit of LV free-wall pacing remain an unresolved issue in CRT research that 
needs further clarification. 
We were also surprised to find that improvements in regional contraction synchrony with 
CRTf were not accompanied by improvements in global LV function (Figure 4-6).  This 
apparent disconnect may be due to the limitations of synchrony analysis using single-plane 
views.  Because the LV free-wall pacing site was in the same cross-sectional plane (mid-LV) as 
that used for TD imaging, it is not surprising that electrical stimulation synchronized contraction 
in this plane.  However, due to slow conducting myocardium [18], delayed activation of the 
remainder of the LV free-wall may have failed to correct contraction dyssynchrony at other 
planes.  Therefore, the failure of global function to improve with CRTf may be a result of 
continued presence of contraction dyssynchrony at sites outside of the mid-LV plane.  Multi-
plane assessment of synchrony is necessary for a more comprehensive characterization. 
4.5 CONCLUSIONS 
Following RV pacing-induced LBBB-like contraction patterns, differential effects were observed 
with two different LV pacing sites during CRT.  Although both modes of CRT significantly 
improved radial contraction synchrony, only CRTa improved global LV performance, likely due 
to increased global LV contractility.  Thus, the LV apex appears to be a superior pacing site in 
the context of cardiac resynchronization therapy.  The observed dissociation between changes in 
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regional contraction synchrony and changes in global LV performance with CRTf suggests that 
regional contraction data obtained from a single cross-sectional plane may not be sufficient to 
adequately characterize contraction synchrony of the LV as a whole; 3D dataset may be 
necessary. 
In summary, the current study introduced the utility of cross-correlation algorithm as a 
robust tool to quantify radial contraction dyssynchrony.  Unfortunately, we found a disconnect 
between regional and global LV function with CRTf possibly due to inadequate characterization 
of LV contraction afforded by TD-derived strain at the mid-LV.  The next study aims to better 
characterize regional LV function using cross-correlation analysis on speckle-derived radial 
strain at multiple LV short-axis levels and investigate the mechanism of changes in global LV 
performance with resynchronization. 
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5.0  STUDY 3: A METHOD TO QUANTIFY SEGMENTAL CONTRIBUTIONS TO 
THE INTEGRATED MEASURE OF CONTRACTION SYNCHRONY 
Specific Aim 3. To investigate the link between regional and global LV function under different 
contraction patterns induced by ventricular pacing at various sites. 
Specific Aim 4. To apply cross-correlation analysis to a multi-plane dataset to quantify integral 
and segmental synchrony for a comprehensive characterization of regional LV 
function. 
5.1 INTRODUCTION 
The COMPANION and CARE-HF trials firmly established the therapeutic benefit of CRT in 
patients with refractory heart failure [7, 9]; however, as previously mentioned, about 30% of 
patients still do not respond to this therapy [4, 26].  These disappointing results have prompted 
investigators to develop better criteria that identify responders before pacemaker implantation.  
Despite its use as an indicator for CRT [2], QRS duration poorly predicts response to CRT [24, 
25].  With this knowledge, emphasis has recently shifted towards refining dyssynchrony criteria 
for CRT by using a mechanical index of dyssynchrony instead of an electrical marker. 
Several small single-center studies have shown that echocardiographic-derived 
mechanical markers of dyssynchrony demonstrate the ability to predict short-term [24] and long-
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term [26-29] response to CRT.  However, despite these promising results, when twelve different 
echocardiographic parameters were used to quantify ventricular dyssynchrony in a prospective, 
multicenter, nonrandomized clinical trial (PROSPECT trial), none of these measures were able to 
distinguish responders from non-responders to CRT to a significant degree [63].  The 
discrepancy between the PROSPECT trial and other small, single-center studies may be a result 
of several factors: (1) technological issues surrounding TDI methods that lead to significant 
interobserver variability, (2) high variability with measures derived from longitudinal imaging 
[97], and/or (3) variable definitions for study end points that identified responders  (e.g., end 
point defined as a clinical status parameter or as an echocardiographic variable such as a 
reduction in end-systolic volume (i.e., reverse remodeling)).  More importantly, it is clear that 
dyssynchrony is a dynamic process and a single measurement may not represent the entire 
burden of this mechanical disease.  Most mechanical indices use an integrated measure to 
quantify dyssynchrony, but information may be lost in using this “global” approach, masking the 
mechanisms underlying changes in contraction patterns. 
In the previous study, a disconnect was observed between regional and global LV 
function with CRTf possibly due to inadequate characterization of LV contraction afforded by 
TD-derived strain at the mid-LV.  The current study attempted to address this dissociation by 
assessing regional contraction patterns at multiple cross-sectional radial levels to more 
adequately characterize synchrony of the LV as a whole.  In addition, a method to quantify 
segmental contributions to the integrated measure of contraction synchrony was developed to 
offer better insight into contraction patterns.  Lastly, the current study better quantified global 
LV mechanical contractility under different ventricular pacing modalities. 
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5.2 METHODS 
5.2.1 Preparation 
The protocol was approved by the Institutional Animal Care and Use Committee and conformed 
to the position of the American Physiological Society on research animal use.  Eight mongrel 
dogs, weighing 20.6 ± 1.5 kg were studied after an overnight fast.  The same preparation as 
described in Section 4.2.1 was performed.  The placement of ventricular pacing leads is shown 
in the schematic in Figure 1A, B (star symbols). 
 
Figure 5-1. Schematic of pacing sites and short-axis echocardiographic imaging levels. 
 Ventricular pacing leads were placed at the RV outflow tract, LV free-wall, and LV apex (stars), shown for LV (A) 
short-axis and (B) long-axis views.  (C) Echocardiographic short-axis images at the LV base, mid-LV, and LV apex 
showing radial segmentation.  Note that the LV apex was segmented into only 4 regions instead of 6 because the LV
tapers as it approaches the apex.  Abbreviations: LV = left ventricular; RV = right ventricular; LVa = LV apex; LVf
= LV free-wall; I = inferior; P = posterior; L = lateral; A = anterior; AS = antero-septal; S = septal. 
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5.2.2 Protocol 
The protocol described in Section 4.2.2 was utilized with the exception of using an A-V delay of 
20 ms.  In addition to steady-state conditions, data was obtained during inferior vena caval (IVC) 
occlusion to evaluate global LV intrinsic properties. 
5.2.3 Echocardiographic Imaging and Speckle Tracking Analysis 
An echocardiographic system (Aplio 80, Toshiba Medical Systems Corp, Tokyo, Japan) was 
used to obtain images with a 3.0 MHz transducer directly applied to the heart.  Digital routine 
gray-scale 2D images from 3 consecutives beats were obtained at end-expiratory apnea from the 
LV basal, mid-LV, and LV apical short axis views at depths of 8 cm using a fixed transducer 
position.  The three short-axis views were identified using the following anatomical landmarks: 
LV base, mitral valve; mid-LV, papillary muscle; and LV apex, below the papillary muscle but 
before the end of the LV cavity.  Great care was taken to orient the images to the most circular 
geometry possible.  Gray scale images were collected at frame rates of 49 Hz and gain settings 
were adjusted to optimize endocardial definition.  Importantly, images were collected without 
LV conductance- or pressure catheters to eliminate the shadowing effects associated with these 
instruments. 
Speckle tracking analysis [98] was used to generate regional LV strain-time waveforms 
[44] from routine B-mode gray scale echocardiographic images at each of the three LV short-
axis levels.  Strain-time waveforms were generated using novel software (Toshiba Medical 
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Systems Corporation, Tokyo, Japan) for frame-by-frame movement of stable patterns of natural 
acoustic markers present in ultrasound tissue images over the cardiac cycle as previously 
described [44].  Briefly, a circular region of interest was traced on the endocardial and epicardial 
border of each LV short axis image, using a point-and-click approach.  The software 
automatically divided the region of interest into 6 equal radial segments: inferior (I), posterior 
(P), lateral (L), anterior (A), antero-septal (AS), and septal (S) (Figure 5-1C).  The LV tapers as 
it approaches the apex, so only 4 strain-time waveforms (I, L, A, and S; Figure 5-1C) were 
calculated for the apical short-axis view as recommended by the Cardiac Imaging Committee of 
the Council on Clinical Cardiology of the American Heart Association [99].  The segments 
automatically created by the software were adjusted as needed, and speckles within each segment 
were tracked in subsequent frames by the imaging software.  The location shift of these speckles 
from frame to frame represented tissue movement and provided the spatial and temporal data.  
Radial strain was calculated as change in length/initial length between speckles as ΔL/Lo.  
Myocardial thickening was represented as positive strain and thinning was represented as 
negative strain.  Radial strain values from multiple circumferential points within each segment 
were calculated and averaged into segmental strain-time curves, as previously validated in 
humans [44].  Quantification of radial synchrony was then performed offline. 
5.2.4 Integrated and Segmental Synchrony Analyses 
Radial synchrony was quantified by analyzing the speckle-derived strain waveforms with our 
proprietary algorithm “Cross-Correlation Analysis: A Novel Bedside Tool to Quantify Left 
Ventricular Contraction Dyssynchrony” (©2008 University of Pittsburgh).  This algorithm has 
been described in detail elsewhere [74] (also see Appendix B.1).  Briefly, an index of radial 
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synchrony (i.e., cross-correlation synchrony index, CCSI) was calculated in the time-domain via 
pair-wise correlation analyses of radial strain waveforms over systole for all myocardial 
segments at each LV short-axis level (integrated synchrony analysis).  Next, to quantify 
segmental contributions to the integrated measure of synchrony, a single CCSI was calculated for 
each segment within its respective short-axis level (segmental synchrony analysis). 
5.2.4.1 Integrated Synchrony Analysis 
Pair-wise cross-correlation analysis of regional strain waveforms was used to develop an 
integrated cross-correlation synchrony index (CCSIint) for each of the three cross-sectional levels 
(i.e., LV basal, mid-LV, and LV apical short-axis levels).  Given that strain data were acquired 
for 6 segments at the LV base and mid-LV, there are 15 segment pairs for each of those levels.  
Within each level, cross-correlation coefficients were obtained for each of the 15 pair-wise 
correlations, summed and normalized to the number of correlations (i.e., 15 for the base and mid-
LV).  A value of 1.0 for CCSIint would imply perfect synchrony and lower values would 
correspond to progressively greater dyssynchrony.  The 15 pair-wise correlations used to derived 
mid-LV CCSIint are shown in Figure 5-2.  The same correlations were used to derive LV basal 
CCSIint, however, the LV apical view possessed only 4 segments, giving 6 pair-wise correlations  
for derivation of LV apical CCSIint: (1) I vs. L; (2) I vs. A; (3) I vs. S; (4) L vs. A, (5) L vs. S; (6) 
A vs. S (Figure 5-2). 
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 Figure 5-2. Pair-wise correlations used to derive integrated measures of synchrony (CCSIint). 
 
Pair-wise correlations (in boxes) for derivation of CCSIint at each short-axis level.  For the derivation of either basal 
or mid-LV CCSIint, 15 correlations are used.  However, there are only 6 pair-wise correlations for the derivation of 
LV apical CCSIint, since this level possesses only 4 segments.  Abbreviations: CCSIint = integrated cross-correlation 
synchrony index; other abbreviations as in Figure 5-1. 
 
5.2.4.2 Segmental Synchrony Analysis 
For the segmental analysis, a CCSI was calculated for each segment (CCSIseg) from pair-wise 
correlations of that segment with all other segments within the same cross-sectional level.  For 
example, CCSIseg for segment I (i.e., CCSIseg I)at the mid-LV level contained the following pair-
wise correlations: (1) I vs. P, (2) I vs. L, (3) I vs. A, (4) I vs. AS, and (5) I vs. S (Figure 5-3A).  
Cross-correlation coefficients derived for each of these pairs were then summed and normalized 
by the total number of correlations (i.e., 5).  A value of 1.0 for CCSIseg would imply perfect 
synchrony for a given segment with respect to all other segments within the same cross-sectional 
level, and lower values would correspond to progressively greater segmental dyssynchrony.  This 
was repeated for the other 5 segments within its respective level to obtain 6 CCSIseg for the mid-
LV.  This was repeated for the LV basal level.  However, since the LV apex was divided into 4 
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segments instead of 6, CCSIseg for each segment had 3 pair-wise correlations instead of 5 as with 
the mid-LV or LV basal CCSIseg (Figure 5-3B). 
 
Figure 5-3. Pair-wise correlations used to derive segmental measures of synchrony (CCSIseg). 
 
(A) Each segment is associated with 5 pair-wise correlations for the mid-LV or LV base.  (B) For the LV apex, each 
segment is associated with 3 pair-wise correlations since the LV is divided into 4 segments at this level.  
Abbreviations: CCSIseg = segmental cross-correlation synchrony index; other abbreviations as in Figure 5-2. 
 
5.2.5 Global LV Mechanical Property Analysis 
Transient pressure-volume data obtained during IVC occlusion were used to quantify LV 
intrinsic mechanical properties.  Specifically, LV contractility was quantified in terms of end-
systolic pressure (ESP)-volume (ESV) relationship, ESPVR [ESP = Ees(ESV – Vd), where Ees 
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and Vd are parameters].  The slope of ESPVR, or end-systolic elastance (Ees), is commonly used 
as an index of contractility [56].  However, we found several hearts with increased Ees for 
conditions wherein LV contractility was clearly depressed, as indicated by a rightward shift of 
ESPVR over the entire operating range (Figure 5-4, solid vs. dashed lines).  Thus, we proposed a 
new index that simultaneously considered both slope (Ees) and intercept (Vd) values for proper 
evaluation of contractile state.  LV contractility was quantified by the area enclosed by ESPVR 
and Y-axis over the end-systolic pressure range of 60-120 mmHg.  This range was chosen based 
upon the working end-systolic pressure range identified throughout the entire study.  A larger 
area (e.g. rightward shift of ESPVR) would correspond to lower contractility and vice versa 
(Figure 5-4, shaded areas). 
 
Figure 5-4. Example of calculation of ESPVR area. 
 
Compared to RA pacing (solid line), ESPVR for RV pacing (dashed line) has a greater slope.  However, ESPVR for 
RV pacing is shifted to the right and pressure-volume loops are smaller signifying a more depressed ventricle. To 
quantify the contractility by taking both ESPVR slope and intercept into account, ESPVR area calculated from the 
RV pacing ESPVR to Y-axis (grey) is larger than that for RA pacing (grey hatched).  The greater ESPVR area 
indicates depressed contractility.  Abbreviations: RA = right atrial; RV = right ventricular; LV = left ventricular; 
ESPVR = end-systolic pressure-volume relationship. 
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5.2.6 Statistical Analysis 
Data are expressed as mean ± SEM.  One-way analysis of variance (ANOVA) with repeated 
measures was used to evaluate the effects of different pacing modalities on regional LV 
synchrony and indices of global LV performance.  Tukey-Kramer test was employed for post 
hoc pair-wise comparisons following each ANOVA.  Significance was determined as P<0.05.  
Linear regression analysis was used to compare CCSIint with a commonly used dyssynchrony 
index.  In addition, multiple linear regression analysis was performed to investigate whether 
additional regional information at the basal level (i.e., basal LV CCSIint) improved the predictive 
power of integrated cross-correlation analysis to identify response to CRT. 
5.3 RESULTS 
Although all echocardiographic images were of acceptable quality, strain data from one animal 
were associated with significant noise, reflecting poor speckle tracking.  Therefore, only 7 of 8 
strain datasets were used for synchrony analysis.  In addition, due to technical challenges, 
accurate steady-state LV pressure-volume data were available in only 7 of 8 experiments and 
inferior vena-caval occlusion data were collected in only 6 of 8 experiments. 
5.3.1 Integrated Synchrony Analysis 
Using the integrated approach, a synchronous contraction pattern was observed with RA pacing 
as indicated by a CCSIint near 1.0 at the LV base (Figure 5-5A, closed circles).  Synchrony was 
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adversely affected with RV pacing reflected by a significant decrease in basal CCSIint compared 
to RA pacing [0.95±0.02 to 0.64±0.14; P<0.05 RA to RV pacing].  Interestingly, 
resynchronization was only successful with CRTa as shown by an increase in CCSIint at the LV 
base [0.93±0.03; P<0.05 vs. RV pacing].  Although CRTf tended to improve synchrony 
compared to RV pacing, the increase in basal CCSIint did not reach statistical significance.  
Similar changes in CCSIint were observed at the mid-LV level; compared to RA pacing, mid-LV 
CCSIint markedly decreased with RV pacing, and only CRTa restored synchrony compared to 
RV pacing (Figure 5-5A, open circles).  Although it appeared that all ventricular pacing modes 
(i.e., RV pacing, CRTa, and CRTf) were associated with some radial dyssynchrony at the apex, 
differences in LV apical CCSIint did not reach statistical significance for any pacing modality 
(Figure 5-5B; P=0.32). 
 
Figure 5-5. Integrated measure of synchrony (CCSIint) for each short-axis view. 
 
CCSIint for (A) LV base (closed-circles), mid-LV (open circles), and (B) LV apex. Data: mean ± SEM, n=7, 
*P<0.05 vs. RA pacing, †P<0.05 vs. RV pacing.  Abbreviations: CCSIint = integrated cross-correlation synchrony 
index; RA = right atrial; RV = right ventricular; CRTa = resynchronization at the LV apex; CRTf = 
resynchronization at the LV free-wall.. 
 
 Although some scatter was present, both the basal and mid-LV CCSIint significantly 
correlated with a commonly used measure of dyssynchrony: time delay between earliest and 
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latest peak strain derived from data at the LV base and mid-LV, respectively (Figure 5-6A, B).  
A significant correlation between time delay and CCSIint was not observed at the apical level due 
to a great degree of scatter (R2=0.12, P=0.08; data not shown).  Trends for group comparisons 
using time delay as an index of dyssynchrony were similar those observed with CCSIint for both 
basal and mid-LV, however, a discrepancy was observed with one pacing modality (Figure 5-
6C, D).  Specifically, synchrony appeared to significantly improve with CRTf when quantified 
by time delay indices for the base and mid-LV (Figure 5-6C, D), whereas CCSIint was not 
statistically different than RV pacing for either cross-sectional level (Figure 5-5A). 
 
Figure 5-6. Correlation of new and standard (dys)synchrony indices and trends of standard 
measures of dyssynchrony for each pacing modality. 
 
Correlation of standard dyssynchrony index (i.e., time delay between earliest and latest peak strain) and CCSIint at 
two LV short-axis levels (A: LV base, B: mid-LV). Also shown are mean (±SEM) standard dyssynchrony measures 
for the (A) LV base and (B) mid-LV.  (A), (B): Data shown are for all pacing modes (RA, RV, CRTa, and CRTf). 
(C), (D): Data: mean ± SEM, n=7, *P<0.05 vs. RA pacing, †P<0.05 vs. RV pacing.  Abbreviations as in Figure 5-5. 
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5.3.2 Segmental Synchrony Analysis 
The synchronous contraction pattern observed with RA pacing can be better appreciated from the 
data presented in Figure 5-7A (left panel), where all CCSIseg are similar with relatively high 
values around 1.0.  To better illustrate this pattern, mean CCSIseg are color-coded and displayed 
in a Bull’s Eye representation shown in Figure 5-7A (right panel), with basal and mid-LV 
segments circling the outer ring and inner rings, respectively.  Note that apical CCSIseg are not 
shown because significant changes in CCSIint were not observed at the apex.  A relatively 
homogeneous yellow Bull’s Eye plot is shown for RA pacing indicating almost perfect 
synchrony (Figure 5-7A, right panel).  Unlike the pattern observed with RA pacing, CCSIseg 
values are less in value and uniformity with RV pacing (Figure 5-7B, left panel), reflected by the 
darker heterogeneous colors in the Bull’s Eye plot (Figure 5-7B, right panel).  Note that CCSIseg 
for the antero-septal (AS) and septal (S) segments at the LV base were less than that of the other 
segments, reflected by the darkest color in the Bull’s Eye plot.  However, these values were not 
significantly different than other CCSIseg within the basal level.  As stated above, CRTa 
improved the integrated synchrony measure (CCSIint) at both the basal and mid-LV short-axis 
levels.  Therefore, it was not surprising that CCSIseg values were not different from each other 
following CRTa (Figure 5-7C, left panel), which gave a relatively homogenous yellow Bull’s 
Eye plot (Figure 5-7C, right panel).  In contrast, a heterogeneous pattern was observed with 
CRTf, such that CCSIseg for the inferior (I) segment was significantly less than that for all other 
segments (Figure 5-7D, left panel).  This segment at the LV base and mid-LV is easily identified 
by the darkest orange colors on the Bull’s Eye plot, reflecting the most dyssynchronous segment 
(Figure 5-7D, right panel). 
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 Figure 5-7. Segmental synchrony indices (CCSIseg) and corresponding Bull’s Eye plots. 
 
CCSIseg at the LV base (closed circles) and mid-LV (open circles) under A: RA pacing, B: RV pacing, C: CRTa, 
and D: CRTf. Color-coded representations of CCSIseg are to the right of each plot with black corresponding to 
values ≤0.5 and yellow representing 1.0. Data: mean ± SEM, n=7, *P<0.05. CCSIseg = segmental cross-correlation 
synchrony index; other abbreviations as in Figure 5-1 and Figure 5-5. 
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In order to compare the performance of CCSIseg to commonly used dyssynchrony indices, we 
applied the same method of analysis to the time delay index (i.e., maximum time delay between 
earliest and latest peak strain) at the LV base and mid-LV.  Specifically, a time delay for each 
segment with respect to the remaining segments in the same cross-sectional level was calculated, 
and from these 5 calculated delays, an average delay for that segment was derived.  This 
procedure was used to derive an average delay for each of the 6 segments at the LV base and 
mid-LV. 
Following RA pacing and CRTa, patterns similar to those observed with CCSIseg were 
observed using the average time delay as a segmental index of synchrony (Figure 5-8A, C).  
Relatively homogenous, synchronous (i.e., low) delays for each segment were observed with 
both RA pacing and CRTa.  Although statistical significance was not reached, the LV basal 
inferior segment was associated with greatest dyssynchrony during RV pacing (Figure 5-8B).  
This observation cannot be physiologically reconciled with ease since RV outflow tract pacing 
mainly induces septal disparities.  Importantly, the CCSIseg data presented in Figure 5-7B above 
revealed that the antero-septal and septal segments were associated with the most segmental 
dyssynchrony with RV pacing, which is consistent with physiological reasoning.  In addition, the 
mean time delay for segmental dyssynchrony failed to identify the significant disparity 
associated with CRTf at the inferior region (Figure 5-8D) that was observed using CCSIseg 
(Figure 5-7D). 
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 Figure 5-8. Segmental time delay dyssynchrony indices. 
 
Segmental time delay at the LV base (closed circles) and mid-LV (open circles) under A: RA pacing, B: RV pacing, 
C: CRTa, and D: CRTf. Data: mean ± SEM, n=7. Abbreviations as in Figure 5-1 and Figure 5-5. 
 
5.3.3 Global LV Performance Analysis 
It is important to note that a short A-V delay adversely affects diastolic filling with ventricular 
pacing.  Therefore, pair-wise statistical comparisons did not include intrinsic RA pacing.  
However, since RV pacing was used as a model of dyssynchrony, it was important to show that 
this pacing modality adversely affected global LV function.  Therefore, we compared RA and 
RV pacing only, with awareness that some depression may be due to short A-V delay effects.  
RV pacing significantly impaired global LV performance as indicated by marked decreases in 
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cardiac output [CO: 2.9 ± 0.3 to 2.3 ± 0.2 L•min-1; P<0.05] and stroke work [SW: 252 ± 23 to 
151 ± 24 mJ; P<0.05] as well as other global LV performance indices (Table 5-1). 
 Similar to the patterns observed with regional synchrony, global LV performance was 
improved with only CRTa (Table 5-1).  Compared to RV pacing, end-systolic volume was 
significantly improved with CRTa which led to a marked increase in CO [3.2 ± 0.2 L•min-1; 
P<0.05 vs. RV pacing] and SW [240 ± 19; P<0.05 vs. RV pacing].  However, following CRTf, 
the only global LV performance index that showed improvement compared to RV pacing was 
dP/dtmin (Table 5-1). 
Table 5-1. Global LV performance values for different pacing modalities. 
 
 Dyssynchrony Resynchronization 
 RA Pacing RV Pacing P-value CRTa CRTf P-value 
HR (beats•min-1) 139 ± 3 139 ± 3 0.2437 139 ± 3 139 ± 3 0.8223 
LV ESP (mmHg) 109 ± 3 92 ± 5* 0.0041 94 ± 2 95 ± 3 0.611 
LV EDP (mmHg) 12 ± 2 11 ± 2* 0.0241 9 ± 2† 10 ± 2 0.0099 
MAP (mmHg) 96 ± 4 78 ± 5* 0.0012 83 ± 4 83 ± 4 0.1829 
EDV (mL) 40 ± 1 34 ± 2* 0.0022 34 ± 2 34 ± 2 0.9771 
ESV (mL) 19 ± 2 18 ± 2 0.3075 11 ± 2† 16 ± 2 0.0014 
SV (mL) 21 ± 2 17 ± 2* 0.0096 23 ± 1† 18 ± 2 0.0095 
CO (L•min-1) 2.9 ± 0.3 2.3 ± 0. 2* 0.0132 3.2 ± 0.2† 2.5 ± 0.2 0.007 
dP/dtmax(mmHg•s-1) 2063 ± 172 1603 ± 160* 0.0001 1946 ± 244† 1699 ± 163 0.0317 
dP/dtmin (mmHg•s-1) -2325 ± 175 -1684 ± 182* 0.0001 -2061 ± 166† -1973 ± 178† 0.0022 
SW (mJ) 252 ± 23 151 ± 24* 0.0019 240 ± 19† 175 ± 18 0.0073 
 
Data: mean ± SEM, n=7; *P<0.05 vs. RA pacing, †P<0.05 vs. RV pacing. Abbreviations: RA = right atrial; RV = 
right-ventricular; CRTa = biventricular apical; BiVf = biventricular free-wall; HR = heart rate; LV = left ventricular; 
ESP = end-systolic pressure; EDP = end-diastolic pressure; MAP = mean arterial pressure; EDV = end-diastolic 
volume; ESV = end-systolic volume; SV = stroke volume; CO = cardiac output; dP/dtmax = maximum rate of 
pressure rise; dP/dtmin = minimum rate of pressure rise; SW = stroke work. 
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5.3.4 Global LV Mechanical Property Analysis 
Compared to RA pacing, the commonly used index of contractility, Ees, increased with RV 
pacing [2.7 ± 0.5 to 5.1 ± 0.7 mmHg•mL-1; P<0.05; Figure 5-9A], a pattern inconsistent with 
changes in global LV performance.  In contrast, the volume-axis intercept of ESPVR, Vd, was 
significantly shifted to the right with RV pacing [-26 ± 5 to -2 ± 5 mL, RA to RV pacing; 
P<0.05; Figure 5-9B], thus, making it difficult to quantify global LV contractility using Ees 
alone.  However, ESPVR area, which simultaneously considers Ees and Vd, increased with RV 
pacing [697 ± 153 to 1019 ± 202 mmHg•mL, RA to RV pacing; P<0.05; Figure 5-9C].  
Therefore, compared to RA pacing, RV pacing was associated with depressed contractility as 
quantified by ESPVR area. 
 The effect of resynchronization on global LV mechanics was also not clear when 
comparing Ees or Vd (Figure 5-9A, B).  Compared to RV pacing, CRTa decreased both the slope 
(i.e., Ees) and intercept (i.e., Vd) of ESPVR.  However, when quantified using our new index, 
ESPVR area, LV contractility improved with CRTa compared to RV pacing, such that ESPVR 
area was less with CRTa than with RV pacing (Figure 5-9C).  This pattern was more consistent 
with changes in global LV performance and synchrony during CRTa.  As observed with regional 
function, CRTf was associated with contractility similar to that observed with RV pacing; 
ESPVR slope, ESPVR intercept, or ESPVR area were not different than RV pacing (Figure 5-
9A-C). 
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 Figure 5-9. Indices of global LV mechanical properties. 
 
Compared to RV pacing, Ees was lower with CRTa (A), indicating depressed LV contractility; however, the volume-
axis intercept was lower with CRTa (B), suggesting improved mechanics. With a combined index of Ees and Vd, 
ESPVR area was significantly less than that with RV pacing (C), indicating improved contractility, a pattern 
consistent with regional synchrony and global LV performance. Data: mean ± SEM, n=6; *P<0.05 vs. RA pacing , 
†P<0.05 vs. RV pacing. Abbreviations as in Figure 5-4 and Figure 5-5. 
 
5.3.5 Correlation of Global and Regional Changes 
We first investigated whether the CRT-induced changes in integrated synchrony measures 
(CCSIint) correlated with the changes in global LV performance (i.e., SW, Figure 5-10A ) and 
contractility (i.e., ESPVR area, Figure 5-10B).  All CRT-induced changes were calculated with 
respect to the values with RV pacing.  The univariate analysis revealed that neither mid-LV nor 
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basal CCSIint was significantly correlated with SW or ESPVR area (Table 5-2).  The 
multivariate analysis using mid-LV and basal CCSIint as two independent variables did not 
improve the correlation (Table 5-2). 
Since the segmental cross-correlation analysis provided useful information that identified 
particular segments that were responsible for the failure to resynchronize with CRTf, we also 
investigated whether this analysis provided a better link between changes in global LV function 
and contraction dyssynchrony.  Specifically, the change in CCSIseg was calculated for the most 
dyssynchronous segment during CRT with respect to its value at RV pacing, and was compared 
to the change in global LV function.  Univariate analysis revealed that neither mid-LV nor basal 
CCSIseg was significantly correlated with SW (Table 5-2).  Mid-LV CCSIseg did not predict 
changes in ESPVR area either, however, basal CCSIseg significantly correlated with changes in 
ESPVR (Table 5-2).  Accordingly, the multivariate analysis using mid-LV and basal CCSIseg as 
two independent variables improved the correlation (Table 5-2). 
Table 5-2. Regression statistical outputs for univariate and multivariate analyses. 
   Univariate Analysis Multivariate Analysis 
   LV Base Mid-LV LV Base and Mid-LV 
R2 0.03 0.03 0.04 
%Δ SW 
P 0.60 0.57 0.83 
R2 0.19 0.23 0.28 
ΔCCSIint 
%Δ ESPVR Area 
P 0.16 0.12 0.23 
%Δ SW R2 0.002 0.04 0.12 
 P 0.88 0.52 0.57 
%Δ ESPVR Area R2 0.68 0.18 0.74 ΔCCSIseg 
 P 0.0009 0.18 0.003 
 
Statistical analyses performed on data calculated from percent changes of CRTa and CRTf compared to RV pacing 
(n=6). Abbreviations: CCSIint, seg = integrated and segmental cross-correlation synchrony index, respectively; SW 
= stroke work; ESPVR = end-systolic pressure-volume relationship; LV = left ventricle. 
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 Figure 5-10. Correlation of global and regional LV function. 
 
Percent change in basal LV CCSIint (closed circles) and mid-LV CCSIint (opened circles) compared to percent 
change in stroke work (A) or ESPVR area (B).  Also, percent change in the most dyssynchronous basal and mid-LV 
CCSIseg were compared to percent change in stroke work (C) or ESPVR area (D).  Regression statistics are shown 
for multivariate analysis.  Abbreviations: CCSIint, seg = integrated and segmental cross-correlation synchrony index, 
respectively; ESPVR = end-systolic pressure-volume area. 
 
5.4 DISCUSSION 
The current study reports three primary findings.  (1) The proposed segmental synchrony 
analysis provided insight into changes in the integrated contraction pattern of the LV.  (2) In the 
setting of contraction dyssynchrony, ESPVR area is a better index of contractility than Ees alone.  
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(3) The addition of regional information at the basal LV level to that of the mid-LV level did not 
improve the predictive response of integrated synchrony index (i.e., CCSIint) to identify global 
LV improvement.  However, changes in the most dyssynchronous segment reflected as the 
segmental cross-correlation index (CCSIseg) significantly correlated with changes in global LV 
contractility.  Before we discuss these findings in detail, we will address an inconsistency 
encountered from our previous canine study. 
5.4.1 Tissue Doppler- vs. Speckle Tracking-Derived Strain 
In the previous study, we observed a disconnect between changes in global and regional LV 
function such that CRTf resynchronized contraction without improving global LV performance 
(see Section 4.0).  It appeared that evaluation of regional wall motion at the mid-LV using TD-
derived strain was not sufficient to completely characterize synchrony of the entire LV.  
However, in the current study, dyssynchrony was observed with CRTf at both the LV base and 
mid-LV as characterized by speckle tracking-derived strain data.  The lack of a significant 
correlation between regional and global LV function may suggest a disconnect in the current 
study, however, the failure to resynchronize with CRTf was consistent with the depression in 
global LV performance.  The discrepancy in observations of synchrony patterns with CRTf may 
be due to the different echocardiographic methods (i.e., color-coded TD vs. speckle tracking) 
used to derive strain in the two studies. 
 In the current study, it appeared that speckle-tracking algorithm more accurately 
characterized contraction patterns occurring across the entire circumference of the myocardium 
than did TD-derived strain in the previous study.  To further investigate this, we derived CCSIseg 
for TD-derived strain waveforms from the previous study.  Consistent with the current study, 
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analysis of the CCSIseg data revealed that RA pacing was not associated with any significant 
disparities across segments; however, CCSIseg indices were lower than expected for a control 
condition (Figure 5-11A).  Similar to the current study, RV pacing induced significant 
dyssynchrony at the mid- and antero-septal (MS and AS, respectively) segments (Figure 5-11B).  
However, resynchronization appeared to be successful with both CRTa and CRTf as indicated by 
nearly homogenous CCSIseg within both pacing modalities (Figure 5-11C, D).  Therefore, unlike 
the current study, disparities at the inferior region with CRTf were not identified when using TD 
derived strain to quantify myocardial contraction.  We therefore concluded that speckle tracking 
derived strain in the current study more accurately quantified contraction patterns than TD 
derived strain in the previous study. 
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 Figure 5-11. CCSIseg and corresponding Bull’s Eye plot for TD derived strain. 
 
CCSIseg at the mid-LV for TD derived strain under A: RA pacing, B: RV pacing, C: CRTa, and D: CRTf. Color-
coded representations of CCSIseg are to the right of each plot with black corresponding to values ≤0.3 and yellow 
representing 1.0. Data: mean ± SEM, n=7, *P<0.05. Abbreviations: I = inferior; P = posterior; PL = postero-lateral; 
AL = antero-lateral; MS = mid-septum; AS = antero-septal; other abbreviations as in Figure 5-7. 
 
A major limitation of TD imaging is that sectors are masked where the angle of incidence 
approaches 90º; therefore myocardial wall motion cannot be quantified for those masked regions 
(Figure 5-11A) [42].  However, speckle-tracked-derived strain may prove superior because it is 
angle independent [100], therefore the entire circumference of the myocardial can be segmented 
(Figure 5-11B).  Interestingly, in the previous study, the inferior segment borders one of the 
regions masked by the angle of incidence (Figure 5-11A).  Importantly, regions that approach 
the angle of incidence are more difficult to image, which may have contributed to a less accurate 
tracing with TD-derived strain in the previous study.  In contrast, when speckle tracking 
algorithm was applied to standard 2D echocardiographic images in the current study, tracing at 
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the inferior region was not compromised due to the angle independent advantage of this 
modality, therefore allowing for more accurate imaging and strain derivation at this region. 
 
Figure 5-12. Comparison of image modalities. 
 
(A) Short-axis Tissue Doppler (TD) image at mid-LV showing that segmentation is not possible at angles 
approaching 90° from the Doppler beam. (B) Standard gray-scale short-axis 2D image at the mid-LV showing that 
segmentation is possible across the entire circumference of the myocardium with speckle tracking algorithm. 
 
5.4.2 Quantification of Synchrony: Integrated vs. Segmental Approach 
Most echocardiographic-derived measures use an integrated approach to quantify dyssynchrony.  
For example, dyssynchrony metrics have been derived from time to peak systolic velocity using 
TDI from echocardiographic apical or short-axis views and expressed principally as either the 
standard deviation of 12 segments or the maximum opposing wall delay [39, 43, 87, 88].  
However, using these integrated measures, it is difficult to determine the role of individual 
segments in overall synchrony.  For example, the time delay index uses information from only 
the two extreme peak values (i.e., earliest and latest).  To address this issue, we developed a 
method to quantify segmental contributions to the integrated measure of contraction synchrony.  
An advantage of the CCSIseg index derived from this methodology is that it characterizes the 
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synchrony of a particular segment with respect to all other segments within the same cross-
sectional level.  Importantly, the segmental cross-correlation approach offers insight into the 
mechanism behind overall synchrony patterns.  For example, in the current study, we determined 
that the basal antero-septal and septal segments may be responsible for the overall decrease in 
synchrony with RV pacing and that resynchronization failure with CRTf was due to contraction 
disparities at the basal and mid-LV inferior segments.  Furthermore, the color-coded plot of 
CCSIseg offers a visual representation of those segments responsible for dyssynchrony; this 
presentation has potential clinical applications for ease of interpretation. 
Although many studies have focused on developing echocardiographic-derived measures 
to quantify dyssynchrony and identify patients for CRT [26, 29, 35, 43, 44], due to conflicting 
results, a standard approach to quantifying dyssynchrony has yet to be established.  It is therefore 
not surprising that utilization of an echocardiographic-derived dyssynchrony parameter is 
presently not recommended to identify patients for CRT [101].  Metrics used in these studies 
have used an integrated approach as mentioned above, however, some segmental disparities may 
be diluted when all pieces are incorporated into a single index.  The loss of this information may 
contribute to the lack of correlation with integrated dyssynchrony measures and response to 
CRT.  Although we failed to find a significant correlation between change in global LV function 
and change in CCSIint, changes in the most dyssynchronous segment as determined by CCSIseg 
predicted changes in global LV contractility.  The use of CCSIint appears to be advantageous in 
assessing overall trends, however changes in the integrated measures of radial synchrony at a 
single or multiple cross-sectional levels are unable to consistently predict the changes in global 
LV function.  These results indicate that multi-faceted dyssynchrony analysis (perhaps, one that 
includes measures of longitudinal dyssynchrony) is necessary for establishing a better link 
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between contraction dyssynchrony and global LV function.  Regardless, it is clear that 
application of cross-correlation analysis to individual segments (i.e., derivation of CCSIseg) 
allows one to identify the mechanism behind contraction patterns.  Furthermore, improvement in 
global LV contractility appeared to be dependent on resynchronization of the most 
dyssynchronous segment (i.e., changes in the lowest CCSIseg).  We expect this new methodology 
to have clinical application in that evaluation of individual segments using cross-correlation 
analysis may offer insight into the underlying response or non-response to CRT. 
5.4.3 Quantification of Global LV Contractility: Ees vs. ESPVR Area 
The slope of ESPVR, or end-systolic elastance (Ees), is commonly used as an index of 
contractility.  However, in the current study, LV contractility was not always adequately 
described using Ees.  For example, there were several instances where both Ees and Vd increased 
(Figure 5-4, dashed ESPVR).  Based on Ees alone, this would imply increased contractility, but a 
rightward shift of ESPVR (i.e., increased Vd) indicates depressed contractility.  Recently, 
Burkhoff et al. noted that LV contractility should only be assessed using Ees alone in well-
defined conditions [102].  Deviations from ideal conditions (e.g., dyssynchronous contraction as 
in the current study) warrant evaluation of LV contractility using both Ees and Vd together.  
Analysis of co-variance (ANCOVA) can be used to simultaneously assess changes in two 
parameters [102].  Although this approach will identify changes in Ees and/or Vd, it does not 
rank-order the contractile states of two conditions.  To address this issue, we developed a new 
method that considers the entire ESPVR over the operating range and quantifies contractility in 
terms of a single number.  Importantly, this new index, ESPVR area, better quantified changes in 
LV contractility than Ees alone. 
 92 
Quantification of LV contractility with ESPVR area clearly and consistently showed a 
decrease in LV contractility (i.e., larger area) with RV pacing in the current study.  Others have 
also reported a detriment in LV contractility following RV pacing in canines [51, 79].  However, 
one study observed a decrease in Ees with little change in Vd [79] and the other study noted a 
rightward shift of ESPVR (i.e., increased Vd) without a change in Ees [51].  This further supports 
the use of ESPVR area to simultaneously account for Ees and Vd in quantifying LV contractility. 
5.5 CONCLUSIONS 
Compared to RA pacing, RV pacing induced a significant decease in the integrated measure of 
synchrony (CCSIint) and only CRTa improved synchrony at both the basal and mid-LV levels.  
Application of cross-correlation algorithm to individual segments revealed that the inferior 
segment was responsible for the failure to resynchronize with CRTf at both the LV basal and 
mid-LV levels; however, a similar approach using standard time delay indices could not 
distinguish any segmental contraction disparity with this pacing modality.  Thus, the proposed 
segmental synchrony analysis using cross-correlation algorithm provided better insight into 
changes in the integrated contraction pattern of the LV.  The utility of this segmental approach 
was further emphasized by the finding that improvement in global LV contractility appeared to 
be dependent on the degree of resynchronization of the most dyssynchronous segment.  Finally, 
it was shown that both the slope (Ees) and intercept (Vd) of ESPVR must be considered 
simultaneously to accurately quantify LV contractility when contraction dyssynchrony is present.  
Therefore, ESPVR area is a better index of contractility than the traditional Ees under conditions 
of dyssynchrony. 
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The current study addressed some of the questions raised in Study 2.  First, we derived a 
method to better quantify global LV contractility by incorporating both the slope and intercept of 
ESPVR into a single index (i.e., ESPVR area).  Second, although we did not observe the 
disassociation between regional and global LV function that was reported in the previous study 
with CRTf when comparing average trends, changes in integrated measures of radial synchrony 
at a single or multiple cross-sectional levels were unable to consistently predict the changes in 
global LV function.  These results indicate that multi-faceted dyssynchrony analysis (perhaps, 
one that includes measures of longitudinal dyssynchrony) is necessary for establishing a better 
link between contraction dyssynchrony and global LV function. 
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6.0  STUDY 4: SYNCHRONY ANALYSIS IN THE SETTING OF HEART FAILURE 
Specific Aim 5. To assess global LV function and synchrony patterns in a tachycardia pacing-
induced model of heart failure. 
6.1 INTRODUCTION 
In the previous two studies, we assessed the differential effects of pacing sites on regional LV 
synchrony and global LV performance and contractility.  Specifically, we showed in healthy 
hearts that RV outflow tract pacing induced significant radial dyssynchrony at the LV base and 
mid-LV mainly due to underlying disparities at the antero-septal and septal regions.  In addition, 
we showed that global LV performance and contractility were depressed with RV pacing.  In an 
attempt to counteract this dyssynchronous contraction pattern, we showed that LV free-wall 
pacing (i.e., CRTf) failed to resynchronize the LV due to disparities at the inferior region.  
Furthermore, we did not observe any improvements in hemodynamic function or LV intrinsic 
contractile properties with resynchronization using LV free-wall pacing.  Although cardiac 
pacing is often used in patients with normal or near-normal cardiac function, CRT is a unique 
pacing therapy that targets patients with dyssynchrony in refractory heart failure [2].  Therefore, 
the goal of the present study was to investigate how the presence of heart failure (HF) influences 
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the link between LV contraction dyssynchrony and global mechanical behavior.  A canine model 
of HF induced by chronic tachycardia pacing was used for this purpose. 
6.2 METHODS 
6.2.1 Pacemaker Implantation and Heart Failure Model 
The protocol was approved by the Institutional Animal Care and Use Committee and conformed 
to the position of the American Physiological Society on research animal use.  Five mongrel 
dogs, weighing 19.9 ± 0.6 kg were studied over a period of 8 weeks.  During a thorocotomy, 
pacing leads were epicardially sewn into the right atrium, right ventricular outflow tract, and left 
ventricular free-wall.  An endocardial lead was also screwed into the right ventricular apex for 
tachycardia-induced heart failure.  One week after the surgery, baseline echocardiographic 
evaluation was performed (referred to as Day 0, Figure 6-1).  Tachycardia pacing was initiated 
after baseline data was collected.  Each dog was endocardially paced at the RV apex at 200 
beats•min-1 for 5 weeks to induce HF, and thereafter, tachycardia stimulation was permanently 
discontinued to allow recovery for 3 weeks. 
6.2.2 Pacing Protocol and Echocardiography 
Subjects were serially studied every week over an eight week period (Figure 6-1).  During each 
study, subjects were pre-medicated with intramuscular injection of acepromazine [0.2 mL] 30-60 
minutes prior to the study.  Tachycardia pacing was confirmed with a pulse oxymeter and 
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temporally discontinued before the induction of isoflurane.  Anesthesia was performed using 
masked isoflurane initially at 3-3.5%, and subjects were quickly weaned to 1.5-2%.  
Echocardiographic images were collected and strain was derived using speckle tracking 
algorithm as described in Section 5.2.3.  Images were collected under control RA pacing, 
dyssynchronous RV pacing, and biventricular free-wall pacing (i.e., RV + LV free-wall pacing; 
CRTf).  Importantly, ventricular stimulation was associated with simultaneous RA pacing to 
control for heart rate across pacing conditions.  In addition, an A-V delay of 20 ms was used to 
prevent fusion beats.  After echocardiographic data was obtained, tachycardia pacing was 
initiated until the following week.  Note that after Day 35, tachycardia pacing was permanently 
discontinued, and the subject was allowed to “recover” for three weeks.  Indices of global LV 
function were derived from standard echocardiographic techniques and included end-diastolic 
volume, end-systolic volume, and ejection fraction. 
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 Figure 6-1. Chronic heart-failure model study design. 
 
At Day 0, after baseline echocardiographic data was obtained, tachycardia pacing was initiated.  Note that during 
each echocardiographic study, tachycardia pacing was temporally discontinued.  The duration of chronic tachycardia 
pacing was 35 days, followed by 21 days of recovery without tachycardia pacing.  Abbreviations: RA = right atrial; 
RV = right ventricular; CRTf = resynchronization at the LV free-wall; HF = heart failure. 
6.2.3 Regional Analysis: Quantification of Synchrony 
Radial strain waveforms were derived from standard echocardiographic grey scale images for 6 
radial segments at the base and mid-LV and 4 at the apical level as described in Section 5.2.3.  
However, due to poor image quality at the LV base and apical-LV short-axis views, 
dyssynchrony analyses were only applied at the mid-LV level.  Cross-correlation analysis was 
performed at both the integrated and segmental levels to quantify synchrony by CCSIint and 
CCSIseg, respectively, as described in Section 4.2.4.  In addition, dyssynchrony was quantified 
using current measures such as the maximum time delay between earliest and latest peak strains 
and the standard deviation of time to peak strains. 
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6.2.4 Statistical Analysis 
Data are presented as mean ± SEM.  The effect of pacing on global LV function and synchrony 
at baseline, maximum deterioration, and maximum recovery (i.e., Day 0, Day 35, and Day 56, 
respectively) was compared by two-way repeated measures ANOVA with Fisher’s LSD post-hoc 
test.  Significance was determined as P<0.05. 
6.3 RESULTS 
6.3.1 Heart Failure Model 
A homogeneous model of heart failure was created by chronic tachycardia pacing as illustrated 
by the data in Figure 6-2 during control RA pacing.  Note that tachycardia pacing was 
temporally discontinued during echocardiographic data collection.  Synchrony patterns did not 
change during the induction or reversal of heart failure as indicated by relatively homogeneous 
mid-LV CCSIint values throughout the entire protocol (Figure 6-2D).  Consistent with other 
heart failure models, end-diastolic and end-systolic volumes both increased during tachycardia 
pacing (Day 0-35), resulting in an overall decrease in ejection fraction (Figure 6-2A-C).  
Interestingly, the decrease in EF occurred almost immediately with a significant depression 
observed after only one week of tachycardia pacing.  After Day 35, tachycardia pacing was 
permanently discontinued, changes in global and regional LV patterns were symmetric to those 
for the heart failure evolution such that end-diastolic and end-systolic volumes decreased and 
ejection fraction improved from Day 35-56.  However, global LV function did not return to 
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baseline values at maximum recovery (i.e., Day 56).  In summary, these data confirm the 
establishment of a reliable, consistent model of heart failure induced by chronic tachycardia 
pacing that was reversible once tachycardia pacing was permanently discontinued. 
 
Figure 6-2. Heart failure model induced by tachycardia pacing. 
 
Effects of tachycardia induced heart failure on (A) ejection fraction, (B) end-diastolic volume, (C) end-systolic 
volume, and (D) CCSIint at the mid-LV with control RA pacing.  Global LV function declined with progressive LV 
dilation and increased end-systolic volumes during tachycardia pacing (Day 0-35), confirming the tachycardia 
pacing-induced model of heart failure.  In addition, once tachycardia pacing was permanently discontinued, global 
LV function improved (Day 35-56).  Note that synchrony patterns did not change during induction or reversal of HF 
indicating a homogeneous HF model.  Data: mean ± SEM, n = 5 for Day 0-28 and n = 4 for Day 35-56; *P<0.05 vs. 
previous week. Abbreviations: RA = right atrial; LV = left ventricular; CCSIint = integrated cross-correlation 
synchrony index. 
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6.3.2 Dyssynchrony at Various Degrees of Heart Failure 
In the presence of heart failure, the effects of dyssynchrony were exaggerated with RV pacing as 
indicated by progressively lower mid-LV CCSIint with worsening heart failure (Figure 6-3D).  
This suggests that sicker hearts were more sensitive to RV pacing-induced dyssynchrony.  In 
addition, compared to control RA pacing, RV pacing was associated with similar end-diastolic 
volumes and slightly higher end-systolic volumes resulting in lower ejection fraction for various 
degrees of heart failure (Figure 6-3A-C).  Since the change in absolute values were similar 
during all degrees of HF, the downward parallel shift observed with EF (Figure 6-3A) indicated 
that the percent change between RA and RV pacing was greater at the maximum degree of HF 
(Day 35) compared to baseline (Day 0).  This message is better illustrated by the data 
presentation in Figure 6-3E.  Therefore, RV pacing-induced dyssynchrony and its adverse 
functional effects were exaggerated as heart failure progressed. 
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 Figure 6-3. Trends in global and regional LV function with dyssynchrony in HF. 
 
Effects of RV pacing on (A) ejection fraction, (B) end-diastolic volume, (C) end-systolic volume, and (D) CCSIint at 
the mid-LV during various degrees of heart failure.  RV pacing-induced dyssynchrony and its adverse functional 
effects were exaggerated as heart failure progressed.  (E) Percent change of ejection fraction between RA and RV 
pacing.  Data: mean ± SEM, n = 5 for Day 0-28 and n = 4 for Day 35-56; †P<0.05 vs. RA pacing for the same week; 
*P<0.05 vs. previous week. Abbreviations as in Figure 6-2. 
 
6.3.3 Resynchronization at Various Degrees of Heart Failure 
Resynchronization was successful regardless of the degree of HF with LVf pacing (i.e., CRTf) as 
indicated by an increase in mid-LV CCSIint to a relatively homogeneous value compared to RV 
pacing during Day 0-35 (Figure 6-4D).  In addition, synchrony was restored with CRTf to levels 
similar to that observed during control RA pacing.  Furthermore, CRTf did not adversely affect 
global LV function.  Specifically, with CRTf, end-diastolic volumes were similar and end-
systolic volumes were lower than during RV pacing, resulting in higher ejection fraction (Figure 
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6-4A-C).  The upward parallel shift indicates that resynchronization with CRTf resulted in 
greater percent change in EF compared to RV pacing at maximum HF (Day 35).  Importantly, 
CRTf resulted in global LV function that was similar to that with RA pacing (Figure 6-4A-C).  
In addition, with respect to values during RV pacing, the degree of improvement in global LV 
function with CRTf significantly correlated with the level of resynchronization (Figure 6-4E; 
R2=0.40, P<0.001). 
 
Figure 6-4. Trends in global and regional LV function with resynchronization in HF. 
 
Effects of CRTf on (A) ejection fraction, (B) end-diastolic volume, (C) end-systolic volume, and (D) CCSIint at the 
mid-LV at various degrees of HF.  CRTf was equally efficacious regardless of the level of heart failure.  In addition, 
the degree of global LV improvement with CRTf, significantly correlated with the degree of resynchronization.  
Data: mean ± SEM, n = 5 for Day 0-28 and n = 4 for Day 35-56; †P<0.05 CRTf vs. RV pacing for the same week. 
Abbreviations as in Figure 6-2. 
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6.3.4 Observations During the Recovery from Heart Failure 
When tachycardia pacing was permanently discontinued after Day 35, patterns in regional and 
global LV function during dyssynchrony and resynchronization were symmetric to those 
observed during HF.  Specifically, during recovery, the effect of RV pacing on dyssynchrony 
became less exaggerated and resynchronization with CRTf was equally efficacious regardless of 
the state of global LV function (Figure 6-5D).  In addition, end-systolic volumes were greater 
during RV pacing resulting in depressed EF compared to RA pacing (Figure 6-5A-C).  Again, 
similar to the patterns observed during heart failure, global LV function during CRTf was similar 
to that during RA pacing. 
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 Figure 6-5. Trends in global and regional LV function with during HF recovery. 
 
Effects dyssynchrony and resynchronization on  (A) ejection fraction, (B) end-diastolic volume, (C) end-systolic 
volume, and (D) CCSIint at the mid-LV during recovery of heart failure.  During recovery, patterns of synchrony and 
global LV function were mirror images of those observed during HF.  Data: mean ± SEM, n = 5 for Day 0-28 and n 
= 4 for Day 35-56. Abbreviations as in Figure 6-2. 
 
6.3.5 Simultaneous Comparisons of Pacing Sites 
For simultaneous comparisons of all pacing modalities, we decided to focus on three discreet 
time points.  A two-factor ANOVA structure (factor 1: pacing, factor 2: day) was used with data 
from baseline (i.e., Day 0), maximum degree of tachycardia pacing (i.e., Day 35), and maximum 
degree of recovery (i.e., Day 56).  Focusing on RA pacing alone, as previously illustrated, 
induction of heart failure was clearly indicated as LV dilation and depression in EF due to an 
increase in end-systolic volumes (Figure 6-6A-C) at Day 35.  The heart failure model was 
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relatively homogeneous with synchronous contraction at all three time points (Figure 6-6D).  
However, a heterogeneous pattern of regional function was observed with RV pacing.  Although 
RV pacing was associated with greater dyssynchrony compared to RA pacing at all three time 
points, the effect of RV pacing on mid-LV CCSIint was exaggerated at Day 35 indicating that 
heart failure is associated with increased sensitivity to RV pacing-induced dyssynchrony.  
Interestingly, synchrony was improved with CRTf compared to RV pacing at baseline (Day 0) 
and maximum heart failure (Day 35); however, mid-LV CCSIint at maximum recovery (Day 56) 
was not different than that during RV pacing (P=NS, CRTf vs. RV pacing).  With respect to 
global LV function, end-diastolic volumes were similar across all pacing modalities.  However, 
RV pacing was associated with significantly higher end-systolic volumes compared to RA 
pacing that resulted in markedly lower EF at both Day 35 and Day 56.  In contrast, 
resynchronization with CRTf improved global LV function compared to RV pacing such that 
end-systolic volumes were lower resulting in an increase in EF at both Day 35 and 56 that 
reached levels associated with RA pacing. 
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 Figure 6-6. Global and regional LV function for all pacing modes at baseline, maximum HF, and 
maximum HF recovery. 
 
Effects of RA and RV pacing and CRTf on (A) ejection fraction, (B) end-diastolic volume, (C) end-systolic volume, 
and (D) mid-LV CCSIint at baseline, maximum induction of heart failure, and maximum level of recovery.  RV 
pacing was the only pacing modality to show marked differences in global LV function and synchrony compared to 
RA pacing.  Compared to baseline, global LV function was depressed at Day 35, and improved at Day 56, but did 
not normalize to baseline values for all pacing modes.  Data: mean ± SEM, n = 5 for Day 0 and n = 4 for Day 35 and 
Day 56.  *P<0.05 vs. RA pacing, §P<0.05 vs. RV pacing, † P<0.05 vs. Day 0, ‡ P<0.05 vs. Day 35. Abbreviations 
as in Figure 6-2. 
6.3.6 Segmental Synchrony Analysis 
In order to investigate if a certain segment was responsible for the exaggeration in dyssynchrony 
and functional depression associated with RV pacing as heart failure progressed, we performed 
segmental cross-correlation analysis as described in Section 5.2.4.1.  At Day 0, mid-LV CCSIseg 
for all segments appeared to be relatively homogeneous (Figure 6-7B), although all values were 
low as reflected by the low integrated measure of synchrony (Figure 6-7A).  Interestingly, as the 
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integrated measure of synchrony decreased at Day 35, the anterior (A) and antero-septal (AS) 
segments were both associated with significantly lower mid-LV CCSIseg values than the other 
segments during maximum HF.  The dyssynchrony at A and AS segments were not observed at 
Day 56 and all segments were associated with nearly homogeneous segmental synchrony 
measures.  These data suggest that the A and AS segments were responsible for the exaggeration 
of dyssynchrony with RV pacing during maximum heart failure. 
 
Figure 6-7. Segmental cross-correlation analysis with RV pacing induced dyssynchrony. 
 
(A) Integrated cross-correlation index at baseline, maximum HF, and maximum recovery during RV pacing.  (B) 
Segmental cross-correlation analysis indices for RV pacing at the same three discreet time points.  Data: mean ± 
SEM, n = 5 for Day 0 and n = 4 for Day 35 and Day 56; *P<0.05 vs. all other segments.  Abbreviations as in Figure 
6-2. 
 
6.3.7 Standard Indices of Dyssynchrony 
Since standard indices of dyssynchrony such as maximum time delay are subject to manual 
identification of peaks, we were interested to see if this analysis would yield the same result as 
observed using the integrated cross-correlation analysis to quantify synchrony.  Since multiple 
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peak strains could occur during the cardiac cycle, especially with RV pacing-induced contraction 
dyssynchrony, the maximum delay between earliest an latest peak strain was chosen by two 
independent observers.  The mid-LV time delay following RV pacing was similar between the 
two observers from Day 0 through Day 28, however, this was not the case from Day 35 through 
Day 56 (Figure 6-8A).  Interestingly, one observer showed that RV pacing was associated with 
dyssynchrony during Day 35 through Day 56, but according to the other observer, dyssynchrony 
decreased during Day 35 and 42, then increased again during Day 49 and 56.  Data derived from 
either of the observers did not follow trends that were observed for global LV function (i.e., EF; 
Figure 6-8C), however synchrony quantified using mid-LV CCSIint followed global LV 
functional trends (Figure 6-8B).  Importantly, if two different observers performed cross-
correlation analysis on the same data, the results would be exactly the same since there are not 
manual inputs into this analysis.  The only potential input would be selection of end-systole, but 
this time point was automatically chosen by the program as the end of the T-wave from the ECG. 
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 Figure 6-8. Indices of dyssynchrony with induction and recovery of heart failure. 
 
(A) Dyssynchrony quantified by maximum time delay between earliest and latest peak strain calculated by two 
different observers.  (B) Note that changes in regional function as quantified by CCSIint were qualitatively similar to 
changes in global LV function (C).  Data: mean ± SEM, n = 5 for Day 0 and n = 4 for Day 35 and Day 56. 
Abbreviations as in Figure 6-2. 
6.4 DISCUSSION 
In the current study, a consistent and reversible model of heart failure was established by chronic 
tachycardia pacing.  Using this model, three primary findings were reported.  (1) As global LV 
function progressively worsened with tachycardia pacing-induced heart failure, RV pacing-
induced dyssynchrony and its adverse functional effects were exaggerated.  (2) 
Resynchronization with CRTf was efficacious regardless of the degree of global LV depression.  
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(3) As global LV function improved during the recovery phase, RV pacing-induced 
dyssynchrony and its functional effects were less exaggerated and the efficacy of 
resynchronization with CRTf did not depend on the state of global LV function.  These trends 
were mirror images of the observations during the heart failure phase.  In addition, observations 
of dyssynchrony quantified using the standard time delay index were not consistent with trends 
in global LV function.  However, changes in synchrony as quantified by mid-LV CCSIint seemed 
to qualitatively track the changes in global LV function.  Before we address these findings in 
detail, we will discuss certain methodological concerns. 
6.4.1 Methodological Considerations 
First, similar to the previous canine studies, a short A-V delay was used with ventricular pacing 
modes.  However, in the current study, end-diastolic volume was not different between RA and 
ventricular pacing modalities.  Since atrio-ventricular coupling was not affected by the short A-V 
delay, direct comparisons of atrial and ventricular pacing modalities were performed.  Second, 
although chronic rapid pacing has been shown to be an effective model of heart failure [103], 
this model may not extrapolate to traditional CRT patients (i.e., those with heart failure and 
conduction disturbances).  Further studies with the induction of heart failure and structural 
abnormalities in the conduction system will address this issue. 
The current study suffered from the methodological limitation of speckle tracking-
derived radial strain.  Echocardiographic data in the present study were collected during 
spontaneous breathing, whereas in the previous acute studies, data were collected during apneic 
states.  Out-of-plane motion caused by breathing results in disappearance of speckles, however, 
this occurs over a few frames rather than within two consecutive frames [104].  Nonetheless, we 
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were still unable to derive reliable and reproducible strain waveforms from the LV basal or 
apical views.  The papillary muscle level is less affected by rotation and out-of-plane movement 
[105], therefore, reliable images were obtained at the mid-LV and reproducible strain waveforms 
were derived at the mid-LV level. 
6.4.2 Dyssynchrony and Resynchronization in Heart Failure 
To our knowledge, this is the first longitudinal study to show that with increasing HF, RV 
pacing-induced dyssynchrony and its functional effects were exaggerated.  Furthermore, we 
showed that the efficacy of CRTf did not depend on the level of heart failure.  A recent study 
reported that speckle tracking-derived radial strain was more accurate than TDI velocity to detect 
cardiac dyssynchrony in a canine model [106].  Similar to the current study, HF was induced by 
rapid endocardial RV apical pacing in their study.  They showed that following His-bundle 
ablation and 4 weeks of rapid RV apical pacing, EF effectively decreased and dyssynchrony as 
measured by the SD of time to peak radial strain was increased compared to baseline values 
during intrinsic sinus rhythm (comparative to RA pacing in the current study).  The increase in 
dyssynchrony was most likely due to the His-bundle ablation, whereas in the current study, we 
did not observe dyssynchrony with heart failure under control RA pacing potentially due to an 
intact conduction system.  Regardless, the strength of the current study was that trends in 
dyssynchrony patterns and global LV function were simultaneously studied during the evolution 
and de-evolution of heart failure.  Importantly, we are the first to show in a comprehensive study 
that RV pacing-induced dyssynchrony became progressively worse as heart failure advanced and 
dyssynchrony became less exaggerated as heart failure was reversed.  These results highlight the 
importance of treating dyssynchrony in heart failure patients. 
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Another study showed that biventricular (RV apical + LV lateral wall) pacing improved 
global and regional function [107].  They showed that, in canine hearts with structural 
abnormalities of the conduction system (i.e., chronic isolated LBBB via ablation), biventricular 
pacing improved global LV function and regional synchrony even in the absence of heart failure.  
These findings support and help extrapolate the results of the current study.  Importantly, our 
model of dyssynchrony (i.e., RV pacing) was associated with an intact conduction system.  
However, since we too report similar efficacy with CRTf, we can cautiously extrapolate our 
results to cases where structural abnormalities, such as LBBB, are present. 
6.4.3 Quantification of Dyssynchrony in Heart Failure 
In the current study, quantification of dyssynchrony using standard time delay index did not 
result in trends that were consistent with changes in global LV function.  This underscores a 
statement made in a recent review which noted that echocardiographic-derived parameters of 
mechanical dyssynchrony may not be useful in the selection of patients for CRT [101].  
Ventricular mechanical motion is extremely intricate, and deformations become increasingly 
complex in dyssynchronous contraction.  Simple parameters derived from time-to-peak data 
reflect only a “snap-shot” of the convoluted contraction pattern with dyssynchrony.  It was 
recently suggested that a more comprehensive characterization of dyssynchrony may be achieved 
by indices that describe discoordination of contraction [108].  Cross-correlation algorithm 
accomplishes this goal in that it describes the overall differences in waveform morphology, as 
opposed to focusing on a single time point.  Importantly, in the current study we showed that 
resynchronization as quantified by mid-LV CCSIint significantly correlated with changes in 
global LV function (Figure 6-4E).  Although this supports the use of cross-correlation analysis 
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in the setting of a chronic canine model of heart failure, a more comprehensive study with human 
patients is required to support its use in the clinical realm. 
6.5 CONCLUSIONS 
As global LV function deteriorated with heart failure, RV pacing-induced dyssynchrony and its 
adverse functional effects were exaggerated.  To correct for dyssynchrony, we used LV free-wall 
pacing (i.e., CRTf) and showed that resynchronization with CRTf was equally efficacious 
regardless of the degree of global LV depression.  Furthermore, as global LV function improved 
during the recovery phase when tachycardia pacing was permanently discontinued, RV pacing-
induced dyssynchrony was less exaggerated and the efficacy of resynchronization with CRTf did 
not depend on the state of global LV function.  These trends were mirror images of the 
observations during the heart failure phase. In addition, we showed that changes in synchrony as 
quantified by mid-LV CCSIint qualitatively tracked the changes in global LV function, whereas 
the traditional dyssynchrony index (i.e., time delay) did not.  Although we demonstrated the 
advantage of cross-correlation analysis in the setting of heart failure in an animal model, its 
utility in the clinical realm still needs to be assessed. 
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7.0  STUDY 5: UTILITY OF THE CROSS-CORRELATION ALGORITHM IN THE 
CLINICAL REALM 
Specific Aim 6. To extend our analyses into the clinical realm by assessing the efficacy of cross-
correlation analysis in a select cohort of human patients. 
7.1 INTRODUCTION 
All studies described so far were conducted using animal models.  However, since CRT is 
ultimately practiced in the clinical realm, it is important to assess the efficacy of the developed 
tools to quantify dyssynchrony in a subset of human data (Specific Aim 6).  Furthermore, in the 
animal models, we used RV outflow tract pacing to induce a LBBB-like pattern of 
dyssynchrony.  However, RV apical (RVa) pacing, which has been implicated in dyssynchrony 
and heart failure exacerbation is more relevant than RVOT pacing in the human setting.  
Increasing evidence has shown that RVa pacing is detrimental to ventricular function, and 
several studies are currently examining other options (e.g., single LV pacing) for these patients 
[109-111].  Therefore, the goals of the current study were to (1) investigate the utility of cross-
correlation analysis of speckle-derived radial strain at the mid-LV level and longitudinal motion 
(i.e., displacement) at the LV septal and lateral walls, and (2) link echocardiographic regional 
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information (i.e., radial strain or longitudinal displacement) with global LV performance using 
different clinically accepted pacing sites in patients with atrial fibrillation without heart failure. 
7.2 METHODS 
7.2.1 Patient Population 
The study was approved by the Institutional Review Boards of University of Pittsburgh Medical 
Center and St. Paul Heart Clinic.  The study cohort was comprised of 26 patients (18 men; 53±13 
years) referred for invasive electrophysiologic evaluation, primarily for ablation of paroxysmal 
atrial fibrillation.  All patients had normal LV dimensions (end-diastolic and end-systolic 
volumes 98±38 and 48±25 mL, respectively), ejection fraction of 54±8%, normal aortic and 
mitral valve function, QRS duration of 81±15 msec, and normal atrioventricular conduction.  In 
addition, patients underwent pre-operative stress-nuclear imaging, which revealed healthy 
myocardial tissue (i.e., no LV scar). 
7.2.2 Pacing Protocol 
Pacing electrodes were placed transvenously into the right atrial appendage (RA), right 
ventricular apical septum (RVa), and left ventricular lateral base (LVf).  The following pacing 
modalities were evaluated, in random order, at the same rate for each patient (10 beats•min-1 
above intrinsic sinus rate): (1) RA pacing for control; (2) simultaneous RA and RVa pacing, 
referred to as RVa pacing; (3) simultaneous RA and LVf pacing, referred to as LVf pacing; and 
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(4) simultaneous RA, RVa, and LVf pacing, referred to as BiVf pacing.  For ventricular pacing 
modes, an atrioventricular delay of 20 milliseconds was used to eliminate the possibility of 
fusion between paced (i.e., RVa, LVf, and BiVf pacing) and intrinsic ventricular activation 
wavefronts. 
7.2.3 Echocardiographic Imaging 
For each pacing modality, images were obtained using commercially available 
echocardiographic equipment (Vivid 7™, General Electric Vingmed Ultrasound Inc., 
Milwaukee, WI, USA) during end-expiratory apnea to minimize translational motion and 
cardiopulmonary interactions.  A 3.5 MHz transducer was used at depths between 12 and 20 cm 
and via the following windows: parasternal long-axis, and apical 2, 3 and 4-chamber views.  
Tissue Doppler Imaging was performed at maximal frame rates (80-135 frames per second; 
velocity range ±16 centimeters/second).  Gray-scale 2-dimensional and cine loops from 3 
consecutive beats were obtained.  Digitized images were analyzed off-line with commercially 
available software (Echopac™, version 6, General Electric Vingmed Ultrasound)  Waveforms 
were extracted and further analyzed off-line using a custom written Matlab code (see Appendix 
B.2). 
Longitudinal regional displacement data was derived using 2-dimensional tissue tracking 
technique.  Tissue Doppler velocity was integrated over time at 5 longitudinally arrayed 
myocardial segments (8 millimeter sample volumes) along the septal and LV lateral walls 
(Figure 7-1A).  Displacement onset was measured relative to mitral valve closure and end-
systole was determined by aortic valve closure.  Movement towards the transducer is represented 
by positive displacement.  In addition, radial strain was derived from standard 2D 
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echocardiographic images taken from parasternal short axis views at the LV base, mid-LV, and 
LV apex using speckle-tracking algorithm similar to that described in Section 5.2.3.  Radial 
strain was derived from 6 circumferentially arrayed segments each at the LV base and mid-LV, 
and 4 segments were assessed at the LV apex (Figure 7-1B). 
 
Figure 7-1. Segmentation for longitudinal and radial synchrony analyses. 
 
Star symbols show location of ventricular pacing leads.  (A) Segments assayed for longitudinal displacement along 
the septum (S1-S5) and LV lateral wall (L1-L5).  Note that RVa and LVf pacing leads abut S5 and L2, respectively.  
(B) Short-axis schematics of the LV base, mid-LV, and LV apex showing segmentation for speckle-derived radial 
strain.  Abbreviations: RVa = right ventricular apex; S1-S5 = septal segments 1-5; L1-L5 = lateral wall segments 1-
5; I = inferior; P = posterior; L = lateral; A = anterior; AS = antero-septal; S = septal. 
 
7.2.4 Synchrony Analyses 
Regional LV systolic function was assessed using cross-correlation analysis and standard 
dyssynchrony indices (i.e., maximum time delay between earliest and latest peaks and standard 
 118 
deviation of time to peak values for various segments).  These analyses were applied to (1) 
longitudinal displacement data at the septal and LV lateral walls, and (2) speckle-tracking-
derived radial strain data at the LV base, mid-LV, and LV apex. 
7.2.4.1 Longitudinal Synchrony Analysis 
Similar to the cross-correlation methods described in Section 4.2.4, longitudinal CCSIint indices 
were calculated for the septum and LV wall and longitudinal CCSIseg indices were calculated for 
each of the 10 longitudinal segments (Figure 7-1A).  Each LV wall was treated as one entity (i.e., 
cross-correlation analysis was not performed with pairs between the two walls).  For example, 
CCSIint for the septum was constructed from 10 pair-wise comparisons (S1 vs. S2, S1 vs. S3, S1 
vs. S4, S1 vs. S5, S2 vs. S3, S2 vs. S4, S2 vs. S5, S3 vs. S4, S3 vs. S5, and S4 vs. S5); it did not 
contain data from any lateral wall segments (i.e., L1-L5).  Similarly longitudinal CCSIint for the 
lateral free-wall was constructed from the following 10 pair-wise comparisons: L1 vs. L2, L1 vs. 
L3, L1 vs. L4, L1 vs. L5, L2 vs. L3, L2 vs. L4, L2 vs. L5, L3 vs. L4, L3 vs. L5, and L4 vs. L5. 
7.2.4.2 Radial Synchrony Analysis 
An analysis identical to that described in Section 4.2.4 was performed for the dataset in the 
current study.  Radial CCSIint indices were calculated for the LV base, mid-LV, and LV apex; 
and radial CCSIseg indices were calculated for each of the 16 radial segments. 
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7.2.5 Global LV Performance Analysis 
Indices of global LV performance were derived using P-V analysis from a conductance catheter 
placed into the LV as described in Section 4.2.5. 
7.2.6 Statistical Analysis 
Data are expressed as mean ± SEM.  One-way analysis of variance (ANOVA) with repeated 
measures was used to evaluate the effects of different pacing modalities on regional LV 
synchrony and indices of global LV performance.  If significant interactions were observed, 
comparisons between groups were performed using Fisher’s least squared difference (LSD) or 
Tukey-Kramer test.  Significance was determined as P<0.05. 
7.3 RESULTS 
7.3.1 Longitudinal Synchrony Analysis 
Due to poor image quality in some patients, longitudinal synchrony was evaluated in only 18 of 
26 patients.  Compared to RA pacing, RVa pacing was associated with dyssynchronous 
longitudinal motion along the septum reflected as a decrease in septal CCSIint from 0.99 ± 0.003 
to 0.74 ±0.07 (Figure 7-2A; P<0.05, RA vs. RV pacing).  Compared to RA pacing, RVa pacing 
significantly decreased septal CCSIseg for all 5 septal segments (Figure 7-2B-F; septal CCSIseg 1-
5: P<0.05, RA vs. RV pacing). 
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When LVf pacing was used in conjunction with RVa pacing (i.e., BiVf pacing), 
resynchronization was not as effective as when LVf pacing was used alone.  Compared to RA 
pacing, BiVf pacing was associated with dyssynchronous septal motion, which was similar to the 
septal dyssynchrony observed with RVa pacing (Figure 7-2A; septal CCSIint: P<0.05, RA vs. 
BiVf pacing; P=NS, RVa vs. BiVf  pacing;).  Interestingly, the quantity of dyssynchrony during 
BiVf pacing was almost half the difference of dyssynchrony during RVa and LVf pacing.  
Furthermore, evaluation of synchrony patterns with BiVf pacing for individual segments 
revealed a significant decrease in septal CCSIseg for segments 3 and 5; this was similar to the 
level of segmental dyssynchrony observed with RVa pacing (Figure 7-2D, F; septal CCSIseg 3, 5: 
P<0.05, RA vs. BiVf pacing; P=NS, RV vs. BiVf pacing). 
Interestingly, single site LVf pacing was associated with septal motion similar to RA 
pacing and markedly more synchronous contraction than RVa pacing (Figure 7-2A; septal 
CCSIint: P=NS, RA vs. LVf pacing; P<0.05, RVa vs. LVf pacing).  Reflecting the synchronous 
integrated motion pattern observed with LVf pacing, septal CCSIseg for all segments were not 
different than that for RA pacing and markedly more synchronous than with RVa pacing (Figure 
7-2B-F; septal CCSIseg 1-5: P=NS RA vs. LVf pacing; P<0.05 RVa vs. LVf pacing). 
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 Figure 7-2. Synchrony analysis using longitudinal displacement data at the LV septum. 
 
(A) Integrated measure of synchrony for longitudinal septal wall motion.  (B-F) Segmental measures of synchrony 
for longitudinal wall motion for 5 septal wall segments.  Data: mean ± SEM, n = 18; *P<0.05 vs. RA pacing; 
†P<0.05 vs. RVa pacing.  Abbreviations: CCSIint = integrated cross-correlation synchrony index; CCSIseg 1-5 = 
segmental cross-correlation synchrony index for segments 1-5; RA = right atrial; RVa = right ventricular apical; LVf 
= left ventricular free-wall; BiVf = biventricular (RVa+LVf). 
 
Some of the longitudinal synchrony responses at the lateral wall were similar to those 
observed at the septum.  Specifically, RVa pacing was associated with dyssynchronous 
longitudinal motion at the lateral wall compared to RA pacing (Figure 7-3A; lateral CCSIint: 
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P<0.05, RA vs. RVa pacing).  Also, we observed synchronous longitudinal motion at the LV 
lateral wall with LVf pacing, which was significantly better than that observed with RVa pacing 
(Figure 7-3A).  However, unlike the pattern observed at the septum, BiVf pacing was not 
associated with dyssynchronous motion at the LV lateral wall compared to RA pacing (Figure 7-
3A).  Interestingly, synchrony at the LV lateral wall was reflected by the synchronous motion for 
all CCSIseg compared to RA pacing (Figure 7-3B-F). 
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 Figure 7-3. Synchrony analysis using longitudinal displacement data at the LV lateral wall. 
 
(A) Integrated measure of synchrony for longitudinal lateral wall motion.  (B-F) Segmental measures of synchrony 
for longitudinal wall motion for 5 lateral wall segments.  Data: mean ± SEM, n = 18; *P<0.05 vs. RA pacing; 
†P<0.05 vs. RV pacing.  Abbreviations as in Figure 7-2. 
 
Standard dyssynchrony indices such as maximum time delay between earliest and latest 
peak displacement (i.e., TD) and standard deviation of time-to-peak displacement (i.e., SD) at 
the septal or lateral walls, did not show any significant differences across pacing modalities 
(Table 7-1).  However, compared to RA pacing, RVa pacing generally tended to be associated 
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with greater dyssynchrony with the highest indices at the septal wall.  In addition, BiVf and LVf 
pacing also tended induce dyssynchrony as indicated by greater indices compared to RA pacing.  
Unlike the tendencies observed with RVa pacing, standard dyssynchrony indices appeared to be 
similar for the septal and lateral LV walls with either BiVf or LVf pacing. 
Table 7-1. Standard dyssynchrony measures for longitudinal displacement data. 
 RA Pacing RVa Pacing BiVf Pacing LVf Pacing P-value 
Septal TD (ms) 100 ± 27 176 ± 49 245  ± 90 296 ± 118 0.28 
Lateral TD (ms) 207  ± 91 333 ± 106 273 ± 115 348 ± 132 0.73 
      
Septal SD (ms) 43  ± 11 86 ± 26 106 ± 39 132 ± 52 0.29 
Lateral SD (ms) 92 ± 41 151 ± 47 117 ± 50 152 ± 59 0.72 
 
Data: mean ± SEM, n=18.  Abbreviations: TD = time delay; SD = standard deviation; RA = right atrial; RVa = right 
ventricular apical; LVf = left ventricular free-wall; BiVf = biventricular (RVa+LVf). 
 
7.3.2 Radial Synchrony Analysis 
Speckle-derived radial strain data was available in a limited number of patients due to poor 
image quality.  Therefore, only 10 of 26 datasets were used for radial synchrony analysis.  No 
significant changes were observed with radial synchrony quantified by CCSIint or standard 
dyssynchrony indices at the basal LV, mid-LV, or LV apex (Table 7-2).  Although it appeared 
that basal CCSIint under RVa pacing was trending toward greater dyssynchrony compared to RA 
pacing, it did not reach statistical significance.  In addition, CCSIint appeared to be similar at the 
mid-LV and LV apex across all pacing modes and standard indices of dyssynchrony appeared 
comparable across all pacing modes at all 3 LV levels.  Furthermore, segmental cross-correlation 
analysis of radial strain data did not show any statistical differences for any pacing modality 
(data not shown). 
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Table 7-2. Standard dyssynchrony measures for longitudinal displacement. 
 RA Pacing RVa Pacing BiVf Pacing LVf Pacing P-value 
LV Basal CCSIint 0.93 ± 0.03 0.76 ± 0.11 0.90 ± 0.24 0.89 ± 0.02 0.24 
Mid-LV CCSIint 0.96 ± 0.01 0.92 ± 0.03 0.96 ± 0.01 0.95 ± 0.02 0.36 
LV Apical CCSIint 0.97 ± 0.01 0.97 ± 0.01 0.93 ± 0.04 0.98 ± 0.005 0.38 
      
LV Basal TD 134 ± 38 130 ± 31 95 ± 39 129 ± 26 0.80 
Mid-LV TD 81 ± 15 84 ± 25 99 ± 28 112 ± 24 0.73 
LV Apical TD 69 ± 23 91 ± 22 77 ± 42 26 ± 11 0.36 
      
LV Basal SD 64 ± 19 57 ± 13 39 ± 15 55 ± 11 0.62 
Mid-LV SD 34 ± 5 34 ±10 43 ± 13 50 ± 12 0.61 
LV Apical SD 28 ± 8 40 ± 10 31 ± 16 11 ± 5 0.27 
 
Data: mean ± SEM, n=10. CCSIint = integrated cross-correlation synchrony index. Abbreviations as in Table 7-1. 
 
7.3.3 Global LV Performance Analysis 
The short A-V delay of 20 ms used for ventricular pacing modes was expected to affect LV 
diastolic filling, so statistical comparisons were performed between ventricular pacing modes 
only.  However, global LV performance values during RA pacing are listed as a reference state.  
As shown in Table 7-1, global LV performance with BiVf pacing was similar to that during RVa 
pacing.  However, pacing at the LV free-wall alone (i.e., LVf pacing) appeared to be least 
detrimental to global LV function with values that tended to be greatest among ventricular 
pacing modes.  Specifically, compared to RVa pacing, LVf pacing resulted in significantly 
greater LV CO, primarily due to increased end-systolic pressures and dP/dtmax. 
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Table 7-3. Global LV performance values for different pacing modalities. 
 RA Pacing RVa Pacing LVf BiVf P-value 
HR (beats•min-1) 63 ± 1 64 ±1 64 ±1 64 ±1 0.39 
LV ESP (mmHg) 125 ± 7 97 ±6 113 ± 6† 99 ± 6 0.004 
LV EDP (mmHg) 15 ± 2 13 ± 1 14 ± 1† 13 ± 1 <0.001 
EDV (mL) 116 ± 11 93 ± 9 118 ± 14† 107 ± 14 0.006 
ESV (mL) 58 ±8 38 ± 4 52 ±6 50 ± 5 0.10 
SV (mL) 58 ± 3 38 ± 4 52  ±6† 50 ± 5 0.04 
CO (L•min-1) 3.7 ± 0.2 2.5 ± 0.3 3.3  ± 0.4† 3.2 ± 0.3 0.03 
dP/dtmax(mmHg•s-1) 1285 ± 77 1083 ± 92 1227 ± 101† 1154 ± 94 0.18 
dP/dtmin (mmHg•s-1) -1569 ± 99 -1157  ± 144 -1200 ± 107 -1266 ± 116 0.048 
SW (mJ) 5929  ± 438 3139 ± 377 4876 ± 624† 4243 ± 466 0.61 
 
Data: mean ± SEM, n=11; †P<0.05 vs. RVa pacing.  Abbreviations: HR = heart rate; LV = left ventricular; ESP = 
end-systolic pressure; EDP = end-diastolic pressure; EDV = end-diastolic volume; ESV = end-systolic volume; SV 
= stroke volume; CO = cardiac output; dP/dtmax = maximum rate of pressure rise; dP/dtmin = minimum rate of 
pressure rise; SW = stroke work; RA = right atrial; RVa = right ventricular apical; LVf = left ventricular free-wall; 
BiVf = biventricular (RVa+LVf). 
 
7.4 DISCUSSION 
The current study reports four primary findings: (1) Global LV depression following RVa and 
BiVf pacing was associated with longitudinal septal wall dyssynchrony.  (2) Although 
longitudinal dyssynchrony was observed with RVa and BiVf pacing, radial contraction 
synchrony was preserved.  Therefore, synchrony measures derived from a single plane of motion 
or contraction may not comprehensively describe regional function.  (3) Synchrony indices 
derived from cross-correlation analysis (CCSIint and CCSIseg) were the only measures that 
captured dyssynchronous longitudinal regional activity; standard dyssynchrony indices such as 
time delay and standard deviation of time to peak displacement failed to reveal longitudinal 
dyssynchrony.  (4) LVf pacing was least detrimental to global LV performance and synchrony 
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compared to RVa and BiVf pacing.  Therefore, BiVf pacing may not be the preferred pacing 
modality in patients with preserved EF.  Before we discuss these findings in detail, we will 
consider some methodological limitations encountered in the current study. 
7.4.1 Methodological Limitations 
First, as with the animal studies, we used a short A-V delay during ventricular pacing, which 
restricts diastolic LV filling.  Therefore, a direct functional comparison of intrinsic activation 
(i.e., RA pacing) and ventricular pacing (i.e., RVa, LVf, and BiVf pacing) could not be 
performed.  Second, the patient cohort in the current study consisted of healthy hearts with 
normal ejection fractions.  Although the results contribute valuable knowledge to this subset of 
patients who might be recommended for ventricular pacing, these observations may not 
extrapolate to heart failure patients.  However, since heart failure is a clinical syndrome 
characterized by the inability to perform activities of daily living to an adequate degree, these 
findings could extrapolate to patients that are symptomatic with heart failure symptoms without 
reduced ejection fraction.  Third, tissue-Doppler-derived displacement can introduce significant 
errors due to tethering [112].  However, these patients did not have myocardial scar tissue as 
noted in Section 7.2.1, therefore, tethering was less likely to occur and displacement data should 
have reflected active motion. 
7.4.2 Mechanism of Global LV Performance Depression with RVa Pacing 
The observed detriment in global LV performance with RVa pacing in the current study was 
consistent with previous reports [109-111].  However, the current study extended this knowledge 
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by showing that the depression in global LV performance with RVa pacing was primarily due to 
regional longitudinal disparities in septal wall motion.  With normal activation, the left 
ventricular base moves towards the apex.  We suspect that RVa stimulation introduces an 
electrical wavefront that pre-excites the septum and elicits movement of septal apical segments 
towards the base, competing with basal segmental displacement towards the apex.  This theory is 
supported by the displacement waveforms during RVa pacing shown in Figure 7-4.  At the 
septum, CCSIint is low (0.31), due to the disparity in the most apical segment (segment 5).  After 
a temporal displacement towards the apex (positive displacement), this segment begins to move 
away from the apex, while the rest of the segments have positive displacement.  Then finally, 
segment 5 has post-systolic movement in the apical direction.  The septal disparity is nicely 
illustrated by the color-coded plot in Figure 7-4 showing that the CCSIseg for segment 5 has the 
darkest color reflecting the lowest synchrony index.  Since the RVa pacing site abuts segment 5 
(Figure 7-1A), it is not surprising that this segment was affected by the early stimulation.  
Therefore, we suspect that the intramural regional disorder at the septum was responsible for the 
detriment in global LV performance observed with RVa pacing. 
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 Figure 7-4. Cross-correlation program output for longitudinal displacement. 
 
Septal and lateral time-displacement curves representing longitudinal myocardial motion during RVa pacing for one 
patient.  The dashed line indicates end-systole determined by aortic valve closure from pulsed-Doppler information.  
The legend shows CCSIint calculated during systole and CCSIseg are color-coded and represented to the right of the 
displacement data with values ≤0.0 being black.  Abbreviations: CCSIint, CCSIseg = integrated and segmental cross-
correlation synchrony index, respectively; Σ = CCSIint. 
 
7.4.3 Assessment of Synchrony 
We assessed both longitudinal (based on displacement) and radial (based on strain) synchrony 
indices.  Interestingly, radial synchrony indices derived from cross-correlation analysis as well as 
traditional indices were not different across pacing modalities.  This was not surprising since LV 
dynamics are multi-dimensional and depending on the pattern of contraction, evaluation of 
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synchrony in a single plane may not completely characterize regional function.  For example, 
although we did not observe radial contraction dyssynchrony in the current study with RVa 
pacing, we previously reported significant radial dyssynchrony (septal to free-wall) in canine 
studies due to RV outflow tract pacing [74].  Therefore, it appeared that although RV outflow 
tract pacing affected radial synchrony, longitudinal synchrony was mainly affected by RVa 
pacing.  This emphasized the notion that not all dyssynchronous contraction patterns are created 
equal. 
In the current study, we demonstrated the utility of cross-correlation analysis in the 
clinical realm.  More importantly, synchrony indices derived using cross-correlation were the 
only measures able to demonstrate the regional disorder along the septum, which seems to 
explain the global detriment associated with RVa pacing.  Currently, measures of dyssynchrony 
that incorporate time to peak values of displacement, strain, strain rate or velocity are the only 
indices being included in clinical studies.  However, due to conflicting results using these indices 
to quantify dyssynchrony, it is not advisable to incorporate mechanical measures of 
dyssynchrony to the selection of candidates for CRT [101].  We suspect that these indices suffer 
from only describing dyssynchrony based on single points in time.  With the discouraging results 
of echocardiographic-based parameters using time differences, it is becoming clear that a more 
comprehensive analysis of myocardial mechanics may be necessary to describe the regional 
discoordination observed with dyssynchrony [108].  Cross-correlation analysis uses the entire 
systolic portion of the waveform to more robustly describe synchrony patterns, and this analysis 
seems to have the ability to determine regional disorders among segments.  Additional studies 
are needed to determine if synchrony measures derived from cross-correlation analysis can 
predict response to and identify patients for CRT. 
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7.4.4 Optimal Pacing Site 
Compared to RVa pacing, we showed that BiVf pacing did not improve global LV performance 
in patients with normal ejection fraction.  Although CRT is an established therapy to improve 
clinical status in heart failure patients, we suspect that CRT using simultaneous BiVf pacing may 
not benefit all patients with preserved ejection fraction.  Other pacing modalities, such as single 
LV free-wall pacing may be superior to those patients.  Previous studies have also reported 
superior global LV performance during LVf pacing relative to RVa pacing [113, 114].  Most of 
the data in these studies were from heart failure patients.  However, a subset of patients with 
preserved ejection fraction was also studied, which showed the same superiority with LV free-
wall pacing as reported in the current study [114].  Regardless, the optimal pacing site may be 
specific to the individual patient based on severity of heart failure, myocardial infarction area, 
and/or baseline dyssynchrony patterns.  Thus, a procedure to determine the optimal pacing site(s) 
that offer the most benefit in global LV function and synchrony for individual patients may be 
necessary. 
7.5 CONCLUSIONS 
In the current study, we showed that in a cohort of patients with preserved ejection fraction, RVa 
pacing was associated with depression in global LV performance mainly caused by 
dyssynchronous longitudinal motion along the septal wall.  Importantly, this dyssynchrony was 
not captured by standard indices using time-to-peak information.  The cross-correlation analysis 
applied to longitudinal displacement data identified individual septal segments that were 
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responsible for the detriment in global LV performance associated with RVa pacing.  In addition, 
we reported no significant changes in radial contraction across pacing modalities, indicating that 
multi-faceted dyssynchrony analysis may be necessary for a more complete evaluation of 
regional LV function.  Finally, we observed a detriment in global LV performance with BiVf 
pacing, mostly due to the continued septal disparities in septal motion associated with RVa 
pacing.  In patients with preserved ejection fraction, LV free-wall pacing appeared to be superior 
in the context of global LV performance and longitudinal synchrony.  In summary, the utility of 
cross-correlation analysis in the clinical realm was established through characterization of 
longitudinal synchrony patterns.  Although these results are promising, a more comprehensive 
study with a larger patient cohort is necessary to translate cross-correlation analysis into the 
clinical realm as a standard tool to quantify dyssynchrony and identify patients for CRT. 
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8.0  TAKE HOME MESSAGES 
• In the presence of contraction dyssynchrony, global LV mechano-energetic function is 
adversely affected.  A disconnect exists between regional (cellular) and global 
mechanical activities such that the observed mechanical energy at the global level 
underestimates internal work at the cellular level, which is likely to be the true 
determinant of myocardial oxygen consumption. 
• Cross-correlation analysis is a robust tool to quantify contraction dyssynchrony, both at 
integrated and segmental levels.  Specifically, cross-correlation analysis is fully 
automated and takes into account the entire systolic portion of the cardiac cycle.  As a 
result, this methodology is associated with less intra-group variability compared to 
currently used indices of dyssynchrony that focus on manually chosen time points and are 
subject to user interpretability.  Furthermore, segmental cross-correlation analysis 
provides insight into the integrated LV contraction pattern.  The utility of this segmental 
approach is further emphasized by the finding that improvement in global LV 
contractility is dependent on the degree of resynchronization at the most dyssynchronous 
segment. 
• Right ventricular pacing induces significant dyssynchrony that adversely affects global 
LV function.  Left ventricular pacing appears superior, with preliminary data suggesting 
that pacing at the LV apex offers greater benefit in global and regional LV function than 
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at the LV free-wall.  Importantly, in the clinical realm, it appears that single-site LV free-
wall pacing is less detrimental than traditional RV apical or biventricular (RVa+LVf) 
pacing modalities.  However, optimal pacing site(s) will clearly be specific to the 
individual patient. 
• Changes in the integrated or segmental measures of radial synchrony at a single or 
multiple cross-sectional levels are unable to consistently predict the changes in global LV 
function.  These results indicate that multi-faceted dyssynchrony analysis (perhaps, one 
that includes measures of longitudinal dyssynchrony) is necessary for establishing a 
better link between contraction dyssynchrony and global LV function. 
• RV pacing-induced contraction dyssynchrony and its adverse functional effects are 
exaggerated as heart failure progresses and the reverse is true during the recovery from 
heart failure.  In contrast, resynchronization using LV free wall pacing is equally 
efficacious regardless of the degree of heart failure. 
• Cross-correlation analysis is applicable in the clinical realm.  Dyssynchrony is better 
characterized using cross-correlation analysis compared to standard indices that focus on 
manually chosen individual points in the cardiac cycle.  Although these results are 
promising, a more comprehensive study with a larger patient cohort is necessary to 
translate cross-correlation analysis into the clinical realm as a standard tool to quantify 
dyssynchrony and identify patients for CRT. 
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APPENDIX A 
DETAILED ISOLATED HEART PREPARATION PROTOCOLS 
A.1 PREPARATION OF ERYTHROCYTE SUSPENDED PERFUSION MEDIUM 
The isolated rabbit hearts were perfused with washed bovine erythrocytes suspended in a 
modified Krebs-Hanseleit (KH) solution.  The following is a detailed description of the 
preparation of this perfusion medium beginning with the bovine blood collection protocol to the 
final resuspension. 
A.1.1 Bovine Blood Collection Protocol 
First prepare two 2 L plastic containers with secure lids by rinsing with saline.  Then add 10 
U•mL-1 of heparin [1000 U•mL-1 concentration] with anticipation of filling each container with 2 
L of blood (therefore, add 20mL of 1000 U•mL-1 heparin to each container).  After blood is 
collected from the slaughterhouse (Thoma Meat Market, 748 Dinnerbell Road, Saxonburg, PA 
16056), transport the containers on ice in a cooler.  Once returning to the lab, add an antibiotic 
[250 mg•L-1 of Gentomyosin] to the blood and filter blood through a 40 μm filter to remove 
 136 
gross particles (e.g., hair, skin).  The blood should be filtered into a 4L plastic container pre-
rinsed with saline. 
A.1.2 Krebs-Hanseleit Solution Preparation 
Fill three 3L glass containers with de-ionized water.  Table A-1 shows the ingredients to add in 
each of the containers.  Note that calcium chloride is not added in this step because this solution 
is used to wash the bovine blood; we experienced significant clotting inside the cell saver 
machine when calcium chloride was added to this solution.  After the KH solutions are well 
mixed and brought to a pH of 7.5, the solution is then filtered through a 5 μm filter.  Note that 
the solution should be prepared before the blood is returned from the slaughterhouse to prevent 
any delays with the blood processing. 
Table A-1. Components of Modified Krebs-Hanseleit Solution 
 Concentration Formula Weight Concentration Add to 3L 
Components (mM•L-1) (g•M-1) (g•L-1) (g) 
NaCl 124 58.44 7.25 21.7397 
KCl 4.96 74.56 0.37 1.1095 
NaHCO3 24 84.01 2.02 6.0487 
NaH2PO4 0.362 137.99 0.05 0.1499 
MgCl2•6H2O 1.08 203.31 0.22 0.6587 
Glucose 11.1 180.16 1.20 5.9993 
A.1.3 Bovine Blood Processing Protocol 
The following procedures will be necessary to process the bovine blood with the cell saver 
machine: Fill, Wash, and Empty.  Before blood is started through the machine, the lines and bowl 
must be rinsed with the KH solution.  This may be achieved by running through the Fill, Wash, 
and Empty procedures with the KH solution.  Now the blood processing can begin.  First, press 
the Fill button and wait about 10 seconds for the centrifuge to steadily spin the bowl.  Then 
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increase the pump speed to 300 mL•min-1.  The bowl will begin to fill with blood with the RBCs 
being centrifuged to the bottom of the bowl and the plasma rising to the top.  Once all plasma is 
eliminated from the bowl, press the Wash button.  When the waste tube is clear the press Stop.  
Once the centrifuge ceases to spin, press Empty and increase the pump speed to 225 mL•min-1.  
Note that it was easiest to empty the isolated RBCs into a plastic container pre-rinsed with KH 
solution and containing ~3mL of 1000 U•mL-1 concentration of heparin.  Press Stop at the first 
signs of bubbles out of the bowl.  Repeat this procedure until all 4L of whole blood is processed.  
Then repeat this entire procedure again with the “isolated RBCs” in the plastic container now at 
the Fill end.  We found that washing the blood once did not efficiently isolate the RBCs; 
centrifuging a small sample revealed that plasma remained after a single wash.  After all blood is 
processed through the cell saver machine twice, take a small sample and centrifuge to ensure that 
all plasma is eliminated; the RBCs should sediment to the bottom with the clear KH solution at 
the top. 
A.1.4 Erythrocyte Suspended Perfusion Medium Protocol 
The desired hematocrit for the final resuspension was 30-35%.  However, the volume of washed 
RBCs was not known at this step of the process.  Therefore, the following procedure allowed us 
to determine the initial volume of KH in the washed RBCs and subsequently the amount of KH 
needed to achieve a final hematocrit of 30-35%.  Using an OSM3 Hemoximeter (Radiometer), 
determine the initial hemoglobin (Hgb) of the washed suspension.  Hematocrit can be estimated 
by multiplying Hgb by three.  Add 300 mL of KH solution to the blood, measure the Hgb with 
the OSM3 machine, and calculate the new hematocrit by multiplying by 3.  The amount of KH to 
be added (VA) to achieve the desired hematocrit of 30-35% can then be calculated by: 
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Where V300 is the volume added to initially change the hematocrit, H1 is the initial hematocrit of 
the washed suspension, H2 is the hematocrit after the 300 mL is added, and HD is the desired 
hematocrit (our target was 33%).  The final volume of the entire suspension can then be 
calculated by the initial volume of the washed suspension plus the volume added by: 
A 2
f 300 A
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Importantly, before VA is added to the washed suspension, calcium chloride [1.8mM], heparin 
[10U•mL-1], albumin [0.1%], and sodium bicarbonate [0.8M] should be mixed within VA.  
However, the amount of these should be based on the final volume expected (Vf), not VA. 
A.2 MATLAB PROGRAM FOR QUANTIFICATION OF LV MECHANO-
ENERGETIC FUNCTION 
The data collection system for the isolated rabbit heart study used a file format that could only be 
read by the National Instrument Lab View program “Analyze Frank-Starling Experiment 
w/Trelax.VI” (this program has existed in the Cardiovascular Systems Laboratory for many 
years).  Using this program, read the data then write the data making sure to export the raw data.  
The resulting text file can then opened and saved in an Excel format.  From this file, time, 
pressures and volumes were saved and two more columns were added for manually entering 
AVO2 and Qcor collected at each volume step during the experiment.  The file must be in this 
format for the following Matlab code to read the raw data.  The program fitted ESPVR, EDPVR, 
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and MVO2-PVA relationship (see equations in Section 2.6) and derived parameters for these 
relationships.  The parameters and raw data were output into a text file for data compilation.  In 
addition, a graphical output was also saved (Figure A-1); this output was helpful in determining 
the reliability of the data.  The program as written in Matlab is as follows: 
clear 
CD = cd; 
 
%Loads File 
[datafile,directory] = uigetfile('*.xls','Choose Data File'); 
cd(directory) 
[data,txt] = xlsread(datafile); 
cd(CD); 
 
%Input dialog: (1) volume steps to identify columns (2) pacing interval to calculate HR (3) balloon volume 
prompstr = {'Enter number of volume steps'}; 
    titlestr = 'Volume Steps'; 
    initstr = {'4'}; 
    numstp = inputdlg(prompstr,titlestr,1,initstr); 
    numstp=numstp{1}; 
    ns=str2double(numstp); 
    int=460; %HR interval ms 
    bal_vol=1.4; % 
HR=(60/int)*1000; 
 
%Assign variables 
t=data(:,1); 
for j=1:ns 
    P(:,j)=data(:,j+1); 
    V(:,j)=data(:,j+ns+1); 
end 
V=V+bal_vol; 
AVO2temp=data(:,1+ns+ns+1); 
 
%Finds text to eliminate header 
i = find(~isnan(AVO2temp)); 
AVO2=AVO2temp(i); 
Qcor=data(i,1+ns+ns+2); 
 
%Find EDP and ESP 
for k=1:ns 
    Ped(1,k)=min(P(:,k)); 
    Pes(1,k)=max(P(:,k)); 
    Vst(1,k)=V(1,k); 
end 
 
%Fit raw data for ESPVR and EDPVR 
%ESPVR --> Pes=Ees(Ves-Vd) %NO CONSTRAINTS 
[y,S]=polyfit(Vst,Pes,1); 
Pes_fit = y(1)*Vst + y(2);     
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%EDPVR --> Ped=alpha*(exp(beta(Ved-Vo))-1) %NO CONSTRAINTS 
Xo = [0.1 0.1 0.1]; 
[x,RESNORM,RESIDUAL] = lsqcurvefit(@EDPVR,Xo,Vst,Ped);  
Ped_fit = x(1)*(exp(x(2)*(Vst-x(3)))-1); 
 
%Coefficients from ESPVR and EDPVR 
Ees=y(1); 
Vd=-y(2)/y(1); 
alpha=x(1); 
beta=x(2); 
Vo=x(3); 
 
%PVA Calculations 
for i=1:ns 
    vol(i,:)=linspace(Vd,Vst(i)); 
    ESP(i,:)=y(1)*vol(i,:)+y(2); 
    EDP(i,:)=  x(1)*(exp(x(2)*(vol(i,:)-x(3)))-1); 
    space=vol(i,2)-vol(i,1); 
    pva(i,:) = trapz(ESP(i,:)-EDP(i,:)); 
    PVA(i,:)=pva(i,:)*space; 
end 
PVA_beat = PVA; % already [mL*mmHg/beat] so do NOT normalize to HR 
MVO2_beat = (Qcor.*AVO2)/HR; %[mL O2 per beat] normalize to HR 
r = polyfit(PVA_beat,MVO2_beat,1); 
a=r(1); b=r(2); 
fit = a*PVA_beat + b; 
name = datafile(1:end-4); 
 
%PLOT RAW DATA******************* 
Hf_figure=figure('Name','Isolated Rabbit Heart Mechano-Energetic Analysis','Position',[4 39 1274 
710],'Resize','on'); 
subplot(subplot('Position',[0.1 0.6 0.25 0.3])) 
    plot(t,P) 
    plttitle=sprintf('%s \n %s','Frank Starling Data',name); 
    title(plttitle,'FontSize',16); 
    ylabel('Pressure (mmHg)') 
    xlabel('Time (s)')  
subplot('Position',[0.1 0.1 0.25 0.3]) 
    plot(t,V) 
    ylabel('Volume (mL)') 
    xlabel('Time (s)') 
 
%PLOT MECHANICAL DATA******** 
subplot(subplot('Position',[0.6 0.6 0.25 0.3])) 
    plot(vol(ns,:),ESP(ns,:),'b--'); 
    hold on 
    plot(vol(ns,:),EDP(ns,:),'b:'); 
    plot(V,P) 
    title('Mechanics') 
    xlabel('Volume (mL)') 
    ylabel('Pressure (mmHg)') 
    PVR1 = sprintf('%s \n %s %6.2f %s \n %s %6.2f %s','ESPVR','E_e_s =',Ees,'mmHg\bulletmL^-^1','V_d =',Vd,' 
mL'); 
    PVR2 = sprintf('%s \n %s %6.2f %s \n %s %6.2f %s \n %s %6.2f %s','EDPVR','\alpha =',alpha,'mmHg','\beta 
=',beta,'mL^-^1','Vo =',Vo,'mL'); 
    h1=legend(PVR1,PVR2,'Location','NorthWest'); 
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    set(h1, 'Box', 'off') 
    set(h1,'Interpreter','tex','FontSize',8) 
 
%PLOT ENERGETIC DATA******* 
subplot('Position',[0.6 0.1 0.25 0.3]) 
plot(PVA_beat,fit) 
hold on 
plot(PVA_beat,MVO2_beat,'*') 
plttitle=sprintf('%s \n %s %s %s','Energetics','HR =',num2str(HR,'%3.0f'),'bpm'); 
    title(plttitle); 
xlabel('PVA (mmHg\bulletmL\bulletbeat^-^1)') 
ylabel('MVO_2 (mL O_2\bulletbeat^-^1)') 
ener = sprintf('%s %6.3e %s \n%s %6.3e %s','a=',r(1),'mL O_2\bulletmmHg^-^1\bulletmL^-^1','b=',r(2),'mL 
O_2\bulletbeat^-1'); 
    [h2] = legend(ener,'Location','NorthWest'); 
    set(h2,'Interpreter','tex','FontSize',8) 
    set(h2, 'Box', 'off') 
filesave=datafile(1:end-4); 
filesave(end+1:end+4)='.fig'; 
saveas(gcf,filesave); 
cd(CD) 
 
%SAVE DATA TO FILE 
fid=fopen('MechanoEnergetic Parameters.txt','a'); 
    fprintf(fid,'%s %06.4f %6.4f %6.4f %6.4f %6.4f %6.4f %6.4f\n',datafile(1:end-4),Ees,Vd,alpha,beta,Vo,a,b); 
    fprintf(fid,'%s %s %s %s %s','- - - - -'); 
    fprintf(fid,'%s\n',''); 
fclose(fid); 
fid1=fopen('Mechano-Energetics.txt','a'); 
    fprintf(fid1,'%s\n',''); 
    fprintf(fid1,'%s %s %s %s %s %s %s','---- ---- ---- ---- ---- ---- ----'); 
    fprintf(fid1,'%s\n',''); 
    fprintf(fid1,'%s',datafile(1:end-4)); 
    fprintf(fid1,'%s\n',''); 
    fprintf(fid1,'%s %s %s %s %s %s %s %s %s %s %s %s %s %s %s 
%s','Vst','EDP','ESP','MVO2','PVA','AVO2','Qcor'); 
    fprintf(fid1,'%s\n',''); 
    fprintf(fid1,'%09.3f %9.3f %9.3f %9.3f %9.3f %9.3f 
%9.3f\n',[Vst;Ped;Pes;MVO2_beat';PVA_beat';AVO2';Qcor']); 
fclose(fid1); 
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 Figure A-1. Graphical output of Matlab program for mechano-energetic function. 
 
(A) LV pressure waveforms collected at incremental end-diastolic volumes. (B) P-V relationships and isovolumic 
pressure trajectories for each volume step. (C) End-diastolic volumes for each isovolumic contraction. (D) MVO2-
PVA data points and derived relationship. 
A.3 MIXED MODEL STATISTICS PROGRAM CODE 
As stated in Section 3.2.1.6, relationships between RA and RVOT pacing were compared using a 
mixed model approach to account for both fixed and random effects.  The “MIXED” process was 
used in the statistical software package, SAS (SAS Institute Inc., Cary, NC).  The model solved 
for simultaneous changes in the slope and intercept of linear relationships for both ESPVR and 
 143 
MVO2-PVA relationship.  Statistical analysis of ESPVR required two separate analyses.  The 
program first solved for Y = mx + b.  However, the intercept, b, is actually the Y-intercept.  A 
separate program was executed to solve for the statistical properties of the X-axis intercept of 
ESPVR (i.e., Vd).  This program simply set ESP as the independent variable and EDV as the 
dependent variable, thus solving for X = 1/m*Y – b/m.  The mean slope values obtained from 
this program was validated against the intercept/slope obtained from the original program.  The 
SAS code is as follows: 
Reads in data and assigns variables: 
libname file1 'C:\Documents and Settings\Lauren\My Documents\RABBIT'; 
PROC FORMAT; 
VALUE PACINGF 1='RA' 2='RV'; 
data one; 
 set file1.mvo2_pva_raw_new; 
  IF PACING='RA' THEN PACINGN=1; 
   ELSE IF PACING='RV' THEN PACINGN=2; 
  label 
   esp="ESP" 
   mvo2="MVO2" 
   pacing="PACING" 
   pva="PVA" 
   vst="EDV"; 
  FORMAT PACINGN PACINGF.; 
  options NODATE NONUMBER; 
  run; 
 
Calculates mean values for Vst, ESP, PVA, and MVO2: 
  PROC MEANS DATA=one MEAN; 
  CLASS VST PACINGN; 
  VAR ESP; 
  VAR PVA; 
  VAR MVO2; 
  PROC FREQ; 
  TABLES RABBIT PACINGN; 
  RUN; 
 
Random Effects Modeling for ESPVR (note: only use results for slope here): 
**ESP AND VST**; 
PROC MIXED DATA=ONE; 
CLASS RABBIT PACINGN; 
MODEL ESP=PACINGN VST PACINGN*VST/DDFM=SATTERTH SOLUTION; 
RANDOM INT VST/SUBJECT=RABBIT TYPE=UN; *RANDOM COEFFICIENT MODEL; 
ESTIMATE 'RA,VST SLOPE' VST 1 PACINGN*VST 1 0; 
ESTIMATE 'RV,VST SLOPE' VST 1 PACINGN*VST 0 1; 
ESTIMATE 'RA SLOPE - RV SLOPE' PACINGN*VST 1 -1; 
ESTIMATE 'RA,INT' INT 1 PACINGN 1 0; 
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ESTIMATE 'RV,INT' INT 1 PACINGN 0 1; 
ESTIMATE 'RA INT - RV INT' PACINGN 1 -1; 
options NODATE NONUMBER formdlim='-'; 
title; 
RUN; 
 
Random Effects Modeling for MVO2-PVA relationship: 
**MVO2 AND PVA**; 
PROC MIXED DATA=ONE; 
CLASS RABBIT PACINGN; 
MODEL MVO2=PACINGN PVA PACINGN*PVA/DDFM=SATTERTH SOLUTION; 
RANDOM INT PVA/SUBJECT=RABBIT TYPE=UN;*RANDOM COEFFICIENTS MODEL; 
ESTIMATE 'RA,PVA SLOPE' PVA 1 PACINGN*PVA 1 0; 
ESTIMATE 'RV,PVA SLOPE' PVA 1 PACINGN*PVA 0 1; 
ESTIMATE 'RA SLOPE - RV SLOPE' PACINGN*PVA 1 -1; 
ESTIMATE 'RA,INT' INT 1 PACINGN 1 0; 
ESTIMATE 'RV,INT' INT 1 PACINGN 0 1; 
ESTIMATE 'RA INT - RV INT' PACINGN 1 -1; 
options NODATE NONUMBER formdlim='-'; 
title; 
RUN; 
 
Random Effects Modeling for ESPVR to obtain statistical values for intercept (Vd): 
*NOTE: VST IS NOW DEPENDENT VARIABLE AND ESP IS INDEPENDENT 
libname file1 'C:\Documents and Settings\Lauren\My Documents\RABBIT'; 
PROC FORMAT; 
VALUE PACINGF 1='RA' 2='RV'; 
data one; 
 set file1.espvrvd; 
  IF PACING='RA' THEN PACINGN=1; 
   ELSE IF PACING='RV' THEN PACINGN=2; 
    label 
   esp="VOLUME STEP (NOW DEPENDENT)"    
   pacing="CONDITION" 
   vst="ESP/SLOPE (NOW INDEPENDENT)"; 
  FORMAT PACINGN PACINGF.; 
  options NODATE NONUMBER; 
  run; 
****RANDOM EFFECTS MODELING****;**ESP AND VST**; 
PROC MIXED DATA=ONE; 
CLASS RABBIT PACINGN; 
MODEL ESP=PACINGN VST PACINGN*VST/DDFM=SATTERTH SOLUTION; 
RANDOM INT VST/SUBJECT=RABBIT TYPE=UN;         
ESTIMATE 'RA,VST SLOPE' VST 1 PACINGN*VST 1 0; 
ESTIMATE 'RV,VST SLOPE' VST 1 PACINGN*VST 0 1; 
ESTIMATE 'RA SLOPE - RV SLOPE' PACINGN*VST 1 -1; 
ESTIMATE 'RA,INT' INT 1 PACINGN 1 0; 
ESTIMATE 'RV,INT' INT 1 PACINGN 0 1; 
ESTIMATE 'RA INT - RV INT' PACINGN 1 -1; 
options NODATE NONUMBER formdlim='-'; 
title; 
RUN; 
The output of the code is as follows: 
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                                      The Mixed Procedure 
                                       Model Information 
                     Data Set                     WORK.ONE 
                     Dependent Variable           ESP 
                     Covariance Structure         Unstructured 
                     Subject Effect               Rabbit 
                     Estimation Method            REML 
                     Residual Variance Method     Profile 
                     Fixed Effects SE Method      Model-Based 
                     Degrees of Freedom Method    Satterthwaite 
                                  Solution for Fixed Effects 
           Label                  Estimate     StdError      DF    t Value    Pr > |t| 
           RA,VST SLOPE            56.0602      5.0657      11      11.07      <.0001 
           RV,VST SLOPE            58.5351      5.0465    10.8      11.60      <.0001 
           RA SLOPE - RV SLOPE     -2.4750      1.9063    93.5      -1.30      0.1974 
           RA,INT                 -33.5617      8.9559    11.3      -3.75      0.0031 
           RV,INT                 -42.1248      8.8925      11      -4.74      0.0006 
           RA INT - RV INT          8.5631      3.6968    93.6       2.32      0.0227 
 
                                      The Mixed Procedure 
                                       Model Information 
                     Data Set                     WORK.ONE 
                     Dependent Variable           MVO2 
                     Covariance Structure         Unstructured 
                     Subject Effect               Rabbit 
                     Estimation Method            REML 
                     Residual Variance Method     Profile 
                     Fixed Effects SE Method      Model-Based 
                     Degrees of Freedom Method    Satterthwaite 
                                  Solution for Fixed Effects 
           Label                  Estimate   StdError      DF    t Value      Pr > |t| 
           RA,PVA SLOPE             0.1492     0.01689     9.2       8.83      <.0001 
           RV,PVA SLOPE             0.1682     0.01695     9.4       9.92      <.0001 
           RA SLOPE - RV SLOPE    -0.01900    0.009777    94.8      -1.94      0.0549 
           RA,INT                  0.02536    0.003459    11.2       7.33      <.0001 
           RV,INT                  0.02864    0.003411    10.6       8.40      <.0001 
           RA INT - RV INT        -0.00328    0.001446    94.8      -2.27      0.0256 
 
                                      The Mixed Procedure 
                                       Model Information 
                     Data Set                     WORK.ONE 
                     Dependent Variable           EDV 
                     Covariance Structure         Unstructured 
                     Subject Effect               Rabbit 
                     Estimation Method            REML 
                     Residual Variance Method     Profile 
                     Fixed Effects SE Method      Model-Based 
                     Degrees of Freedom Method    Satterthwaite 
                                  Solution for Fixed Effects 
           Label                  Estimate   StdError      DF    t Value      Pr > |t| 
           RA,VST SLOPE            0.01833    0.001500    10.7      12.22      <.0001 
           RV,VST SLOPE            0.01800    0.001493    10.5      12.06      <.0001 
           RA SLOPE - RV SLOPE    0.000335    0.000454    93.2       0.74      0.4622 
           RA,INT                   0.5846      0.1024    10.9       5.71      0.0001 
           RV,INT                   0.6659      0.1013    10.5       6.57      <.0001 
           RA INT - RV INT        -0.08128     0.03398    93.3      -2.39      0.0188  
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A.4 MECHANO-ENERGETIC FUNCTION DURING BIVENTRICULAR PACING 
In addition to assessing mechano-energetic function between RA and RVOT pacing, we also 
measured mechanical and energetic function during simultaneous RA, RVOT, and LV pacing at 
either the apex (BiVa) or free-wall (BiVf).  These pacing modalities were investigated to assess 
the effects of counter-pacing (or resynchronization) RVOT pacing on mechano-energetic 
function.  The ESPVR and MVO2-PVA relationships under BiVa and BiVf pacing are 
superimposed on the data obtained for RA and RVOT pacing in Figure A-2.  Although a 
statistical analysis was not performed for the BiVa and BiVf dataset, it appears that the ESPVR 
under BiVa pacing is similar to that of RVOT pacing.  However, the MVO2-PVA relationship 
under BiVa pacing is elevated compared to RVOT pacing, indicating lower mechano-energetic 
efficiency.  In contrast, as the ESPVR for BiVf pacing seems slightly lower than that for RVOT 
pacing, the MVO2-PVA relationship appears similar to that of RVOT pacing.  However, we were 
not convinced of the stability of the data collected at the time of these pacing modalities.  These 
data were collected approximately 1.5-2 hours after the preparation began.  This was mainly due 
to repetition of RA pacing between each ventricular pacing modality.  Future studies without 
repeated RA pacing conditions may allow one to collect data under all 4 conditions before 
deterioration of the preparation.  We therefore focused on reporting mechano-energetic function 
during RA and RVOT pacing conditions only, which were collected <1 hour of the initiation of 
the experiment. 
 147 
 Figure A-2. Mechano-energetic function for several pacing modalities. 
 
 
(A) Compared to RA pacing, the ESPVR was depressed with RVOT, BiVa, and BiVf pacing. (B) Despite the 
depression in mechanics, all ventricular pacing modes adversely affected global LV energetics manifested as an 
increase in the MVO2-PVA intercept with BiVa pacing having the most elevated MVO2-PVA relationship. Data: 
n=8 for RA and RVOT pacing, n=7 for BiVa pacing, n=6 for BiVf pacing. 
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APPENDIX B 
MATLAB PROGRAMS FOR CROSS-CORRELATION ANALYSES 
B.1 CROSS-CORRELATION ANALYSIS FOR TISSUE DOPPLER-DERIVED 
RADIAL STRAIN AT THE MID-LEFT VENTRICLE 
For Study 2 (Section 4.0), we used tissue-Doppler derived radial strain waveforms to quantify 
dyssynchrony using cross-correlation analysis.  Six circumferentially arrayed segments at the 
mid-LV were assessed by deriving time-strain waveforms describing radial strain 
(thickening/thinning) at each of these segments.  The cross-correlation analysis including 
derivation of cross-correlation spectrum is performed by using the Matlab statistics toolbox 
function regress.  This function performs multiple linear regression where a response (strain for 
one segment in a pair) is modeled as a linear combination of functions (not necessarily linear) of 
a predictor (strain of second segment in the pair).  From this function, several outputs relevant to 
statistical analysis of the regression can be derived.  Specifically, the direction of the effects 
(signs of β term) and R2 term was calculated to obtain the cross-correlation coefficient which 
indicated how well the two signals “lined up”.  In order to calculate a spectrum of cross-
correlation coefficients, one segment in a pair was held constant, while the other segment was 
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shifted in time, and for each time shift, a cross-correlation coefficient was calculated.  To 
accomplish this, a for loop is used in the code.  An example of derivation of the cross-correlation 
spectra for 5 sine waves with varying amplitude and phase shifts is illustrated in Figure B-1.  
Correlation of the first two waveforms (which are both equally sin(x)) results in perfect 
synchrony at zero time shift (i.e., cross-correlation coefficient of 1.0 at zero time shift.  The 
cross-correlation coefficient then decreases as the second waveform is shifted with respect to the 
first giving the lowest correlation of -1.0 when they are completely out of phase with each other 
at a shift of ±π units (Figure B-1B).  Note that although the third waveform is twice the 
amplitude of the first sine wave, the same spectrum just described (i.e., comparing the first two 
sine waves) is obtain when correlating the first and third waveforms because cross-correlation 
analysis cannot distinguish between differing amplitudes.  In contrast, since the fourth waveform 
is already out of phase from the first waveform by π units, then it is not surprising that the cross-
correlation spectrum reveals the lowest correlation (-1.0) at zero time shift and highest 
correlation (+1.0) at ±π units.  Similarly, the fifth waveform is out of phase with the first by π/2 
units, therefore the lowest correlation is at + π/2 and the highest correlation is at - π/2.  As shown 
in Figure B-1C, the same spectra as in Figure B-1B are obtained when the second waveform is 
correlated with the rest since they are both sin(x).  Similarly, the spectra are repeated in Figure 
B-1D since the waveforms 2•sin(x) and sin(x) do not result in different cross-correlation spectra 
when combined with other waveforms because amplitude does not affect derivation of cross-
correlation coefficients.  Finally, when combining the last two segments, it is now clear that 
since they are shifted by π/2, this is where the maximum correlation occurs (Figure B-1E). 
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 Figure B-1. Example of cross-correlation spectrum derivation. 
 
(A) Five sine waves with varying amplitude and phase shifts.  Note that the first two waveforms are the same.  (B) 
Cross-correlation spectra obtained for correlations of the first waveform [i.e., sin(x)] and the other 4.  (C) Cross-
correlation spectra obtained for correlations of the second waveform [i.e., sin(x)] and the other 3.  (D) Cross-
correlation spectra obtained for correlations of the third waveform [i.e., 2*sin(x)] and the other 2.  (E) Cross-
correlation spectra obtained for correlations of the fourth waveform [i.e., sin(x-pi)] and the fourth. 
 
The Matlab code allows one to load a dataset containing a column of time and 6 columns 
of strain.  The data is interpolated to yield 10 ms sampling interval for easier calculation of the 
cross-correlation spectrum.  Outputs from this analysis are saved into a text file for offline data 
compilation.  In addition, a graphical output is also saved as shown in Figure B-2.  The actual 
code is protected under copyright by the University of Pittsburgh and therefore is not displayed 
in the current thesis. 
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 Figure B-2. Graphical output for TD-strain and corresponding cross-correlation analysis. 
 
The top plot shows TD derived radial strain from the mid-LV.  End of systole is also marked on the plot to 
emphasize that cross-correlation analysis was only performed during systole.  The bottom plot contains cross-
correlations spectra derived for the 15 pair-wise correlations. 
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B.2 CROSS-CORRELATION ANALYSIS FOR SPECKLE-DERIVED STRAIN AT 
MULIPLE LV CROSS-SECTIONS 
The previous analysis was extended for a multi-dimensional approach to quantify dyssynchrony 
in Study 3 (Section 5.0).  Here, radial strain was derived using speckle tracking algorithm on 
standard gray scale 2D echocardiographic images at three short-axis LV levels (i.e., LV base, 
mid-LV, and LV apex).  In addition, the speckle tracking software derived circumferential strain 
of each of the segments in addition to deriving radial strain.  Therefore, the cross-correlation 
analyses for radial strain were repeated for circumferential strain.  In addition to applying cross-
correlation analysis within each short-axis level, we also assessed “longitudinal” disparities by 
correlating segments I, L, A, and S across LV levels.  However, we did not report indices derived 
from this analysis since it did not actually represent longitudinal dyssynchrony because the strain 
was radially derived.  Furthermore, we were also able to assess torsion since the speckle tracking 
software derived rotation of segments at the LV base and LV apex.  However, we did not report 
circumferential or torsion indices in our results.  Essential to this study, we developed a new 
method to quantify segmental contributions to the integrated measure of synchrony (Section 
5.2.4.2).  With this information, Bull’s Eye plots were constructed which color-coded synchrony 
indices in order to easily interpret the results. 
The developed Matlab code contains several imbedded files for an extensive software 
suite to quantify dyssynchrony using cross-correlation analysis.  The code is self-automated such 
that the user loads 3 files containing time, radial and circumferential strain, and rotation at the 
LV base, mid-LV, and LV apex and the program performs the analysis automatically.  In 
addition, several more files were written to save graphical outputs and data derived from this 
analysis.  The code to perform the cross-correlation analysis is now protected under copyright 
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(“Cross-Correlation Analysis: A Novel Bedside Tool to Quantify Left Ventricular Contraction 
Dyssynchrony” ©2008 University of Pittsburgh) and therefore will not be shown in the current 
thesis.  Graphical outputs are as follows: 
 
Figure B-3. User interface for multi-dimensional cross-correlation analysis. 
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 Figure B-4. Radial strain Bull’s Eye plots from cross-correlation analysis. 
 
Figure B-5. Circumferential strain Bull’s Eye plots from cross-correlation analysis. 
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 Figure B-6. Basal and apical rotation and corresponding torsion plots. 
B.3 CROSS-CORRELATION ANALYSIS IN THE HUMAN REALM: RADIAL AND 
LONGIDUDINAL SYNCHRONY ANALYSES 
The cross-correlation analysis suite from Study 3 (see Appendix B.2) was slightly modified to 
handle the strain data obtained in the human study.  Specifically, the “Loading” file needed to be 
adjusted since the raw data files were extracted using different speckle tracking software 
providers.  In addition, the human data contained 6 apical segments.  However, the radial strain 
at the base and apex were not reliable due to image quality.  Therefore, only results derived from 
radial strain were reported. 
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The cross-correlation analysis was extended to handle longitudinal displacement data.  As 
described above (see Section 7.2.4), the septal and LV lateral walls were each segmented into 5 
regions which were tracked by the software and time-displacement curves were derived.  Each 
patient had a file with time and displacement data for the septum and another file for the LV 
lateral wall.  For each wall, an integrated cross-correlation synchrony index was derived in 
addition to segmental indices for each of the 5 regions.  An example of the graphical output from 
this code is shown in Figure 7-4.  Again, the code is not displayed because of copyright issues. 
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APPENDIX C 
MATLAB PROGRAM FOR PRESSURE-VOLUME LOOP ANALYSIS 
Indices of global LV performance were derived using P-V analysis from a conductance catheter 
placed into the LV.  Electrical conductance of blood in the LV was converted into volume using 
the following equation: 
 2LV c
1V ( L V= ρ× −α )  (C-1) 
where  α is a dimensionless constant, ρ is blood resistivity, L is electrode spacing, and Vc is an 
offset, or corrective volume, that represents parallel conductance (i.e., conductance of 
myocardial tissue and/or surrounding electrical conductance) [55].  Unfortunately, when LV 
volumes were collected, proper calibration factors (i.e., α, ρ, L, and Vc) were not applied to the 
calculation of total LV volume.  Therefore, volumes had to be calibrated during post-processing 
of the data.  A custom-written Matlab code was used to calibrate and select the desired segmental 
volumes to be included in the analysis (see below).  First, conductance (G) for each segment was 
back-calculated using the preset calibration values of α = 1.0, Vc = 0 mL, ρ = 146.91 Ω•cm, and 
L = 0.6 cm and the equation: 
 i 2
VG
L
= ρ×  (C-2) 
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where i is for each segment along the conductance catheter.  Then blood resistivity, ρ, was 
calculated from hematocrit data using an equation derived by Geddes and Sadler [115] given by: 
  (C-3) 0.025 Hematocrit0.537e ×ρ =
where hematocrit is in %.  Next, α and Vc were derived from echocardiographic measures of LV 
volumes.  Under baseline conditions (i.e. RA pacing), α was calculated by the stroke volume 
derived from the conductance catheter divided by echocardiographic-derived stroke volume.  
Under the same conditions, Vc was calculated as the end-diastolic volume derived from the 
conductance catheter minus the product of α and echocardiographic-derived end-diastolic 
volume.  Since echocardiographic volume data was not available for other pacing modalities, we 
assumed that the calibration factors α and Vc derived under baseline were the same throughout 
the pacing protocols.  After α, ρ, and Vc were derived for each patient, LV volume was 
calculated using Equation C-1 above for the other pacing modalities.  Conductance (or volume) 
was measured for 7 segments, however, we assumed that segments 2, 3, and 4 were most likely 
the segments that were consistently within the LV cavity (i.e., away from apical tissue and the 
mitral valve).  Therefore, total LV volume was calculated by the sum of only segments 2-4.This 
program code was written because it was unclear which volume segments to include into the 
calculation of total LV volume.  In addition, the volumes (or conductance) needed to be scaled 
since appropriate calibration coefficients were not applied during data collection (see Section 
7.2.5). 
The program written to calibrate and analyze P-V data consists of several files and 
callbacks.  The first file loads the user interface so that patient data may be loaded (Figure C-1).  
Once the data is loaded, a graphical user interface asks the user to select the range of data to be 
analyzed; this was incorporated because some datasets contained several minutes of data.  Once 
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loaded, several check boxes are displayed for the user to select which segments to be included 
(Figure C-1).  Each time a box is checked, total LV volume is calculated and a P-V loop is 
displayed.  This was necessary because the loops become distorted if the segmental volume is 
not accurate (e.g., outside of the ventricle).  Once the user is satisfied with the morphology of the 
P-V loop, the “finished” button is pressed and indices of global LV performance are calculated 
for each of the cardiac cycles contained in the dataset; the indices are averaged and displayed on 
the plot (Figure C-1). 
 
Figure C-1. User interface and graphical output for P-V loop analysis. 
The Matlab code for P-V loop analysis is as follows: 
User Interface: 
close all; clear all; clc; 
  
Hf_figure=figure('Name','P-V Analysis','Position',[4 39 1274 710],'Resize','off'); 
set(Hf_figure,'Menubar','none') 
    Hm_File = uimenu(Hf_figure,'Label','File','Position',1); 
        Hm_PatientNew = uimenu(Hm_File,'Label','Open New Patient','Callback','Another=0;Loading;'); 
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        Hm_Another = uimenu(Hm_File,'Label','Open Another File','Enable','on','Callback',... 
            
'Another=1;set(cbh1,''value'',0);set(cbh2,''value'',0);set(cbh3,''value'',0);set(cbh4,''value'',0);set(cbh5,''value'',0);set(cb
h6,''value'',0);set(cbh7,''value'',0);Loading'); 
        Hm_FilePrint = uimenu(Hm_File,'Label','Print Figure','Enable','on','Callback','orient landscape;printdlg'); 
        Hm_FilePrintReport = uimenu(Hm_File,'Label','Print Report','Enable','on','Callback','PrintReport'); 
    Hm_window = uimenu(Hf_figure,'Label','Window','Position',2,'Enable','on'); 
        Hm_PV = uimenu(Hm_window,'Label','PV Loops','Enable','off'); 
        Hm_CCA = uimenu(Hm_window,'Label','Cross-Correlation Analysis','Enable','on','Callback','Plot_CCA;'); 
    Hm_save = uimenu(Hf_figure,'Label','Save Analysis','Enable','on'); 
        Hm_saveGP = uimenu(Hm_save,'Label','Save Global and CC Analysis','Callback','SaveData'); 
        Hm_saveCCA = uimenu(Hm_save,'Label','Save Cross-Correlation Analysis','Enable','off'); 
        Hm_saveAll = uimenu(Hm_save,'Label','Save All 
Analyses','Enable','off','Callback','SaveData;Plot_CCA;SaveCCA'); 
%----------------------------------------------------------- 
hp = uipanel('BorderType','line','BorderWidth',2,'HighlightColor','black','BackgroundColor','White','Position',[0.42 
0.06 0.18 0.5]); 
hc_title=uicontrol(hp,'style','text','FontSize',11,'string','Global LV 
Performance','Units','normalized','FontWeight','bold','Position',[0.0328 0.74 0.93 0.05],'BackgroundColor','White'); 
hc_und1=uicontrol(hp,'style','text','FontSize',11,'string','_____________________________________','Units','norma
lized','FontWeight','bold','Position',[0.0328 0.83 0.93 0.0487],'BackgroundColor','White'); 
hc_patientname=uicontrol(hp,'style','text','FontSize',11,'string','Patient 
Name','Units','normalized','FontWeight','bold','Position',[0.0285 0.94 0.96 0.05],'BackgroundColor','White'); 
hc_filename=uicontrol(hp,'style','text','FontSize',11,'string','Pacing 
Mode','Units','normalized','FontWeight','bold','Position',[0.0285 0.8709 0.96 0.05],'BackgroundColor','White'); 
  
    hc_hr= uicontrol(hp,'style','text','FontSize',10,'string','HR =       bpm','Units','normalized','Position',[0.05 0.64 0.9 
0.06],'BackgroundColor','White'); 
    hc_edv= uicontrol(hp,'style','text','FontSize',10,'string','EDV =       mL','Units','normalized','Position',[0.05 0.58 0.9 
0.06],'BackgroundColor','White'); 
    hc_esv= uicontrol(hp,'style','text','FontSize',10,'string','ESV =      mL','Units','normalized','Position',[0.05 0.52 0.9 
0.06],'BackgroundColor','White'); 
    hc_sv= uicontrol(hp,'style','text','FontSize',10,'string','SV =      mL','Units','normalized','Position',[0.05 0.46 0.9 
0.06],'BackgroundColor','White');         
    hc_co= uicontrol(hp,'style','text','FontSize',10,'string','CO =      mL*min^-1','Units','normalized','Position',[0.05 0.4 
0.9 0.06],'BackgroundColor','White'); 
    hc_ef= uicontrol(hp,'style','text','FontSize',10,'string','EF =      %','Units','normalized','Position',[0.05 0.34 0.9 
0.06],'BackgroundColor','White'); 
    hc_esp= uicontrol(hp,'style','text','FontSize',10,'string','ESP =      mmHg','Units','normalized','Position',[0.05 0.28 
0.9 0.06],'BackgroundColor','White'); 
    hc_edp= uicontrol(hp,'style','text','FontSize',10,'string','EDP =      mmHg','Units','normalized','Position',[0.05 0.22 
0.9 0.06],'BackgroundColor','White'); 
    hc_pdpdt= uicontrol(hp,'style','text','FontSize',10,'string','+dp/dt =      mmHg*s^-
1','Units','normalized','Position',[0.05 0.16 0.9 0.06],'BackgroundColor','White'); 
    hc_ndpdt= uicontrol(hp,'style','text','FontSize',10,'string','-dp/dt =      mmHg*s^-
1','Units','normalized','Position',[0.05 0.10 0.9 0.06],'BackgroundColor','White'); 
    hc_sw= uicontrol(hp,'style','text','FontSize',10,'string','SW =      mL*mmHg','Units','normalized','Position',[0.05 
0.04 0.9 0.06],'BackgroundColor','White'); 
 
    hp2 = uipanel('BorderType','line','BorderWidth',2,'HighlightColor','black','BackgroundColor','White', 
'Position',[0.42 0.655 0.18 0.3154]); 
    hp1_title=uicontrol(hp2,'style','text','FontSize',10,'string','Select Segments To Be 
Used','Units','normalized','BackgroundColor','White','FontWeight','bold','Position',[0.05 0.92 0.93 0.08]); 
    hp2_title=uicontrol(hp2,'style','text','FontSize',10,'string','In Total Volume 
Calculation','Units','normalized','BackgroundColor','White','FontWeight','bold','Position',[0.05 0.84 0.93 0.08]); 
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    cbh1 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 1 
(Distal)','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.0860 0.7 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh2 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
2','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.191 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh3 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
3','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.296 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh4 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
4','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.401 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh5 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
5','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.506 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh6 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
6','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.611 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh7 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 7 
(Proximal)','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.716 0.7 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    h_push_done=uicontrol(hp2,'style','pushbutton','String', 'Finished','Units','normalized','Position',[0.05 0.001 
0.8954 0.10],'Callback','Finished=1;Global_Analysis'); 
    hp3p=uipanel('BorderType','line','HighlightColor','black','BackgroundColor','White','Position',[0.05 0.955 0.05 
0.03]); 
    hp3 = uicontrol(hp3p,'style','pushbutton','string','Zoom','Units','Normalized','Position',[0 0 1 1],'Callback','Zoom'); 
    Finished=0;  
%----------------------------------------------------------         
subplot('Position',[0.05 0.7 0.35 0.25]) 
    cla 
    ylabel('LV Volume (mL)') 
     
subplot('Position',[0.05 0.38 0.35 0.25]) 
    cla 
    ylabel('LV Pressure (mmHg)') 
     
subplot('Position',[0.05 0.06 0.35 0.25])  
    cla 
    xlabel('Time (s)') 
    ylabel('Total LV Volume (mL)') 
subplot('Position',[0.65 0.06 0.34 0.85]) 
    cla 
    xlabel('Volume (mL)') 
    ylabel('Pressure (mmHg)') 
    title('Pressure-Volume Loops'); 
 
This file is used to load the file and calibrate conductance signals: 
if Another==0 
    directory='C:\Documents and Settings\Lauren\My Documents\HUMAN DATA\OPTIMA P-V Files\OPTIMA 
Code'; 
    cd(directory); 
else 
    cd(directory) 
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end 
  
%-------------------------------------------------------------- 
subplot('Position',[0.05 0.7 0.35 0.25]) 
    cla 
    ylabel('LV Volume (mL)') 
     
subplot('Position',[0.05 0.38 0.35 0.25]) 
    cla 
    ylabel('LV Pressure (mmHg)') 
     
subplot('Position',[0.05 0.06 0.35 0.25])  
    cla 
    xlabel('Time (s)') 
    ylabel('Total LV Volume (mL)') 
subplot('Position',[0.65 0.06 0.34 0.85]) 
    cla 
    xlabel('Volume (mL)') 
    ylabel('Pressure (mmHg)') 
    title('Pressure-Volume Loops'); 
  
    hc_hr= uicontrol(hp,'style','text','FontSize',10,'string','HR =       bpm','Units','normalized','Position',[0.05 0.64 0.9 
0.06],'BackgroundColor','White'); 
    hc_edv= uicontrol(hp,'style','text','FontSize',10,'string','EDV =       mL','Units','normalized','Position',[0.05 0.58 0.9 
0.06],'BackgroundColor','White'); 
    hc_esv= uicontrol(hp,'style','text','FontSize',10,'string','ESV =      mL','Units','normalized','Position',[0.05 0.52 0.9 
0.06],'BackgroundColor','White'); 
    hc_sv= uicontrol(hp,'style','text','FontSize',10,'string','SV =      mL','Units','normalized','Position',[0.05 0.46 0.9 
0.06],'BackgroundColor','White');         
    hc_co= uicontrol(hp,'style','text','FontSize',10,'string','CO =      mL*min^-1','Units','normalized','Position',[0.05 0.4 
0.9 0.06],'BackgroundColor','White'); 
    hc_ef= uicontrol(hp,'style','text','FontSize',10,'string','EF =      %','Units','normalized','Position',[0.05 0.34 0.9 
0.06],'BackgroundColor','White'); 
    hc_esp= uicontrol(hp,'style','text','FontSize',10,'string','ESP =      mmHg','Units','normalized','Position',[0.05 0.28 
0.9 0.06],'BackgroundColor','White'); 
    hc_edp= uicontrol(hp,'style','text','FontSize',10,'string','EDP =      mmHg','Units','normalized','Position',[0.05 0.22 
0.9 0.06],'BackgroundColor','White'); 
    hc_pdpdt= uicontrol(hp,'style','text','FontSize',10,'string','+dp/dt =      mmHg*s^-
1','Units','normalized','Position',[0.05 0.16 0.9 0.06],'BackgroundColor','White'); 
    hc_ndpdt= uicontrol(hp,'style','text','FontSize',10,'string','-dp/dt =      mmHg*s^-
1','Units','normalized','Position',[0.05 0.10 0.9 0.06],'BackgroundColor','White'); 
    hc_sw= uicontrol(hp,'style','text','FontSize',10,'string','SW =      mL*mmHg','Units','normalized','Position',[0.05 
0.04 0.9 0.06],'BackgroundColor','White'); 
  
    hp2 = 
uipanel('BorderType','line','BorderWidth',2,'HighlightColor','black','BackgroundColor','White','Position',[0.42 0.655 
0.18 0.3154]); 
    hp1_title=uicontrol(hp2,'style','text','FontSize',10,'string','Select Segments To Be 
Used','Units','normalized','BackgroundColor','White','FontWeight','bold','Position',[0.05 0.92 0.93 0.08]); 
    hp2_title=uicontrol(hp2,'style','text','FontSize',10,'string','In Total Volume 
Calculation','Units','normalized','BackgroundColor','White','FontWeight','bold','Position',[0.05 0.84 0.93 0.08]); 
    cbh1 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 1 
(Distal)','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.0860 0.7 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
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    cbh2 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
2','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.191 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh3 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
3','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.296 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh4 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
4','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.401 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh5 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
5','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.506 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh6 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
6','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.611 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh7 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 7 
(Proximal)','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.716 0.7 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    h_push_done=uicontrol(hp2,'style','pushbutton','String', 'Finished','Units','normalized','Position',[0.05 0.001 
0.8954 0.10],'Callback','Global_Analysis'); 
     
    hp3p=uipanel('BorderType','line','HighlightColor','black','BackgroundColor','White','Position',[0.05 0.955 0.05 
0.03]); 
    hp3 = uicontrol(hp3p,'style','pushbutton','string','Zoom','Units','Normalized','Position',[0 0 1 1],'Callback','Zoom'); 
    Finished=0; 
%---------------------------------------------------------- 
clc 
clear all 
WD=('C:\Documents and Settings\Lauren\My Documents\HUMAN DATA\OPTIMA P-V Files\OPTIMA Code'); 
  
[datafile,directory] = uigetfile('*.csv;*.xls','Choose Data File'); 
cd(directory)  %allows to choose file from another directory 
[data,txt] = xlsread(datafile); 
filename=datafile(1:end-4); 
patientname=directory(75:84); %Will need to change this if directory changes! 
  
cd(WD) 
  
beat=data(:,1); 
time=data(:,2); 
Volumes_unsc=data(:,3:9); 
ECG=data(:,10); 
LVP=data(:,11); 
    %Smooth LVP 
%     LVP=csaps(time,LVP,0.9999,time); 
x=1:length(time); 
 
%Need to convert "volumes" back to conductance 
%[know that alpha=1;Vc=0;rho=146.91;L=0.6cm (except #17:1.0cm)] 
 
patient_number=str2double(patientname(8:9)); 
pacing_site=str2double(filename(end-1)); 
  
if patient_number == 17 
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    l=1.0; 
else 
    l=0.6; 
end 
  
G=Volumes_unsc/(146.91*(l^2)); 
  
%Now convert conductance to volume each case refers to each patient (only 2 are displayed to save space) 
switch patient_number 
    case 11 
        rho=142.37;         
        EDVecho=153; 
        ESVecho=90; 
        alpha=0.2899; 
        Vc=93.5765; 
    case 12 
         rho=139.9;         
        EDVecho=74; 
        ESVecho=31; 
        alpha=0.5634; 
        Vc=84.8776; 
end 
L=1.0; 
%Volumes_o=(rho*L^2*G - 0); %Let alpha = 1.0 for now 
Volumes_o = G; %Let individual segments just be conductance for now 
G_sum = sum(G,2); 
 
PV_loops 
Finished=0; 
%FILTERING SCRIPT*********************** 
        blackmanNum = [0.0 0.0023325 -0.017436 -0.032217 0.26477 0.5651 0.26477 -0.032217 -0.017436 
0.0023325]; 
        blackmanDen = [ 1 ]; 
         
        Volumes_o = filtfilt(blackmanNum,blackmanDen,Volumes_o); 
        LVP = filtfilt(blackmanNum,blackmanDen,LVP); 
%*************************************** 
%Smoothing volumes 
for i=1:7 
    ys(:,i)=csaps(time,Volumes_o(:,i),0.999,time); 
end 
Volumes_o=ys; 
%************************************* 
subplot('Position',[0.05 0.7 0.35 0.25]) 
    cla 
    plot(x,Volumes_o) 
    ylabel('LV Conductance') 
    axis([0 length(x) min(min(G)) max(max(G))]) 
subplot('Position',[0.05 0.38 0.35 0.25]) 
    cla 
    plot(x,LVP) 
    ylabel('LV Pressure (mmHg)') 
    axis([0 length(x) 0 max(max(LVP)+5)]) 
subplot('Position',[0.05 0.06 0.35 0.25])  
    cla 
 165 
    xlabel('Time (s)') 
    ylabel('Total LV Volume (mL)') 
subplot('Position',[0.65 0.06 0.34 0.85]) 
    cla 
    hold on 
    xlabel('Volume (mL)') 
    ylabel('Pressure (mmHg)') 
    title('Pressure-Volume Loops'); 
     
hp = uipanel('BorderType','line','BorderWidth',2,'HighlightColor','black','Position',[0.42 0.06 0.18 
0.5],'BackgroundColor','White'); 
hc_title=uicontrol(hp,'style','text','FontSize',11,'string','Global LV 
Performance','Units','normalized','FontWeight','bold','Position',[0.0328 0.74 0.93 0.05],'BackgroundColor','White'); 
hc_und1=uicontrol(hp,'style','text','FontSize',11,'string','_____________________________________','Units','norma
lized','FontWeight','bold','Position',[0.0328 0.83 0.93 0.0487],'BackgroundColor','White'); 
hc_patientname=uicontrol(hp,'style','text','FontSize',11,'string',patientname,'Units','normalized','FontWeight','bold','P
osition',[0.0285 0.94 0.96 0.05],'BackgroundColor','White'); 
hc_filename=uicontrol(hp,'style','text','FontSize',11,'string',filename,'Units','normalized','FontWeight','bold','Position'
,[0.0285 0.8709 0.96 0.05],'BackgroundColor','White'); 
%Selects window to analyze 
h=helpdlg('Select the first and last points of the beats you want to analyze','User Input'); 
uiwait(h); 
  
[x_sel,y_sel]=ginput(2); 
x1=round(x_sel(1)); 
x2=round(x_sel(2)); 
  
x_new=x1:x2; 
  
%Assign only selected region to variables 
beat=beat(x_new); 
time=time(x_new)-min(time(x_new)); %starts from zero again 
Volumes_o=Volumes_o(x_new,:); 
ECG=ECG(x_new); 
LVP=LVP(x_new); 
%V_tot_unsc=sum(Volumes_o,2); 
V_tot_unsc = rho*(L^2)*G_sum; 
x=1:length(time); 
  
S1=0; S2=0; S3=0; S4=0; S5=0; S6=0; S7=0; 
subplot('Position',[0.05 0.7 0.35 0.25])  
    cla 
    plot(time,Volumes_o) 
    xlabel('Time (s)') 
    ylabel('LV Conductance') 
    axis([0 max(time) min(min(G)) max(max(G))]) 
    legend('Distal (Seg1)','Seg2','Seg3','Seg4','Seg5','Seg6','Proximal (Seg7)','Location','NorthEastOutside') 
subplot('Position',[0.05 0.38 0.35 0.25]) 
    cla 
    plot(time,LVP) 
    xlabel('Time (s)') 
    ylabel('LV Pressure (mmHg)') 
    axis([0 max(time) 0 max(max(LVP)+5)]) 
subplot('Position',[0.65 0.06 0.34 0.85]) 
    cla 
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    hold on 
    xlabel('Volume (mL)') 
    ylabel('Pressure (mmHg)') 
    
  
    hp2 = 
uipanel('BorderType','line','BorderWidth',2,'HighlightColor','black','BackgroundColor','White','Position',[0.42 0.655 
0.18 0.3154]); 
    hp1_title=uicontrol(hp2,'style','text','FontSize',10,'string','Select Segments To Be 
Used','Units','normalized','BackgroundColor','White','FontWeight','bold','Position',[0.05 0.92 0.93 0.08]); 
    hp2_title=uicontrol(hp2,'style','text','FontSize',10,'string','In Total Volume 
Calculation','Units','normalized','BackgroundColor','White','FontWeight','bold','Position',[0.05 0.84 0.93 0.08]); 
    cbh1 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 1 
(Distal)','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.0860 0.7 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh2 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
2','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.191 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh3 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
3','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.296 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh4 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
4','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.401 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh5 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
5','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.506 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh6 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 
6','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.611 0.4687 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    cbh7 = uicontrol(hp2,'Style','checkbox','Tag','save option','String','Segment 7 
(Proximal)','Units','Normalized','BackgroundColor','White','Position',[0.2397 0.716 0.7 
0.1145],'Value',0,'Callback','Plot_PV_loop'); 
    h_push_done=uicontrol(hp2,'style','pushbutton','String', 'Finished','Units','normalized','Position',[0.05 0.001 
0.8954 0.10],'Callback','Global_Analysis'); 
 
Global LV Performance Calculations: 
%Calculate # of combo's n!/(k!(n-k)! where n=segments k=#in combo 
nc = factorial(ns)/(factorial(2)*factorial(ns-2)); 
  
%DETERMINES LEGEND BASED ON SELECTED SEGMENTS 
for i=1:7 
    if s(i)>0 
        SegLeg(i,:)=sprintf('%s %1.0f','Segment',s(i)); 
    end 
end             
SegLeg=SegLeg(S,:);             
 
%Identify cycles by finding end diastole (before isovolumic contraction) 
    edvx=[]; 
    minitemp=[]; 
    pp=spline(x,LVP); %spline is a curve fitting tool 
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    ppd=mmspder(pp); %mmspder takes derivative; smooths curve 
    slope=ppval(ppd,x); %ppval gets slope 
    mark=0; 
    for i=1:length(slope)  %for loop goes through slope curve and looks for 0's on the curves --> peaks of fx! b/c 
derivative 
        if slope(i)<0.55 && slope(i)>-.50 %& LVpressure(i)<lim 
            mark=1; %just a counter 
            Minimumtemp=i; %remembers iteration 
        end 
        if mark==1 
            if slope(i)>= 2.2  %(1.2=>2.1)Adjust the sensitivity, up is less sensitive (tells you have a major peak b/c big 
jump in slope) 
                edvx(i)=Minimumtemp; 
                mark=0; %if slope not >=2.2, mark still is 1 so continues in this loop 
                %only when slope >=2.2 does mark=0 and edvx is chosen! 
            end 
        end 
    end 
    edvx=nonzeros(edvx)'; %gets rid of all zeros so now have only edvx 
  
%*END SYSTOLE DETERMINED FROM MAX Ees*******************      
for i=1:length(edvx)-1 
    [PPdPdt(i),PPdPdt_x(i)]=max(slope(edvx(i):edvx(i+1))); 
    [PNdPdt(i),PNdPdt_x(i)]=min(slope(edvx(i):edvx(i+1))); 
    dpdt_x(i)=edvx(i)+PPdPdt_x(i); 
    dpdt_x2(i)=edvx(i)+PNdPdt_x(i); 
end 
%CONITNUED BELOW***************%NEED TO DETERMINE ALPHA VIA SVcc/SVdop 
ESVtemp=[];EDVtemp=[];SVcc=[]; 
for i=1:(length(edvx)-1) 
    ESVtemp(i)        = V_tot_unsc(dpdt_x2(i));  %V_tot(ES(i)); 
    EDVtemp(i)        = V_tot_unsc(dpdt_x(i)); %V_tot(edvx(i)); 
    SVcc(i)      = EDVtemp(i)-ESVtemp(i);   
end 
%THIS IS USED INITIALLY TO SOLVE FOR ALPHA AND VC FOR BASELINE CONDITIONS  
% alpha = mean(SVcc)/(EDVecho-ESVecho); 
% Vc = mean(EDVtemp) - alpha*EDVecho; 
  
% %Now need to convert into real volume 
V_tot = (1/alpha)*(V_tot_unsc-Vc); %alpha and Vc derived from AAI (in Loading.m) 
 
%Find end systole 
Ees = LVP./(V_tot); 
    for i=1:length(dpdt_x) 
        [Emax(i),ind2(i)] = max(Ees(dpdt_x(i):dpdt_x2(i))); 
         ES(i)=dpdt_x(i)+ind2(i);    
    end 
  
%GLOBAL LV PERFORMANCE************************ 
%Averages total volume waveform to find global end systole (min vol) 
V=[];Mean_Seg=[];vtot=[];Mean_V_tot=[];Mean_LVP=[];GES=[]; 
cycle=min(diff(edvx)); 
for j=1:length(edvx)-1 
    vtot(:,j)=V_tot(edvx(j):edvx(j)+cycle); 
    LVp(:,j)=LVP(edvx(j):edvx(j)+cycle); 
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end 
Mean_V_tot=mean(vtot,2); 
Mean_LVP=mean(LVp,2); 
GES=find(Mean_V_tot==min(Mean_V_tot)); %Global End Systole 
  
%Averages segmental volume waveforms 
for i=1:ns; 
    for j=1:(length(edvx)-1) 
    V(:,j)=Volumes(edvx(j):edvx(j)+cycle,i); 
    end 
    Mean_Seg(:,i)=mean(V,2); 
end 
  
freq=250; 
pp=spline(time,V_tot); 
pp2=spline(time(1:length(LVP)),LVP); 
ppd=mmspder(pp); 
ppd2=mmspder(pp2); 
Pressureslope=ppval(ppd2,time); 
%% 
HR=[]; Vmin=[]; Vmax=[];ESV=[];EDV=[];SV_minmax=[];SV=[];EF=[]; 
ESP=[];EDP=[];dPdt_max=[];dPdt_min=[];EA=[];SW=[];CO=[]; 
for i=1:(length(edvx)-1) 
    HR(i)      = 60/((edvx(i+1)-edvx(i))/freq);                 % Cycle Time of Beat in seconds 
    Vmin(i)    = min(V_tot(edvx(i):edvx(i+1)));                 % Minimum Area [cm^2] 
    [Vmax(i),VmaxX(i)]    = max(V_tot(edvx(i):edvx(i+1)));                 % Maximum Area [cm^2] 
    ESV(i)        = V_tot(dpdt_x2(i));  %V_tot(ES(i)); 
    EDV(i)        = V_tot(dpdt_x(i)); %V_tot(edvx(i)); 
    SV_minmax(i)  = Vmax(i)-Vmin(i); 
    SV(i)      = EDV(i)-ESV(i);                              % Stroke Area [cm^2] 
    EF(i)      = (SV(i)/EDV(i))*100;                          % Ejection Fraction  
    ESP(i)     = LVP(ES(i));                               % End Systolic Pressure [mmHg] 
    EDP(i)     = LVP(edvx(i));                            % End Diastolic Pressure [mmHg] 
    dPdt_max(i)  = max(Pressureslope(edvx(i):edvx(i+1)));        % Peak Positive dPdt [mmHg/s] 
    dPdt_min(i)  = min(Pressureslope(edvx(i):edvx(i+1)));        % Peak Negative dPdt [mmHg/s] 
    EA(i)      = ESP(i)/SV(i);                                 % Arterial Elastance [mmHg/cc] 
    SW(i)      = -1*trapz(V_tot(edvx(i):edvx(i+1)),LVP(edvx(i):edvx(i+1))); %Stroke Work mmHg*cm^3 
    %SW_mJ(i)=SF(i)*0.133;                                     % SW in mJ 
    CO(i)      = HR(i)*SV(i)/1000; 
    %CO(i)      = HR(i)*SV_minmax(i)/1000; %Cardiac output 
end 
%% 
HRm=mean(HR);Vminm=mean(Vmin);Vmaxm=mean(Vmax);ESVm=mean(ESV);EDVm=mean(EDV);SV_minm
axm=mean(SV_minmax);SVm=mean(SV);EFm=mean(EF); 
ESPm=mean(ESP);EDPm=mean(EDP);dPdt_maxm=mean(dPdt_max);dPdt_minm=mean(dPdt_min);EAm=mean(E
A);SWm=mean(SW);COm=mean(CO); 
  
HRsd=std(HR);Vminsd=std(Vmin);Vmaxsd=std(Vmax);ESVsd=std(ESV);EDVsd=std(EDV);SV_minmaxsd=std(S
V_minmax);SVsd=std(SV);EFsd=std(EF); 
ESPsd=std(ESP);EDPsd=std(EDP);dPdt_maxsd=std(dPdt_max);dPdt_minsd=std(dPdt_min);EAsd=std(EA);SWsd=
std(SW);COsd=std(CO); 
  
subplot('Position',[0.05 0.7 0.35 0.25]) 
        cla 
        plot(time,Volumes) 
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        hold on 
        axis([min(time) max(time) min(min(G)) max(max(G))]) 
        xlabel('Time (s)') 
        ylabel('LV Conductance') 
        legend(SegLeg,'Location','EastOutside') 
subplot('Position',[0.05 0.38 0.35 0.25]) 
        cla 
        plot(time,LVP) 
        hold on 
        plot(time(edvx),LVP(edvx),'g*') 
        plot(time(ES),LVP(ES),'r*') 
        axis([min(time) max(time) min(min(LVP))-5 max(max(LVP))+5]) 
        xlabel('Time (s)') 
        ylabel('LV Pressure (mmHg)') 
subplot('Position',[0.05 0.06 0.35 0.25])  
        cla 
        plot(time,V_tot) 
        hold on 
        plot(time(edvx),V_tot(edvx),'g*') 
        plot(time(ES),V_tot(ES),'r*') 
        axis([min(time) max(time) min(min(V_tot))-3 max(max(V_tot))+3]) 
        xlabel('Time (s)') 
        ylabel('Total LV Volume (mL)') 
subplot('Position',[0.65 0.06 0.34 0.85])  
    cla 
    plot(V_tot,LVP) 
    hold on 
    plot(V_tot(edvx),LVP(edvx),'g*') 
    plot(V_tot(ES),LVP(ES),'r*') 
    xlabel('Volume (mL)') 
    ylabel('LV Pressure (mmHg)') 
     
%hp defined in PV_loops 
    hc_hr= uicontrol(hp,'style','text','FontSize',10,'string',['HR = ' num2str(HRm,'%6.0f') ' 
bpm'],'Units','normalized','Position',[0.05 0.64 0.9 0.06],'BackgroundColor','White'); 
    hc_edv= uicontrol(hp,'style','text','FontSize',10,'string',['EDV = ' num2str(EDVm,'%6.0f') ' 
mL'],'Units','normalized','Position',[0.05 0.58 0.9 0.06],'BackgroundColor','White'); 
    hc_esv= uicontrol(hp,'style','text','FontSize',10,'string',['ESV = ' num2str(ESVm,'%6.0f') ' 
mL'],'Units','normalized','Position',[0.05 0.52 0.9 0.06],'BackgroundColor','White'); 
    hc_sv= uicontrol(hp,'style','text','FontSize',10,'string',['SV = ' num2str(SVm,'%6.0f') ' 
mL'],'Units','normalized','Position',[0.05 0.46 0.9 0.06],'BackgroundColor','White');         
    hc_co= uicontrol(hp,'style','text','FontSize',10,'string',['CO = ' num2str(COm,'%6.2f') ' mL*min^-
1'],'Units','normalized','Position',[0.05 0.4 0.9 0.06],'BackgroundColor','White'); 
    hc_ef= uicontrol(hp,'style','text','FontSize',10,'string',['EF = ' num2str(EFm,'%6.0f') ' 
%'],'Units','normalized','Position',[0.05 0.34 0.9 0.06],'BackgroundColor','White'); 
    hc_esp= uicontrol(hp,'style','text','FontSize',10,'string',['ESP = ' num2str(ESPm,'%6.0f') ' 
mmHg'],'Units','normalized','Position',[0.05 0.28 0.9 0.06],'BackgroundColor','White'); 
    hc_edp= uicontrol(hp,'style','text','FontSize',10,'string',['EDP = ' num2str(EDPm,'%6.0f') ' 
mmHg'],'Units','normalized','Position',[0.05 0.22 0.9 0.06],'BackgroundColor','White'); 
    hc_pdpdt= uicontrol(hp,'style','text','FontSize',10,'string',['+dp/dt = ' num2str(dPdt_maxm,'%6.0f') ' mmHg*s^-
1'],'Units','normalized','Position',[0.05 0.16 0.9 0.06],'BackgroundColor','White'); 
    hc_ndpdt= uicontrol(hp,'style','text','FontSize',10,'string',['-dp/dt = ' num2str(dPdt_minm,'%6.0f') ' mmHg*s^-
1'],'Units','normalized','Position',[0.05 0.10 0.9 0.06],'BackgroundColor','White'); 
    hc_sw= uicontrol(hp,'style','text','FontSize',10,'string',['SW = ' num2str(SWm,'%6.0f') ' 
mL*mmHg'],'Units','normalized','Position',[0.05 0.04 0.9 0.06],'BackgroundColor','White'); 
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Hf_figure=gcf;     
PlotCCA=0; 
Finished=1; 
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APPENDIX D 
ERROR PROPAGATION 
Calculated variables are affected by the errors associated with the experimental measurements 
used to quantify them.  For example, myocardial oxygen consumption (MVO2) is calculated 
using several measured variables: coronary flow (Qcor), arteriovenous oxygen content difference 
(AVO2), heart rate (HR), and the mass of the left ventricle (LV).  The specific equation is as 
follows: 
 cor 22
Q AVOMVO
HR LV
⋅= ⋅  (D-1) 
Uncertainties due to measurement limitations of these variables propagate through the 
calculation of MVO2.  Specifically, the total error in MVO2 due to measurement inaccuracies in 
Qcor, AVO2, HR, and LV can be determined by the following equation: 
2 2 2
2 cor 2
cor 2
MVO MVO MVO MVOMVO Q AVO HR LV
Q AVO HR LV
∂ ∂ ∂ ∂Δ = ⋅ Δ + ⋅ Δ + ⋅ Δ + ⋅ Δ∂ ∂ ∂ ∂
2  (D-2) 
where the partial derivatives with respect to each of the measured variable are given by: 
cor cor 2 cor 22 2 2 2 2
2 2
cor 2
Q Q AVO Q AVOMVO AVO MVO MVO MVO; ; ;
Q HR LV AVO HR LV HR HR LV LV HR LV
⋅ ⋅∂ ∂ ∂ ∂= = = − = −∂ ⋅ ∂ ⋅ ∂ ⋅ ∂ ⋅  (D-3) 
Substituting Eq. (D-3) into Eq. (D-2), one gets: 
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cor cor 2 cor 22
2 cor 2 2 2
Q Q AVO Q AVOAVOMVO Q AVO HR LV
HR LV HR LV HR LV HR LV
⋅ ⋅Δ = ⋅Δ + ⋅Δ + ⋅Δ + ⋅Δ⋅ ⋅ ⋅ ⋅  (D-4) 
Note that the goal of error propagation is to determine the percentage error of the calculated 
variable, which in this case is the error associated with MVO2 divided by some nominal value of 
MVO2 (i.e., ΔMVO2/MVO2).  Therefore, equation D-4 can be simplified to: 
cor2 2
2 cor 2
QMVO AVO HR LV
MVO Q AVO HR LV
ΔΔ Δ Δ Δ= + + +  (D-5) 
Interestingly, in this case, Equation D-1 is simplified such that the total error in the calculation of 
MVO2 can be determined by the simple addition of the errors associated with each measured 
variable.  The percentage errors for each of the measured quantities was found by technical 
specification literature supplied by the company for each device (Qcor=5%, AVO2=4.4%, 
LV=0.02%, HR=0.001%).  Therefore, a 9.4% error is propagated through the calculation of 
MVO2 due to inaccuracies of measured variables used to calculate this quantity.  Of note, this is 
a relatively large percent error, however, it should be kept in mind that this is an estimate based 
on a “worst case” scenario. 
 The determination of error propagation for cross-correlation analysis is much more 
difficult.  For example, it is not possible to write explicit equations for cross correlation-based 
indices of LV regional synchrony in terms of measured quantities.  However, one can 
theoretically speculate that the majority of error associated with the quantification of regional 
function would be due to the methodology used to derive the strain waveforms.  In the current 
research, speckle tracking was shown to be superior to other methods in quantifying myocardial 
contraction.  However, echocardiographic images must be of acceptable quality for the speckle 
tracking algorithm to yield reliable and reproducible results.  The temporal resolution of strain 
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data can affect the results of the cross correlation analysis and therefore, the sampling rate of the 
imaging system should be maximized. 
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